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Histone H4 is one of four core histone proteins that make up the nucleosome, the 
smallest building block of chromosomes. Alanine-scanning mutagenesis of histone 
H4 had determined that the three mutant proteins H4Y51A, H4E53A and H4Y98A 
conferred sensitivity to 3-aminotriazole (AT), antimycin A and high temperature 
when expressed in place of endogenous histone H4. Multi-copy phenotypic 
suppressor screens were performed and the histone acetyltransferases Gcn5, Hpa1 and 
Hpa2 were isolated as multi-copy suppressors of the AT sensitivity of the H4Y98A 
mutant strain. Chromatin immunoprecipitation studies carried out at the HIS3 gene 
showed that the histidine starvation-induced histone eviction was reduced in the 
H4Y98A mutant strain and restored back to the WT levels upon the over-expression 
of Gcn5. By controlling all aspects of DNA biology, histones play an important role 
in human diseases, and the homologous human proteins of the isolated suppressors 










Epigenetics, by definition, is the study of all mitotically and meiotically heritable 
changes in phenotype that do not result from changes in the genomic 
deoxyribonucleic acid (DNA) nucleotide sequence (Petronis, 2010; Zhu and Reinberg, 
2011). Several important cellular processes were found to be fundamentally regulated 
by epigenetic modifications, such as gene expression, DNA-protein interactions, 
suppression of transposable element mobility, cellular differentiation and 
embryogenesis. Thus, several major pathologies, including cancer, syndromes 
associated with chromosomal alterations and neurological diseases, often arise due to 
the occurrence of aberrant epigenetic modifications. Within cells, there are at least 
three mechanisms of epigenetic modifications that can interact and stabilise one 
another to lead to the expression or silencing of genes — DNA methylation, 
ribonucleic acid (RNA)-associated silencing and histone modifications (Egger et al., 
2004). 
 
1.1.1 DNA methylation 
DNA methylation is one of the most-studied epigenetic modifications because it plays 
an important role in several key processes, such as genomic imprinting,  
X chromosome inactivation and suppression of repetitive element transcription and 
transposition (Jin et al., 2011), where it ensures the proper regulation of gene 
expression and stable gene silencing (Khavari et al., 2010; Kulis and Esteller, 2010). 
DNA methylation involves the covalent addition of a methyl group (-CH3) to DNA, 
specifically at the carbon-5 position of the cytosine ring. DNA methyltransferases 
(DNMTs) establish and maintain the methylation pattern, which occurs generally 
within CpG dinucleotides where a cytosine nucleotide is linked by a phosphate 
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directly to a guanine nucleotide. DNA methylation is often associated with gene 
silencing as it blocks the binding of transcription factors and also promotes the 
recruitment of methyl-CpG-binding domain proteins, which then help to recruit 
histone-modifying complexes and chromatin-remodelling complexes (Khavari et al., 
2010; Kulis and Esteller, 2010; Jin et al., 2011). 
 
1.1.2 RNA-associated silencing 
In living cells, RNA can have a regulatory effect on DNA and the expression profile 
of the genome (Morris, 2005). RNA may affect gene expression by causing the 
formation of heterochromatin or by triggering DNA methylation and histone 
modification (Egger et al., 2004). RNA-associated silencing is achieved through a 
RNA interference (RNAi)-based mechanism, which is mediated by small interfering 
RNAs (siRNAs) that can specifically direct epigenetic modifications to targeted loci 
to silence target genes (Egger et al., 2004; Morris, 2005). 
 
1.1.3 Histone modifications 
Histones are proteins, which together with non-histone chromosomal proteins, 
associate with DNA to form chromatin. Four core histones, H2A, H2B, H3 and H4, 
make up an octameric complex, around which 147 base pairs (bp) of double stranded 
super helical DNA winds to form the nucleosome (Millar and Grunstein, 2006). 
Initially, histones were regarded only as static, non-participating structural elements 
of the nucleosome for DNA packaging (Felsenfeld and McGhee, 1986). However, 
experimental evidence has shown histones to be dynamic and integral in regulating 
chromatin condensation and DNA accessibility, where histones can undergo multiple 
types of post-translational modifications. This is important for the regulation of all 
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aspects of DNA biology, including transcriptional activation or repression, 
homologous recombination, DNA repair or replication, cell cycle regulation and 
chromatin compaction in apoptosis. 
 
1.2 Approaches utilised towards the study of epigenetics 
1.2.1 Model organism S. cerevisiae 
Saccharomyces cerevisiae (S. cerevisiae) or budding yeast has been used as the model 
eukaryotic organism in this study because of several characteristics — size, doubling 
time, accessibility, manipulation, genetics and conservation of mechanisms (Botstein 
et al., 1997; Botstein and Fink, 2011). S. cerevisiae is a small, unicellular eukaryote 
that has a relatively short doubling time and can be easily cultured. Transformation of 
S. cerevisiae is straightforward, which allows for the addition of new or foreign genes 
through vector introduction or homologous recombination. Similarly, haploid  
S. cerevisiae strains make it simple to generate gene knock out strains by the deletion 
of genes through homologous recombination, where gene deletion is a common 
genetic method for studying gene function. More importantly, S. cerevisiae genome 
sequence and data on the complete set of deletion strains is freely available on 
Saccharomyces Genome Database (http://www.yeastgenome.org/). 
 
In relation to this study, S. cerevisiae is the model eukaryotic system for analysis of 
histone genetics and functions due to its simple gene organisation and ease of 
manipulation (Smith and Santisteban, 1998). The mechanisms of transcriptional 
regulation are relatively similar in most eukaryotic cells because many proteins 
involved in histone modification and chromatin assembly are evolutionarily 
conserved. Hence, the findings obtained from S. cerevisiae can be directly applied to 
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research in humans. In fact, histone H4 is the most highly conserved in evolution, 
with a difference of only eight amino acids out of 102 between S. cerevisiae and 
humans (Wolffe, 1995). The amino acid sequence identities between S. cerevisiae and 
humans are 92 % for histone H4, 90 % for histone H3, 71 % for histone H2A and 63 % 
for histone H2B (Huang et al., 2009). S. cerevisiae also allows for easy exchange of 
wild type histones with mutant histones, where this forms the basis of the multi-copy 
suppressor screen. 
 
1.2.2 Alanine-scanning mutagenesis 
In this study, the histone H4 mutants Y51A, E53A and Y98A were generated by site-
directed mutagenesis, where the original amino acid residue was substituted with 
alanine. This technique is called alanine-scanning mutagenesis and is commonly 
employed during the characterisation of individual amino acid residues for protein 
function and the identification of connections between various components of the 
cellular pathway (Cunningham and Wells, 1989; Matsubara et al., 2007). Alanine 
mutations do not impose electrostatic or steric effects on a protein, as alanine does not 
undergo covalent modifications, will not alter the main chain conformation and 
eliminates side chains beyond the β carbon (Lefèvre et al., 1997). In addition, alanine 
is an abundant amino acid, where it is often found on either buried or exposed 
surfaces and in all varieties of secondary structures. Thus, alanine is often the 
replacement amino acid of choice. 
 
1.2.3 Phenotype testing 
Genetic mutations may lead to observable phenotypes, where phenotype testing is a 
basic tool of genetics (Hampsey, 1997). Primary phenotype tests like 
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complementation involves replacing the wild type allele with a mutant allele to 
determine whether the mutant allele is able to support cell growth. Conditional 
phenotypes can also be tested, such as heat sensitivity, cold sensitivity and sensitivity 
to certain chemicals or analogues like 3-amino-1,2,4-triazole (3-AT). Other possible 
phenotypes that can be tested include respiratory deficiency, nucleic acid metabolism 
defects using 6-Azauracil, nitrogen utilisation defects, carbon catabolite repression, 
cell cycle defects, mating defects, cell morphology and cell wall defects like 
flocculence. In this study, phenotype testing was focused on 3-AT sensitivity (AT), 
antimycin A sensitivity (AA) and temperature sensitivity (TS) phenotypes, which 
could arise due to transcriptional defects that may be a result of changes caused by 
histone mutations, reflecting defects in the activation and repression of gene 
expression. 
 
1.2.3.1 Sensitivity to 3-AT 
The HIS3 gene codes for imidazoleglycerol phosphate dehydratase, which is an 
enzyme that catalyses the sixth step in the histidine synthesis pathway (Sinha et al., 
2004). The chemical 3-AT is an analogue that competitively inhibits 
imidazoleglycerol phosphate dehydratase. When S. cerevisiae strains are plated onto 
histidine-depleted media containing 3-AT, the histidine starvation elicits a general 
control response (McCusker and Haber, 1988). This results in transcriptional 
activation of the HIS3 gene and other amino acid biosynthetic genes, where this 
response is mediated by the positive regulatory transcription factor Gcn4 (Joo et al., 
2011). Mutant strains that are unable to lead to the activation of these genes have 
impaired growth on histidine-depleted media containing 3-AT, as compared to wild 
type strains (refer to section 2.3.1.1). 
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1.2.3.2 Sensitivity to antimycin A 
Gal4 and Gal80 are two regulatory proteins that affect the expression of the GAL 
genes, which enable cells to utilise galactose as a carbon source. In the presence of 
galactose, Gal4 binds to sites in the upstream activation sequence and activates 
transcription. In the presence of glucose, Gal4 is inactivated by the binding of Gal80. 
Mutant strains that have defects in the activation of the GAL genes have impaired 
growth on galactose media, as compared to wild type strains. Although S. cerevisiae 
does not exhibit Kluyver effect for galactose and can ferment galactose under 
anaerobic conditions, low ATP yield and a dramatic decrease of energy charge make 
S cerevisiae less able to induce a functional Leloir pathway for galactose utilisation 
under anaerobic conditions (van den Brink et al., 2009). Thus, growth defects of  
S cerevisiae are often more severe under anaerobic conditions because the cells need 
to utilise more galactose to sustain growth under anaerobic conditions as compared to 
under aerobic conditions. Anaerobic conditions are mimicked by the addition of 
antimycin A, which is an antibiotic that inhibits mitochondrial respiration by blocking 
the electron transport chain (Goffrini et al., 2002). 
 
1.2.3.3 Sensitivity to temperature 
Mutant strains that have growth defects at a relatively high temperature like 38°C may 
have mutations in genes that are essential for cell viability or cellular events, such as 
mRNA stability, transcription start site selection, translation initiation or cell cycle 
control (Hampsey et al., 1991). 
 
1.2.4 Suppression 
Suppression is another genetic tool commonly used to identify the functions of 
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proteins and functional interactions between proteins. There are two main types of 
suppression — suppression via over-expression of genes involved in affected pathway 
and suppression via extragenic mutation. 
 
1.2.4.1 Suppression via over-expression of genes involved in affected pathway 
The histone H4 mutants Y51A, E53A and Y98A were found to be conferred with 
phenotypic deficiencies. These phenotypic deficiencies most likely arose due to the 
disruption of normal genetic interactions, which include direct changes to protein 
interactions, loss of protein interactions and direct or indirect changes to gene 
expression levels (Smith and Santisteban, 1998). In order to suppress the phenotypic 
deficiencies of the histone H4 mutants such that they are restored to that of wild type, 
over-expression of genes involved in affected pathway were achieved through a 
multi-copy suppressor screen. Upon the isolation of the dosage suppressor, the 
specific gene involved in the defective genetic interaction could be identified. 
 
In the event that the specific gene involved coded for an interacting protein, functional 
protein interactions and their relevance could be discovered. This is important as 
protein interactions form the basis of major cellular process, including gene 
transcription and protein translation. Two mechanisms of suppression may take place, 
where one involves the restoration of the mutation to wild type through the formation 
of novel contacts between interacting proteins, while the second involves the 
restoration of the original contact points between interacting proteins (Sujatha et al., 
2001; Prelich, 2012). 
 
If the specific gene involved coded for an enzyme responsible for the direct or indirect 
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regulation of gene expression levels, the pathway and its mechanisms could 
potentially be elucidated. In a multi-copy suppressor screen, suppression of the 
mutant phenotype is achieved either by direct dosage compensation of the affected 
enzymatic activity or by indirect changes in enzymatic activity of upstream factors. 
For example, the methylation of H4R3 by histone methyltransferase PRMT1 is 
essential for establishing or maintaining a wide range of subsequent chromatin 
modifications for transcriptional activation. Through the indirect activity of PRMT1, 
transcriptional activation was restored through an alternative chromatin modification 
(Huang et al., 2005). 
 
1.2.4.2 Suppression via extragenic mutation 
Extragenic mutation refers to a second mutation at a site distinct from the original 
mutation, where the second mutation is able to partially or completely suppress the 
phenotypic deficiencies of the original mutation. The identification of an extragenic 
suppressor may provide indirect information on the gene containing the original 
mutation, as the extragenic suppressor may code for an interacting protein (Phizicky 
and Fields, 1995). For example, the missense allele of ILV5 is able to rescue yme2-4 
growth phenotypes through synthetic interactions with yme2-4 and suppression of 
mitochondrial DNA transfer to the nucleus (Park et al., 2006). 
 
1.2.5 Chromatin immunoprecipitation (ChIP) 
ChIP is a widely used technique to examine histone modifications, chromatin 
remodelling and other chromatin related processes that play crucial roles in gene 
regulation (Haring et al., 2007). Briefly, ChIP relies on antibodies that target specific 
histone modifications at loci-of-interest on the chromosome, i.e. selective enrichment 
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of a chromatin fraction containing the specific antigen. ChIP is highly versatile, where 
it may be used to compare the enrichment of a protein or protein modification at 
different loci, to map a protein or protein modification across a locus-of-interest or 
even to quantify a protein or protein modification at an inducible gene over a time 
course. Chromatin is extracted, fragmented and incubated with the antibody of choice. 
Chromatin fragments that bind to the antibody of choice are captured using protein 
A/G beads. DNA is isolated from the precipitate and analysed to determine the 
abundance of the loci-of-interest in the precipitated material. There are two general 
procedures to carry out ChIP experiments (Figure 1.1) — X-ChIP, where chromatin is 
crosslinked then fragmented by sonication, as well as N-ChIP, where native 
chromatin is not crosslinked and is fragmented by micrococcal nuclease digestion 
(O'Neill and Turner, 2003). The analysis of isolated DNA can be carried out using 
several methods, such as conventional PCR, quantitative real-time PCR, microarray 
analysis and slot blotting (Haring et al., 2007). In this study, X-ChIP coupled with 
quantitative real-time PCR was used to analyse isolated DNA. 
 
Figure 1.1 Schematic diagram of the X-ChIP and N-ChIP protocols. Figure adapted from “A 
Beginner’s Guide to ChIP” (Abcam). Reproduced with permission from Abcam. 
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1.3 Aims of this study 
This study is focused on understanding the effects of post-translational modifications 
of histones in epigenetics. In addition, the scope of this study was restricted to 
transcriptional regulation, where the other aspects of DNA biology were excluded. 
 
In this study, three histone H4 mutants Y51A, E53A and Y98A were expressed in the 
simple model organism S. cerevisiae to study how histones affect the transcriptional 
regulation of gene expression via a genetic approach. The first aim of this study was 
to screen these three conditional histone mutants for multi-copy phenotypic 
suppressors, where the restrictive conditions tested were 3-AT sensitivity (AT), 
antimycin A sensitivity (AA) and temperature sensitivity (TS) phenotypes. The multi-
copy phenotypic suppressors were isolated from a multi-copy library of genomic 
DNA fragments by their ability to confer growth under those restrictive conditions. 
 
The second aim of this study was to elucidate the mechanism of suppression by the 
HATs Gcn5, Hpa1 and Hpa2, which were isolated as multi-copy phenotypic 
suppressors of the AT phenotype of the H4Y98A mutant strain. Strains expressing 
tagged forms of these HATs were used for quantitative real-time PCR, Western blot 
and chromatin immunoprecipitation studies. The effects of the H4Y98A mutation on 
known histone modifications in the histone H4 N-terminal tail were studied with the 
help of anti-modification specific antibodies, where these antibodies were further used 








2.1 Nucleosomal structure 
In the nucleus of eukaryotic cells, DNA is associated with histones and non-histone 
chromosomal proteins to form chromatin. The fundamental structural subunit of 
chromatin is the nucleosome, which is highly conserved evolutionarily and repeats at 
intervals of approximately 200 bp ± 40 bp throughout all eukaryotic genomes (Luger 
et al., 1997). The structure of chromatin imposes significant obstacles on all aspects of 
transcription, where the occupancy of nucleosomes was found to be lower at active 
promoters, as compared to inactive promoters (Bernstein et al., 2004; Pokholok et al., 
2005; Belch et al., 2010). In fact, it has been found that nucleosomes are removed 
from gene promoters upon transcriptional activation, which is likely to help increase 
the accessibility of the transcriptional machinery to the exposed naked DNA (Reinke 
and Hörz, 2003; Boeger et al., 2004; Belch et al., 2010). 
 
The nucleosome is a nucleoprotein complex consisting of 147 bp double stranded 
super helical DNA wound 1.65 turns around an octameric complex of core histone 
proteins, H2A, H2B, H3 and H4 (Luger et al., 1997; Millar and Grunstein, 2006; Peng 
et al., 2012). In a nucleosome, the H3-H4 heterodimers interact via a four helix bundle 
arrangement at the histone H3 C-termini to form a kernel of (H3-H4)2 heterotetramer. 
Each H2A-H2B heterodimer interacts with the (H3-H4)2 heterotetramer via a similar 
four helix bundle arrangement to form the compact octamer core (Figure 2.1; Luger et 
al., 1997; Wood et al., 2005; Peng et al., 2012). In some nucleosomes, the canonical 
histone H2A may be substituted by the histone variant H2A.Z in a wide but non-
random genomic distribution (Kawano et al., 2011). Next, a DNA fibre is lined up 
with consecutive nucleosomes to form a beads-on-a-string structure with a diameter 
of 11 nm (Peterson and Laniel, 2004). The structure is further compacted into a 30 nm 
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Figure 2.1 X-ray crystal structure of the nucleosome core particle. (A) The view of the nucleosome 
core particle down the DNA super helix axis. (B) The view of the nucleosome core particle 
perpendicular to the DNA super helix axis. (C) The view of half of the nucleosome core particle, 
showing the histone proteins primarily associated with 73 bp of double stranded super helical DNA. 
The histone tails resemble flexible strings that are unstructured and exposed on the nucleosomal 






In between successive nucleosomes, linker DNA of 10–60 bp in length is associated 
with histone H1 to allow for the formation of higher order structures (Kamieniarz et 
al., 2012). Unlike core histones, histone H1 shows appreciable variation between 
eukaryotic genomes and is not essential for viability (Mariño-Ramírez et al., 2005). In 
S. cerevisiae, the homologous Hho1 was found to have similar roles as histone H1 
(Ushinsky et al., 1997; Baxevanis and Landsman, 1998; Yu et al., 2009) but Hho1 is 
restricted to specific chromosomal locations like ribosomal DNA sequences (Freidkin 
and Katcoff, 2001). 
 
2.1.1 Core histones 
Histones were once considered negative transcription factors that block the 
transcriptional machinery from associating with gene promoters, hindering the 
procession of transcriptional elongation. However, recent studies have now revealed 
that histones are important for both transcriptional repression and activation. Histones 
are rich in lysine and arginine, which are amino acid residues with basic side chains. 
This can effectively neutralise the negatively charged DNA backbone, where the 
histone-DNA interactions hold the DNA in place on the nucleosome (Füllgrabe et al., 
2011). 
 
Core histones H2A, H2B, H3 and H4 are highly conserved evolutionarily and are 
characterised by the presence of a tertiary structural motif known as the histone fold, 
where three α-helices are connected by two loops (“helix-loop-helix-loop-helix” 
motif). The histone fold is found in the globular core domain of histones and is critical 
for the maintenance of nucleosome structure through histone-histone and histone-
DNA interactions. Besides the globular core domain, core histones also have flexible, 
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unstructured histone tails of about 15–30 amino acid residues at the N-termini, with 
the exception of histone H2A, which has histone tails at both the N-terminal and  
C-terminal (Luger et al., 1997; Biswas et al., 2011). The histone tails are exposed on 
the nucleosomal surface with sites available for post-translational modifications, 
which are crucial for the nucleosome’s role in the regulation of gene expression and 
repression, silencing, DNA replication, DNA damage repair and apoptosis (Kornberg 
and Lorch, 1999; Peterson and Laniel, 2004; Peng et al., 2012). 
 
2.1.2 Core histones in S. cerevisiae 
In S. cerevisiae, each of the canonical core histones is encoded by two genes — 
histone H2A by HTA1 and HTA2; histone H2B by HTB1 and HTB2; histone H3 by 
HHT1 and HHT2; and histone H4 by HHF1 and HHF2. These eight genes are 
organised into four pairs of divergently transcribed loci — HTA1-HTB1 and HTA2-
HTB2, each encoding histones H2A and H2B; and HHT1-HHF1 and HHT2-HHF2, 
each encoding histones H3 and H4 (Smith and Santisteban, 1998; Rando and Winston, 
2012). Due to this redundancy, the deletion of any one histone locus does not lead to 
lethality. It is important to note that while S. cerevisiae does possess some histone 
variants, it has only one form of histone H3 that is similar to the vertebrate histone 
H3.3 variant (Nowak and Corces, 2004; Rando and Winston, 2012). 
 
2.2 Histone code hypothesis 
Histones were first regarded only as static, non-participating structural elements of the 
nucleosome for DNA packaging (Felsenfeld and McGhee, 1986). More recently, 
experimental evidence has shown histones to be dynamic and integral in regulating 
gene expression. As the genetic information contained within the genome is limited, 
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epigenetics imposed on histones may possibly exist to distinguish and direct nuclear 
processes, including transcriptional activation or repression. This adds several layers 
of complexity, effectively extending the wealth of information hidden within the 
genetic code and is known as the histone code hypothesis (Strahl and Allis, 2000; 
Jenuwein and Allis, 2001; Barth and Imhof, 2010). The histone code hypothesis 
predicts that residue specific post-translational modifications of histone tails would 
induce interaction affinities for chromatin associated proteins, where the 
modifications on the same or different histone tails may be interdependent and 
generate various combinations on any one nucleosome and it is likely that the local 
concentration and combination of differentially modified nucleosomes may have long 
range effects on the distinct qualities of higher order chromatin (Jenuwein and Allis, 
2001; Barth and Imhof, 2010). 
 
Two possibilities for the need of a histone code can be discussed, where firstly, 
different histone variants can provide various sequence modules that undergo 
different post-translational modifications for recognition by specific effectors to bring 
about distinct biological functions and secondly, different histone variants can alter 
nucleosomal structure to bring about changes in chromatin and underlying DNA 
(Bernstein and Hake, 2006; Kawano et al., 2011). Such alterations to generate 
different histone variants include at least three interrelated mechanisms — ATP-
dependent chromatin remodelling involving ATP-driven complexes such as SWI/SNF, 
incorporation of specialised histone variants or non-histone chromosomal proteins 





2.2.1 ATP-dependent chromatin remodelling 
Chromatin remodelling refers to the energy dependent modulation of interactions 
between histones and DNA in chromatin by dedicated nuclear enzymes that are often 
part of larger, multi-subunit complexes (Becker and Hörz, 2002; Hargreaves and 
Crabtree, 2011). Chromatin-remodelling ATPases have several catalytic functions, 
including catalysing mobilisation or repositioning of nucleosomes, transferring 
nucleosomes to a separate DNA, facilitating nuclease access to nucleosomal DNA and 
generating super helical torsion in DNA (Lusser and Kadonaga, 2003; Hargreaves and 
Crabtree, 2011). There are usually several different chromatin-remodelling complexes 
in each eukaryotic cell, where each complex has specific chromatin substrates and 
affects the transcription of a specific subset of genes by altering chromatin structure. 
 
Based on the identity of the ATPase subunit, the chromatin-remodelling complexes 
can be divided into at least four classes (Narlikar et al., 2002; Martens and Winston, 
2003; Hargreaves and Crabtree, 2011). The first class is the SWI2/SNF2 family, 
whose ATPase subunit contains an ATPase domain and a bromodomain. The 
members in this family include SWI/SNF and RSC complexes in S. cerevisiae, 
hSWI/SNF complex in humans and dSWI/SNF complex in Drosophila melanogaster 
(D. melanogaster). The second class is the ISWI family, whose ATPase subunit 
contains an ATPase domain and a SANT (SWI3/ADA2/N-CoR/TFIIIB) domain. The 
members in this family include ISW1 and ISW2 complexes in S. cerevisiae, RSF, 
hACF/WCRF and hCHRAC complexes in humans and NURF, CHRAC and ACF 
complexes in D. melanogaster. The third class is the Mi-2 family, whose ATPase 
subunit contains an ATPase domain, a plant homeodomain (PHD) finger and a double 
chromodomain. The representative member in this family is the NuRD complex in 
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humans (Narlikar et al., 2002; Rando and Winston, 2012). The fourth class is the 
INO80 family, whose ATPase subunit contains a split ATPase domain. The members 
in this family include INO80 complex, SWR1 complex and NuA4 complex in  
S. cerevisiae, Pho-dINO80 and Tip60 in D. melanogaster, as well as INO80 complex, 
SRCAP complex and TRAAP/Tip60 in humans (Hargreaves and Crabtree, 2011). 
 
2.2.2 Nucleosomal incorporation 
The incorporation of specialised histone variants or non-histone chromosomal 
proteins into nucleosomes allows for structural and functional modifications of 
chromatin (Kawano et al., 2011). Histone variants may differ from canonical histones 
by subtle differences or by significant alterations that could drastically change the 
nature of the histone and even the chromatin (Figure 2.2). These differences in 
combination with specific chaperone proteins mediate various localisation patterns in 
a cell (Bernstein and Hake, 2006). Unlike the other canonical histones, there is no 





Figure 2.2 Schematic diagram of mammalian histone variants. (A) Histone H2A variants.  
(B) Histone H2B variants. (C) Histone H3 variants. Histone variants in different colour shades 
represent highly divergent protein sequences between the canonical histones and its histone variants. 
Figure adapted from Bernstein and Hake, 2006. Reproduced with permission from NRC Research 
Press. 
 
According to the extent of amino acid sequence changes from the main isoforms, 
histone variants can be classified into the homomorphous family or heteromorphous 
family (Ausió, 2006). The homomorphous family contains histone variants that have 
only a few sequence changes, such as histone variants H2A.1, H2A.2, H3.1, H3.2 and 
H3.3. For example, there is only one amino acid sequence change between histone 
variants H3.1 and H3.2 (Bernstein and Hake, 2006). The heteromorphous family 
contains histone variants that have more extensive sequence changes, such as histone 
variants H2A.X, H2A.Z, macroH2A, H2A Barr body deficient and centromeric 
protein A. For example, there is a fusion of a histone H2A-like protein to a non-







2.2.3 Post-translational modifications of histones 
Post-translational modifications (PTMs) of histones are a component of the 
epigenome, where they may occur on a global scale to induce changes in chromatin 
structure and function as switches for the transcriptional regulation of gene expression 
(Mariño-Ramírez et al., 2005; Bannister and Kouzarides, 2011). However, only 
histone H3 has been shown to affect transcriptional regulation on a global scale, 
instead of a gene specific scale (He and Lehming, 2003). 
 
Some PTMs of histones include interactions with adenosine diphosphate ribose 
polymers (Panzeter et al., 1993; Messner et al., 2010), noncovalent modifications like 
proline isomerisation of H3P30 and H3P38 (Nelson et al., 2006) and the enzymatic 
addition or removal of covalent modifications (Figure 2.3; Table 2.1). The molecules 
added covalently may be relatively large, such as sumoylation of lysine and 
ubiquitylation of lysine, or relatively small, such as acetylation of lysine, methylation 
of arginine, histidine and lysine, phosphorylation of histidine, serine, threonine and 
tyrosine, adenosine diphosphate ribosylation of arginine, glutamate, glutamine and 
lysine, biotinylation of lysine, butyrylation of lysine, propionylation of lysine, 
nitrosylation of cysteine and glycosylation of asparagine, serine and threonine (Berger, 
2002; Fischle et al., 2003; Peterson and Laniel, 2004; Chen et al., 2007; Kouzarides, 
2007; Portela and Esteller, 2010; Gardner et al., 2011; Singh and Gunjan, 2011; 
Waldmann et al., 2011; Besant and Attwood, 2012; Hanover et al., 2012). These 
PTMs may change the charge or conformation of histones, or in other cases, the 
attached molecule regulates protein-protein interaction by providing a better surface 
for binding partners like transcription factors, such as the histone acetyltransferase 






Figure 2.3 Schematic diagram of PTMs of histones. The main PTMs shown in this diagram are 
acetylation (blue), methylation (red), phosphorylation (yellow) and ubiquitination (green). Figure 














Table 2.1 Some known sites of PTMs of histones (Table adapted from He and 
Lehming, 2003; Camporeale et al., 2004; Margueron et al., 2005; Millar and 
Grunstein, 2006; Portela and Esteller, 2010; Gardner et al., 2011; Singh and Gunjan, 
2011; Waldmann et al., 2011; Besant and Attwood, 2012) 
Histone PTM Residue modified 
H1 Acetylation K17, K26, K34, K46, K52, K64, K85, K90, K97, K168 
Methylation K26, K52, K63, K97, K106, K149, K168 
Phosphorylation T3, T18, S27, S36, T154, S172, S186 
Ubiquitination K46 
H2A Acetylation K5, K9, K13, K15, K36, K119 
Methylation R3, R11, R29, K99, K119 
Phosphorylation S1, T120 
Ubiquitination K4, K119, K120, K123, K126 
H2B Acetylation K5, K12, K15, K20, K85, K108, K116, K120 
Methylation K5, K37, K49 
Phosphorylation S10, S14 
Ubiquitination K20, K120 
H3 Acetylation K4, K9, K14, K18, K23, K27, K36, K56 
Methylation R2, K4, R8, K9, K14, R17, K23, R26, K27, K36, K37, 
K56, K79 
Phosphorylation T3, S10, T11, S28, Y41, T45, Y99 
H4 Acetylation K5, K8, K12, K16, K20, K77, K79, K91 
Methylation R3, K12, K20, K59, K92 
Phosphorylation S1, H18, S47, H75 
Biotinylation K8, K12 
 
2.2.3.1 Fundamental PTMs of histones 
Experimental findings have shown that PTMs of histones can either activate or 
repress transcription, where histone modifications on different amino acid residues 
may result in different effects on transcription and multiple levels of histone 
modifications on the same amino acid residue may result in different effects on 
transcription (Table 2.2). For example, histone H3K4, H3R17 or H3K79 methylation 
activates transcription but histone H3K9 methylation has the opposite effect of 
repressing transcription (He and Lehming, 2003; Lu et al., 2008; Murr, 2010). In 
addition, histone H3K4 has three states of methylation — mono-, di- and tri-
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methylated states — where di-methylated H3K4 can be associated with both 
transcriptional activation and repression, while tri-methylated H3K4 is associated 
only with transcriptional activation of protein encoding genes (Santos-Rosa et al., 
2002, He and Lehming, 2003; Murr, 2010). 
 
Table 2.2 Some proposed functions of PTMs of core histones carried out by 
different histone modifying enzymes (Table adapted from Sterner and Berger, 2000; 
He and Lehming, 2003; Peterson and Laniel, 2004) 
Histone PTM Histone modifying 
enzyme 
Proposed function 
H2A K4ac Esa1 Transcriptional activation 
K7ac Hat1 Unknown 
Esa1 Transcriptional activation 
S1ph Msk1 Transcriptional repression 
S129ph Mec1, Tel1 DNA repair 
H2B K5ac p300, Atf2 Transcriptional activation 
K11ac Gcn5 Transcriptional activation 
K16ac Gcn5, Esa1 Transcriptional activation 
K20ac p300 Transcriptional activation 
S10ph Ste20 Apoptosis 
H3 K4ac Esa1 Transcriptional activation 
Hpa2 Unknown 
K9ac Gcn5, SRC-1 Transcriptional activation 
K14ac Gcn5, PCAF Transcriptional activation 
Esal, Tip60 Transcriptional activation, DNA repair 
Hpa1 (Elp3) Transcriptional activation (elongation) 
Hpa2 Unknown 
Sas2 Euchromatin 
K18ac Gcn5 Transcriptional activation, DNA repair 
K23ac Gcn5 Transcriptional activation, DNA repair 
K27ac Gcn5 Transcriptional activation 
K56ac Spt10 Transcriptional activation, DNA repair 
K4me Set1 Permissive euchromatin 
R8me PRMT5 Transcriptional repression 
S10ph Snf1 Transcriptional activation 
H4 K5ac Hat1 Histone deposition 
Esal, Tip60 Transcriptional activation, DNA repair 
Hpa2 Unknown 
K8ac Gcn5, PCAF Transcriptional activation 
Esal, Tip60 Transcriptional activation, DNA repair 
Hpa1 (Elp3) Transcriptional activation (elongation) 
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Histone PTM Histone modifying 
enzyme 
Proposed function 
K12ac Hat1 Histone deposition, telomeric silencing 
Esal, Tip60 Transcriptional activation, DNA repair 
Hpa2 Unknown 
K16ac Gcn5 Transcriptional activation 
Esal, Tip60 Transcriptional activation, DNA repair 
Sas2 Euchromatin 
K91ac Hat1 Chromatin assembly 
Hat2 Chromatin assembly 
R3me PMRT1 Transcriptional activation 
PMRT5 Transcriptional repression 
S1ph CK2 DNA repair 
 
PTMs of histones may also have effects on a global scale or on a gene specific scale. 
For example, high levels of lysine acetylation on core histones or high levels of 
trimethylation on histone H3K4, H3K36 and H3K79 allow for actively transcribed 
euchromatin, while low levels of lysine acetylation or high levels of methylation on 
H3K9, H3K27 and H4K20 allow for transcriptionally inactive heterochromatin 
(Berger, 2002; Edwards et al., 2011). The dynamic role of nucleosomes in the 
regulation of transcription may be influenced by the PTMs of histones (He and 
Lehming, 2003). When the histone tails of core histones are methylated and non-
acetylated, they carry a high positive net charge that enhances interaction with the 
negatively charged DNA backbone, causing the DNA strands to become inaccessible 
to the transcriptional machinery (Figure 2.4A). When the histone tails of core histones 
are acetylated or phosphorylated, they carry a lower positive net charge that decreases 
the interaction with the negatively charged DNA backbone, causing the DNA strands 
to become accessible to the transcriptional machinery, especially at the promoter 
regions (Figure 2.4B). On the other hand, the promoter region of actively transcribed 
genes may have high levels of acetylation on histone H2BK5 and H3K27 and high 
levels of methylation on histone H3K4 and H4K20, while the open reading frame of 
actively transcribed genes may have high levels of methylation on H3K79 and H4K20 
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(Vakoc et al., 2005; Edwards et al., 2011). 
 
 
Figure 2.4 The dynamic role of nucleosomes in transcriptional regulation may be influenced by 
the PTMs of histones. (A) High levels of methylation on the histone tails of core histones allow for 
transcriptionally inactive heterochromatin. (B) High levels of acetylation or phosphorylation on the 
histone tails of core histones allow for actively transcribed euchromatin. Figure adapted from He and 
Lehming, 2003. Reproduced with permission from Oxford University Press. 
 
PTMs of histones are catalysed by histone modifying enzymes (Table 2.2), such as 
histone acetyltransferases (HATs) for acetylation, histone deacetylases (HDACs) for 
deacetylation, histone methyltransferases (HMTs) for methylation, histone 
demethylases (HDMs) for demethylation, histone kinases for phosphorylation, histone 
phosphatases for dephosphorylation, E3 ubiquitin ligases for ubiquitination, 
deubiquitinases for deubiquitination, and small ubiquitin related modifier (SUMO) 
conjugating enzymes for sumoylation (Keppler and Archer, 2008a; Keppler and 
Archer, 2008b; Atanassov et al., 2011; Besant and Attwood, 2012). These histone 
modifying enzymes are recruited to histones through various signals. One signal is the 
direct interaction with sequence specific DNA-binding factors, such as the targeting 
of the SAGA complex by the activator Gal4 to lead to histone acetylation (Bhaumik 




kinase-mediated phosphorylation of histone H2A or histone variant H2A.X after 
DNA damage, which leads to the recruitment of the histone acetylase complex Tip60 
that turns off the DNA repair response after DNA has been repaired (Kusch et al., 
2004; Li et al., 2010). A third signal is the recruitment of the HMT Clr4 and the 
chromodomain-binding protein Swi6 by siRNA to establish and maintain 
heterochromatin (Hall et al., 2002). The following sections detail some common 
PTMs of histones, where this study has increased emphasis on acetylation of histones. 
 
2.2.3.1.1 Histone acetylation 
Of the known PTMs of histones, acetylation is the best described histone modification. 
Histone acetylation was in fact, the first described modification of histones (Phillips, 
1963). The acetylation state of core histone tails is important for chromatin structure 
and for the regulation of transcription. Moderate levels of histone acetylation by 
HATs destabilise chromatin higher order folding by weakening histone-DNA 
interactions and correlates with enhanced transcriptional elongation by RNA 
polymerase II, while reduced levels of histone acetylation by HDACs stabilise 
chromatin higher order folding by strengthening histone-DNA interactions and 
correlates with transcriptional repression (Horn and Peterson, 2002). The exact 
mechanism behind the effects of histone acetylation on transcriptional regulation is 
unknown. Two hypothetical models have been suggested to explain the link — the 
charge neutralisation model and the histone code model (Füllgrabe et al., 2011). 
 
In the charge neutralisation model, histone acetylation may reduce the affinity 
between nucleosomes and DNA as acetylation neutralises the positive charge of the 
lysine side chain in the core histone tails (Figure 2.4B; Hong et al., 1993; Muller et al., 
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2011). This change in the local chromatin structure may become more permissive for 
the access of transcriptional machinery to gene promoters (Grunstein, 1997). For 
example, the acetylation of histone H3K9 and H3K14 is strongly associated with 
euchromatin (Kurdistani and Grunstein, 2003; Guillemette et al., 2011). 
 
In the histone code model, histone acetylation may produce a histone code, serving as 
a signal to recruit transcription factors and other effector proteins to the specific site 
of modification (Strahl and Allis, 2000; Kurdistani and Grunstein, 2003; Hahn and 
Young, 2011). The histone code model is supported by experimental findings where 
many transcriptional regulatory proteins and protein complexes contain binding 
domains that specifically recognise modified histone tails, such as the recognition of 
acetylated lysines by bromodomains found in transcription factors (Dhalluin et al., 
1999; Jacobson et al., 2000; Khorasanizadeh, 2004; Hahn and Young, 2011; Muller et 
al., 2011). The charge neutralisation model and the histone code model are not 
mutually exclusive, where it is highly likely that the chromatin structure and the 
regulation of transcription are controlled by a combination of both models (refer to 
section 2.3). 
 
2.2.3.1.2 Histone methylation 
Methylation of arginine and lysine residues in histones serves as the major 
determinant for the formation of transcriptionally active or inactive chromatin and is 
important for proper genome programming during development, where the 
misregulation of the methylation machinery can lead to diseases like cancer 
(Jenuwein, 2001; Van Den Broeck et al., 2008). Unlike acetylation, methylation does 
not alter the charge of arginine and lysine residues in histones, thus it is unlikely to 
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directly modulate nucleosomal interactions for chromatin folding. 
 
HMTs catalyse the methylation of histones, where in S. cerevisiae, specific lysine 
residues in histone H3 (K4, K9, K36 and K79), specific arginine residues in histone 
H3 (R2, R17 and R26) and specific arginine residue in histone H4 (R3) are covalently 
modified with methyl groups (Peterson and Laniel, 2004). Arginine methylation leads 
to the active state of transcription (Chen et al., 1999) and is mediated by protein 
arginine methyltransferases (PRMTs), including the coactivators PRMT1 and PRMT4 
(CARM1) (Daujat et al., 2002; Huang et al., 2005; Feng et al., 2011). PRMTs do not 
contain a SET domain but they possess highly conserved non-contiguous amino acid 
residues that are essential for forming the catalytic core, which catalyses the transfer 
of the methyl group from S-adenosylmethionine to the guanidine group of arginine 
residues (Bauer et al., 2002). 
 
Lysine methylation leads to the inactive state of transcription by blocking the binding 
of proteins that interact with unmethylated histones, by inhibiting the catalysis of 
regulatory modifications on neighbouring amino acid residues and by providing a 
binding surface for chromatin-remodelling complexes that regulate chromatin 
condensation and nucleosome mobility (Qian and Zhou, 2006; Hou and Yu, 2010). 
For example, histone H3K9 methylation serves as an epigenetic mark for silenced 
heterochromatin and provides a binding surface for the chromodomain protein 
heterochromatin associated protein (Jenuwein and Allis, 2001; Pokholok et al., 2005; 
Hou and Yu, 2010). Lysine methylation also leads to the active state of transcription, 
for example, tri-methylation of histone H3K4 is a mark for gene activation (Santos-
Rosa et al., 2002). Lysine methylation is mediated by histone lysine 
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methyltransferases (HKMTs), whose catalytic core is the SET [Su(var)3-9, Enhancer 
of zeste and Trithorax] domain (Qian and Zhou, 2006; Rando and Winston, 2012). 
 
2.2.3.1.3 Histone phosphorylation 
Phosphorylation of serine and threonine residues in histones facilitates chromatin 
condensation and transcriptional activation, where phosphorylation of histone H3S10 
is a well-known PTM that is important for mitosis, chromosome condensation and 
transcriptional activation (Berger, 2002; Nowak and Corces, 2004; Zippo et al., 2009). 
In mammals, phosphorylation of histone H3 is mediated by histone kinases that target 
serine and threonine residues surrounded by basic residues, which include Aurora-
B/Ipl1, PKA, Rsk-2, and Msk1 (Khorasanizadeh, 2004). More interestingly, the 
interaction of the HAT domain of Gcn5 with the adjacent phosphoserine has been 
shown to increase lysine acetylation capacity (Khorasanizadeh, 2004). 
 
2.2.3.2 Combinatorial PTMs of histones 
As discussed earlier (refer to section 2.2.3), histones can undergo post-translational 
modifications and there exists several sites for modifications within each histone 
(Table 2.1). Although more than 60 modification sites on histones have been detected, 
a single histone PTM does not determine the resultant biological effect alone 
(Kouzarides, 2007). On the contrary, different histone PTMs in a nucleosome or 
chromatin region function in a combinatorial manner, where one histone PTM may 
induce or inhibit another histone PTM (He and Lehming, 2003; Kouzarides, 2007). 
For example, lysine residues on histones can be acetylated, methylated, sumoylated or 
ubiquitylated, where these various modifications obviously exclude one another on a 
particular lysine residue. In addition, there are several examples of interdependency 
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and crosstalk between different residues on the same histone or on different histones 
(Jenuwein and Allis, 2001; Rice and Allis, 2001; Fischle et al., 2003; Zippo et al., 
2009). 
 
There are several established mechanisms through which PTMs mediate crosstalk, 
where these mechanisms can be classified as positive or negative crosstalk (Hunter, 
2007). Positive crosstalk refers to the situation where one histone PTM serves as a 
signal for either the addition or the removal of another PTM. Positive crosstalk can 
also refer to the situation where one histone PTM serves as the recognition site or 
docking site for a binding protein that leads to the addition or the removal of another 
PTM (Hunter, 2007). For example, mono-ubiquitination of histone H2BK123 by 
ubiquitin conjugating enzyme Rad6 is essential for methylation of histone H3K4 and 
H3K79 by HMTs Set1 and Dot1 respectively, while the loss of methylation appears to 
have no effect on ubiquitination in S. cerevisiae (Sun and Allis, 2002; Shahbazian et 
al., 2005). In a second example, phosphorylation of histone H3S10 was found to 
promote acetylation of histone H3K14 after stimulating mammalian cells with 
epidermal growth factor (Cheung et al., 2000). In a similar example, phosphorylation 
of histone H3S10 was found to promote acetylation of histone H4K16, leading to 
transcriptional activation (Zippo et al., 2009). In another example, acetylation of 
histone H3K18 and H3K23 by p300/CREB-binding protein acetyltransferase initiated 
the recruitment of PRMT4 (CARM1) to catalyse methylation of histone H3R17 
(Daujat et al., 2002). In fact, non-covalent PTMs may even affect the occurrence of 
covalent PTMs, such as the necessity of proline isomerisation of histone H3P30 and 
H3P38 by proline isomerase Fpr4 for methylation of histone H3K36 by Set2 (Nelson 
et al., 2006). 
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On the other hand, negative crosstalk refers to the situation where there is direct 
competition for the modification of a particular residue in histones. Negative crosstalk 
can also refer to the situation where there is an indirect effect of one histone PTM on 
another PTM, possibly by masking the recognition site to prevent the other PTM from 
occurring (Hunter, 2007). For example, methylation of histone H3K4 prevents the 
binding of transcriptional repressor complex NuRD, thus NuRD is not able to catalyse 
the deacetylation of histone H3K9 (Zegerman et al., 2002). In a similar example, 
methylation of histone H3K9 by HMT SUV39H1 inhibits the subsequent methylation 
of histone H3K4 by HMT Set7 and vice versa (Wang et al., 2001). In another example, 
phosphorylation of histone H3S10 was found to inhibit the methylation of histone 
H3K9 (Rea et al., 2000). 
 
2.2.3.3 Influences of histone H4 acetylation on transcription 
As this study is focused on the understanding of the role of histone H4 and the effects 
of PTMs of histone H4 in epigenetics, especially acetylation, this section will discuss 
in detail the influences of histone H4 acetylation on transcription. 
 
Matrix-assisted laser desorption ionisation time-of-flight (MALDI-TOF) mass 
spectrometry analysis of histone H4 purified from HeLa cells revealed that out of the 
15 lysine acetylation sites possible, only four sites in the N-terminal histone tail were 
observed to be acetylated (Zhang et al., 2002) — H4K5 (tetra-acetylated), H4K8 (tri- 
and tetra-acetylated), H4K12 (di-, tri- and tetra-acetylated) and H4K16 (mono-, di-, 
tri- and tetra-acetylated). In addition, histone H4 was found to be acetylated in its 
globular core domain at H4K91 (Ye et al., 2005; Martinato et al., 2008; Yang et al., 
2011). The PTMs of histones, especially acetylation of histone H4 N-terminal histone 
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tail, are conserved from unicellular eukaryotes, such as S. cerevisiae and Tetrahymena 
thermophila (T. thermophila), to multicellular eukaryotes, such as Arabidopsis 
thaliana (A. thaliana), mouse and human (Table 2.3; Smith et al., 2003; Garcia et al., 
2007; Zhang et al., 2007). 
 
Table 2.3 PTMs of histone H4 N-terminal histone tail in different organisms 
(Table adapted from Garcia et al., 2007; Zhang et al., 2007) 
Modification 
site 
S. cerevisiae T. 
thermophila 
A. thaliana Mouse Human 
S1 Phosphorylation   Phosphorylation Phosphorylation 
K5 Acetylation Acetylation Acetylation Acetylation Acetylation 
K8 Acetylation Acetylation Acetylation Acetylation Acetylation 
K12 Acetylation Acetylation Acetylation Acetylation Acetylation 
K16 Acetylation Acetylation Acetylation Acetylation Acetylation 
K20   Acetylation Methylation Methylation 
 
Histone H4 acetylation has been linked to both transcriptional activation and 
repression. For example, during transcriptional repression in D. melanogaster, three 
of the four lysine residues in the N-terminal histone tail of histone H4 (H4K5, H4K8 
and H4K16) are hypoacetylated but H4K12 was found to be significantly acetylated 
(Braunstein et al., 1996). In a second example, histone H4K5 acetylation was found to 
decrease PRMT1 activity and increase PRMT5 activity (Feng et al., 2011). Although 
both HMTs mediate the methylation of histone H4R3, they have opposite biological 
impacts with PRMT1-mediated H4R3 methylation correlating to transcriptional 
activation and PRMT5-mediated H4R3 methylation correlating to transcriptional 
repression (Feng et al., 2011). 
 
On the other hand, histone H4 acetylation has been found to promote transcriptional 
activation by recruiting bromodomain-containing chromatin-remodelling complexes 
to the promoters of target genes in order to alter chromatin structure and increase the 
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accessibility of the transcriptional machinery (Dhalluin et al., 1999; Jacobson et al., 
2000). As different chromatin-remodelling complexes containing different HATs are 
recruited to different promoters, different lysine residues on histone H4 are acetylated 
(Millar and Grunstein, 2006). For example, the progesterone receptor interacts and 
recruits the coactivator SRC-1, which then recruits the HAT CBP that mediates 
histone H4K5 acetylation (Li et al., 2003). In a second example, the MSL complex in 
D. melanogaster contains the HAT MOF, a protein sharing amino acid sequence 
homology with the MYST family, which mediates histone H4K16 acetylation (Smith 
et al., 2000). 
 
Histone H4 acetylation also prevents the spread of heterochromatin, where 
experimental findings have shown that acetylation of histone H4K16 leads to the 
destabilisation of nucleosomes, decondensation of chromatin and contributes to the 
establishment of euchromatin (Shogren-Knaak and Peterson, 2006; Shogren-Knaak et 
al., 2006; Zippo et al., 2009). In a second example, global acetylation of histone 
H4K16 mediated by Sas2 opposes the deacetylation of this residue by HDAC Sir2 to 
prevent the spread of telomeric heterochromatin (Suka et al., 2002; Kozak et al., 
2010). 
 
2.3 Histone acetyltransferases 
As discussed earlier (refer to section 2.2.3.1.1), histones can undergo acetylation, 
where this process is catalysed by HATs. HATs carry out acetylation by transferring 
an acetyl group from acetyl coenzyme A onto the epsilon amino group of lysine 
residues in the N-terminal tail of core histones (Albaugh et al., 2011). Based on the 
cellular localisation, HATs can be classified into two groups — Type A HATs that 
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are localised in the nucleus, where they catalyse histone acetylation involved in 
transcription related events and Type B HATs that are localised in the cytoplasm, 
where they catalyse histone acetylation involved in the transport of newly synthesised 
histones from the cytoplasm to the nucleus for deposition onto newly replicated DNA 
during DNA replication (Grunstein, 1997; Kuo and Allis, 1998; Grant and Berger, 
1999; Sterner and Berger, 2000; Roth et al., 2001; Bannister and Kouzarides, 2011; 
Ghizzoni et al., 2011). 
 
Type B HATs are highly conserved, where they share amino acid sequence homology 
with the founding member, S. cerevisiae Hat1 (Grant and Berger, 1999; Bannister and 
Kouzarides, 2011; Zhang et al., 2012). Type B HATs usually target newly synthesised 
histone H4 at positions K5 and K12 for acetylation, where the acetylation marks are 
removed after the deposition of the histones (Parthun, 2007; Zhang et al., 2012). 
 
Type A HATs are a more diverse family of enzymes as compared to Type B HATs, 
where Type A HATs can be further classified into at least three groups based on 
amino acid sequence homology and the motif organisation of the catalytic subunit — 
Gcn5-related acetyltransferase (GNAT) family, MOZ-Ybf2/Sas3-Sas2-Tip60 (MYST) 
family and p300/CREB-binding protein family (Bannister and Kouzarides, 2011; 
Sampley and Ozcan, 2012). The catalytic subunit of the GNAT family contains both a 
HAT domain and a bromodomain, the catalytic subunit of the MYST family contains 
both a HAT domain and a chromodomain and the catalytic subunit of the 
p300/CREB-binding protein family contains a HAT domain, a bromodomain and 




In vivo, HATs are large complexes with multiple subunits, i.e. HATs have varying 
protein compositions (Brown et al., 2000; Roth et al., 2001). The conserved core is 
the most important part of a HAT, where it is involved in the recognition of acetyl 
coenzyme A as the cofactor for acetylation. Many HATs also function as 
transcriptional coactivators, where they promote the association of the TATA-binding 
protein with the basal promoter (Brown et al., 2000; Berger, 2002). 
 
There is a large number of HATs, where even within the relatively small S. cerevisiae 
genome, at least six different HATs can be characterised (Brown et al., 2000; Lee and 
Young, 2000; Sterner and Berger, 2000; Rando and Winston, 2012) — SAGA 
complex (containing Gcn5 as the catalytic subunit), ADA complex (containing Gcn5 
as the catalytic subunit), TFIID complex (containing TFII130 as the catalytic subunit), 
NuA3 complex (containing Sas3 as the catalytic subunit), NuA4 complex (containing 
Esa1 as the catalytic subunit) and Elongator complex [containing Hpa1 (Elp3) as the 
catalytic subunit]. 
 
Different HATs target different histones, such as SAGA (Spt-Ada-Gcn5 
acetyltransferase) complex and ADA (Ada-containing complex) complex acetylating 
nucleosomal histones H2B and H3, TFIID complex acetylating transcription factors 
and free histones H3 and H4, NuA3 complex acetylating nucleosomal histone H3, 
NuA4 complex acetylating nucleosomal histones H2A and H4, as well as Elongator 
complex acetylating nucleosomal histones H2A, H2B, H3 and H4 (Brown et al., 2000; 
Hahn and Young, 2011; Krebs et al., 2011). There are differences even for HATs 
when they are free and when they are part of a complex. For example, free Gcn5 and 
Hpa1 (Elp3) are able to acetylate histone H3K14, which is the only acetylation 
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activity they are known to share. When Gcn5 is a part of the SAGA complex, it 
acetylates nucleosomal histones H2B and H3. On the other hand, when Hpa1 (Elp3) is 
a part of the Elongator complex, it acetylates nucleosomal histones H3 and H4 (Grant 
et al., 1997; Li et al., 2005). 
 
In addition, different HATs may be involved in distinct biological functions due to 
different catalytic specificities and recruitment to different chromatin domains 
(Turner, 2000). This is supported by experimental findings where deleting a crucial 
SAGA subunit affected only 10 % of S. cerevisiae genes, while deleting an essential 
TFIID subunit affected as much as 90 % of S. cerevisiae genes (Huisinga and Pugh, 
2004). In addition, SAGA complex is recruited to GAL promoters by the activator 
Gal4 to stimulate activation of GAL genes, Elongator complex regulates 
transcriptional elongation together with RNA polymerase II, and Gcn5 is recruited by 
the activator Gcn4 to regulate genes targeted by Gcn4 (Kuo et al., 2000; Narlikar et al., 
2002). The following sections detail some HATs that are of interest in this study, 
namely Gcn5, Hpa1 (Elp3) and Hpa2, all of which belong to the GNAT family of 
HATs (Neuwald and Landsman, 1997; Angus-Hill et al., 1999). 
 
2.3.1 Gcn5 
General control nonderepressible 5 (GCN5) encodes a HAT, whose activity affects 
the transcriptional activation of target genes in vivo (Brownell et al., 1996; Kuo et al., 
1998; Lee and Young, 2000; Barth and Imhof, 2010). T. thermophila protein p55, a  
S. cerevisiae Gcn5 homologue, was the first HAT discovered, where this observation 
clearly established that S. cerevisiae Gcn5 possessed HAT activity (Brownell et al., 
1996). Gcn5 was next identified as a transcriptional regulator, which collaborates with 
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specific DNA-binding activators for Gcn4-mediated transcriptional activation 
(Georgakopoulos and Thireos, 1992; Rando and Winston, 2012). 
 
Gcn5 homologues have been identified in diverse eukaryotic organisms, including 
Schizosaccharomyces pombe (S. pombe), T. thermophila, Toxoplasma gondii  
(T. gondii), D. melanogaster, A. thaliana, mouse and human (Candau et al., 1996; 
Smith et al., 1998; Hettmann and Soldati, 1999). Humans possess two Gcn5 
homologues, which are hGcn5 and p300/CREB-binding protein associated factor 
(PCAF) (Sterner and Berger, 2000). In particular, there are two forms of hGcn5 — 
hGcn5L (long) and hGcn5S (short) (Smith et al., 1998). Both human Gcn5 
homologues have conserved functions similar to that found in S. cerevisiae Gcn5, 
where hGcn5 was found to have the same activity as S. cerevisiae Gcn5 (Candau et al., 
1996) and PCAF was found to acetylate histone H3K14 and H4K8 in vitro (Schiltz et 
al., 1999). 
 
Gcn5 homologues contain an N-terminal extension and three conserved functional 
domains — catalytic HAT domain, Ada2 interaction domain and C-terminal 
bromodomain that is required for SAGA complex-mediated histone acetylation 
(Figure 2.5; Candau et al., 1997; Sterner et al., 1999; Sterner et al., 2002b). The  
N-terminal extension lies upstream of the catalytic HAT domain and varies in size in 
different eukaryotic organisms (Figure 2.5; Smith et al., 1998; Xu et al., 1998). The 
N-terminal extension of Gcn5 homologues in plants is of moderate length between 
150 amino acids (aa) to 250 aa (Bhat et al., 2003), while that of lower eukaryotes is 
usually of a shorter length approximately less than 100 aa (Brownell et al., 1996). The 
N-terminal extension of Gcn5 homologues in metazoans is usually of a longer length 
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approximately 500 aa (Xu et al., 1998; Bhat et al., 2003). The relatively longer  
N-terminal extensions present in plants and metazoans may be important for substrate 
recognition and nuclear localisation (Xu et al., 1998; Bhat et al., 2003). For example, 
the removal of the N-terminal extension from mouse and human Gcn5 homologues 
led to the inability of Gcn5 to recognise and acetylate nucleosomal histones in vitro 
(Xu et al., 1998). Experimental findings also suggest that the N-terminal extension of 
Gcn5 homologues in maize plants may be involved in nuclear targeting of the HAT 
(Bhat et al., 2003). 
 
 
Figure 2.5 Schematic diagram of Gcn5 homologues and their sizes. All Gcn5 homologues contain 
three functional domains — catalytic HAT domain, Ada2 interaction domain and C-terminal 
bromodomain. The N-terminal extension lies upstream of the catalytic HAT domain and varies in size 
in different eukaryotic organisms. h: human, m: mouse, d: D. melanogaster, a: A. thaliana,  
y: S. cerevisiae, Tet: T. thermophila, N: N-terminal extension, HAT: catalytic HAT domain,  
Ada2: Ada2 interaction domain, Bro: C-terminal bromodomain. 
 
Gcn5 functions as the catalytic subunit in three HAT complexes that are involved in 





























Pollard and Peterson, 1997; Sterner et al., 1999; Lee and Young, 2000; Lee et al., 
2000; Pray-Grant et al., 2002; Sterner et al., 2002a; Krebs et al., 2011; Spedale et al., 
2012). All three HAT complexes are recruited to specific gene promoters by the 
transcriptional activator Gcn4 (Kuo et al., 2000; Qiu et al., 2005). The transcriptional 
coactivator Ada2 found in all three HAT complexes functions by enhancing Gcn5 
HAT activity (Candau et al., 1997; Syntichaki and Thireos, 1998). 
 
The SAGA complex is a 1.8 MDa multi-subunit complex composed of the Ada 
proteins (Ada1, Ada2, Ada3, Gcn5 and Ada5), Spt proteins (Spt3, Spt7, Spt8 and 
Spt20), a subset of TATA-binding protein associated factors (TAF5, TAF6, TAF9, 
TAF10 and TAF12) and the essential Tra1 protein, where the complex functions as a 
cofactor to remodel chromatin for RNA polymerase II activity (Sterner et al., 1999; 
Sterner and Berger, 2000; Spedale et al., 2012). The ADA complex is a smaller 
800 kDa multi-subunit complex composed of Gcn5, Ada2, Ada3 and Ahc1 (ADA 
HAT complex component 1), where the complex acetylates nucleosomes but its 
function remains unknown (Eberharter et al., 1999). The SLIK/SALSA complex is 
almost identical to the SAGA complex, except that it lacks Spt8 and contains a 
shortened form of Spt7 (Pray-Grant et al., 2002). It is associated with Chd1, which is 
a chromodomain-containing chromatin-remodelling complex, forming a link between 
acetylation and histone H3 methylation (Pray-Grant et al., 2005). 
 
Experimental findings have shown that Gcn5 targets the N-terminal histone tails of 
histones H2B, H3 and H4 (Table 2.2; Kuo et al., 1996; Ruiz-García et al., 1997; 
Zhang et al., 1998; Suka et al., 2001; Kikuchi et al., 2005). When on its own, Gcn5 
acetylates only free histones in vitro, primarily histone H3K14 and H4K8 (Kuo et al., 
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1996; Grant et al., 1997), but Gcn5 alone is unable to acetylate nucleosomal histones 
(Grant et al., 1997). When in association with other subunits in HAT complexes, 
Gcn5 is able to acetylate nucleosomal histones in vivo (Grant et al., 1997; Grant et al., 
1999; Brown et al., 2000; Roth et al., 2001). For example, Gcn5 in the SAGA 
complex acetylates histone H3K9, H3K14, H3K18, and H3K23, while Gcn5 in the 
ADA complex acetylates histone H3K14 and H3K18 (Kuo and Allis, 1998; Grant et 
al., 1999). In addition, Gcn5 in the ADA complex acetylates histone H2B as well 
(Grant et al., 1997). 
 
Gcn5 is also involved in the combinatorial PTMs of histones. For example, 
phosphorylation of histone H3S10 promotes Gcn5-mediated acetylation of histone 
H3K14 in vitro (Lo et al., 2000). Similarly, the phosphorylation of histone H3S10 
also promotes Gcn5-mediated acetylation of histone H3K14 in vivo after stimulating 
mammalian cells with epidermal growth factor (Cheung et al., 2000). In addition to 
acetylating lysine residues on N-terminal histone tails, Gcn5 also acetylates non-
histone targets. For example, Gcn5 mediates S. cerevisiae Rsc4 K25 acetylation, 
where Rsc4 is a subunit of the chromatin-remodelling complex RSC (VanDemark et 
al., 2007; Rando and Winston, 2012). Gcn5 also mediates D. melanogaster 
chromatin-remodelling ATPase ISWI K753 acetylation (Ferreira et al., 2007) and 
human Cdc6 at three lysine residues flanking the cyclin docking motif (Paolinelli et 
al., 2009). Gcn5 itself can even be modified, where Gcn5 was found to undergo 
sumoylation that does not affect Gcn5 activity in vitro but may contribute to 
transcriptional regulation (Sterner et al., 2006). 
 
Gcn5 is involved in transcriptional regulation, both on a global level and at specific 
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genes. For example, Gcn5 in the SAGA complex is recruited to the promoters of 
active genes on a global level, where Gcn5 localises to the promoter instead of 
spreading into the open reading frame (ORF) (Robert et al., 2004). Under certain 
conditions like amino acid starvation or phosphate starvation, Gcn5 is recruited on a 
gene specific basis. For example, Gcn5 was found to maintain substantial acetylation 
activity specifically at the HIS3 promoter under histidine starvation conditions (Kuo 
et al., 2000). In a second example, cells lacking Gcn5 were found to have severely 
impaired basal level activation of the PHO5 promoter, which suggests that Gcn5 may 
mediate chromatin remodelling under phosphate starvation conditions (Gregory et al., 
1998; Rando and Winston, 2012). 
 
Besides transcriptional defects at promoter regions, deletion of GCN5 also leads to 
disruption of chromatin structure, chromosomal fusions, dysfunctional telomeres, 
increased G2 cells with unsegregated nuclei, delayed entrance to mitosis, meiotic 
arrest in diploid cells, cerebellar degeneration, retinal degeneration and embryonic 
lethality (Gregory et al., 1998; Pérez-Martín and Johnson, 1998; Burgess et al., 1999; 
Burgess and Zhang, 2010; Turner et al., 2010; Vernarecci et al., 2010; Chen et al., 
2012). In addition, cells lacking Gcn5 also exhibit temperature sensitivity at 37°C, 
slow growth on minimal media, increased sensitivity to microtubule depolymerising 
agents and hypersensitivity to overexpression of Clb2, which is a B-type cyclin 
involved in normal cell cycle progression (Zhang et al., 1998; Turner et al., 2010). 
 
2.3.1.1 HIS3 as a model for the study of Gcn5 
HIS3 is one of the known targets of Gcn5 regulation, where it codes for 
imidazoleglycerol phosphate dehydratase, which is an enzyme that catalyses the sixth 
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step in the histidine synthesis pathway (Sinha et al., 2004). The cross pathway 
regulatory system named general amino acid control regulates HIS3 transcription 
(Harashima and Hinnebusch, 1986; Ljungdahl and Daignan-Fornier, 2012). The 
positive regulatory protein Gcn4 regulates most of the genes involved in this pathway 
(Joo et al., 2011). Under normal growth conditions, HIS3 has a low basal level of 
transcription and does not require Gcn4 function (Oettinger and Struhl, 1985). Under 
histidine starvation conditions, Gcn4 production is stimulated, leading to 
transcriptional activation of the HIS3 gene and other amino acid biosynthetic genes 
(Joo et al., 2011). This histidine starvation condition can be generated by the addition 
of the chemical 3-AT, which is an analogue that competitively inhibits 
imidazoleglycerol phosphate dehydratase (Joo et al., 2011). 
 
Gcn5 HAT activity is important for both basal level and activated level of HIS3 
expression and acetylation (Mai et al., 2006). Under histidine starvation conditions, 
HIS3 transcription and histone hyperacetylation is induced, where Gcn4 has been 
shown to recruit Gcn5 to the HIS3 promoter, leading to activated levels of HIS3 
expression (Kuo and Allis, 1998; Kuo et al., 1998; Mai et al., 2000). HIS3 regulation 
by the well-studied cis-acting elements (DNA and nucleosomes) and trans-acting 
elements (transcriptional coactivators) further aid the detailed study of the 
mechanisms for HAT targeting (Iyer and Struhl, 1995; Rando and Winston, 2012). 
Although HIS3 and its neighbouring genes PET56 and DED1 are closely spaced, their 
expression has been shown to be independent of each other (Struhl, 1985; Struhl, 
1986). This allows for a stringent test to determine whether histone acetylation is a 
global event or a targeted event (Kuo et al., 2000). The HIS3 locus also allows for 
further analysis to map histone acetylation at single nucleosome level due to its 
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phased nucleosomal array organisation (Losa et al., 1990). Due to the reasons detailed 
above, the HIS3 gene is an attractive model for studying the functions of Gcn5. 
 
2.3.2 Hpa1 (Elp3) 
Hpa1 (Histone and other protein acetyltransferase 1), also known as Elp3 (Elongator 
protein 3), is the HAT present in the Elongator complex, which is a six subunit 
complex that associates with the elongating form of RNA polymerase II (Otero et al., 
1999; Wittschieben et al., 1999; Winkler et al., 2001). The association of the 
Elongator complex with RNA polymerase II requires the phosphorylation of RNA 
polymerase II at its C-terminal domain, before elongation can occur (Otero et al., 
1999). As nucleosomes inhibit transcriptional elongation, Hpa1 HAT activity on 
nucleosomal histones may help increase the accessibility of the transcriptional 
machinery to DNA (Tse et al., 1998). When on its own, Hpa1 acetylates the  
N-terminal histone tails of all four core histones H2A, H2B, H3 and H4 in vitro 
(Wittschieben et al., 1999). When in association with other subunits in the Elongator 
complex, Hpa1 acetylates primarily histone H3K14 and H4K8 in vivo (Winkler et al., 
2002). In addition, human Hpa1 was found to be functionally similar to S. cerevisiae 
Hpa1, where hHpa1 can rescue S. cerevisiae HPA1 deletion strain (Li et al., 2005). 
 
Although different HATs have their own specific targets, those of Gcn5 and Hpa1 
sometimes overlap. For example, both Gcn5 in the SAGA complex and Hpa1 in the 
Elongator complex preferentially acetylate histone H3K14 (Grant et al., 1999; 
Wittschieben et al., 2000). However, Gcn5 is involved in SAGA-mediated 
transcriptional activation, while Hpa1 is involved in transcriptional elongation after 
activation (Georgakopoulos and Thireos, 1992; Wittschieben et al., 1999). More 
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importantly, the ∆GCN5∆HPA1 double deletion strain exhibited phenotypes similar to 
the GCN5 deletion strain, which suggests that Gcn5 interacts with Hpa1 and this 
interaction is specific for their roles in transcriptional regulation (Wittschieben et al., 
2000). 
 
Deletion of HPA1 led to a decreased activation of target genes, slow growth 
adaptation, salt sensitivity and temperature sensitivity (Otero et al., 1999; 
Wittschieben et al., 1999). More interestingly, the double deletion strain did not 
exhibit lethality, which suggests that there exists some redundancy of HAT activities 
(Wittschieben et al., 2000). However, the double deletion strain exhibited increased 
temperature sensitivity as compared to the single deletion strains (Turner et al., 2010; 
Wittschieben et al., 2000). In addition, unlike the single deletion strains, the double 
deletion strain was unable to grow on alternative carbon sources like galactose, 
raffinose and sucrose (Wittschieben et al., 2000). 
 
2.3.3 Hpa2 and Hpa3 
Hpa2 (Histone and other protein acetyltransferase 2) is a HAT that has similarity to 
Gcn5, Hpa1 (Elp3), Hpa3 and Hat1 (Angus-Hill et al., 1999). Hpa2 was found to form 
stable dimers in solution, which associate in the presence of the cofactor acetyl 
coenzyme A to form tetramers, where the crystal structure of the tetramer has been 
elucidated (Angus-Hill et al., 1999). Hpa2 is also able to autoacetylate itself in an 
intermolecular reaction, as well as acetylate histone H3K4, H3K14, H4K5 and H4K12 
in vitro, although it has a preference for histone H3K14 (Angus-Hill et al., 1999, 
Sterner and Berger, 2000). The function of Hpa2 in vivo is still unknown, as deletion 
of HPA2 conferred no apparent growth phenotype (Angus-Hill et al., 1999). However, 
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experimental findings have shown that Hpa2 may target a small proportion of genes 
for transcriptional activation (Rosaleny et al., 2007). 
 
Hpa2 and Hpa3 were found to share a 49 % DNA sequence identity and 81 % amino 
acid sequence identity (Angus-Hill et al., 1999). However, although Hpa3 was also 
able to autoacetylate itself, it exhibited very weak HAT activity in vitro as compared 
to Hpa2 (Angus-Hill et al., 1999, Sterner and Berger, 2000). In addition, Gcn5 may 
also interact with Hpa2, where both HATs preferentially acetylate histone H3K14 
(Angus-Hill et al., 1999; Grant et al., 1999). Experimental findings have also shown 
that the ∆GCN5∆HPA2 double deletion strain is viable (Howe et al., 2001). 
 
2.4 Diseases 
Histones are dynamic and integral in regulating chromatin condensation and DNA 
accessibility, where PTMs of histones are important in the regulation of all aspects of 
DNA biology, including transcriptional activation or repression, homologous 
recombination, DNA repair, DNA replication, cell cycle regulation and chromatin 
compaction in apoptosis. Thus, aberrant patterns of PTMs of histones predispose one 
towards diseases due to the dysregulation of gene expression (Portela and Esteller, 
2010; Sawan and Herceg, 2010). In addition, other epigenetic modifications like DNA 
methylation and nucleosome positioning have also been implicated in diseases, which 
include cancers, neurological disorders and autoimmune diseases (Portela and Esteller, 
2010; Sun et al., 2012). 
 
Experimental findings are gradually elucidating the role of epigenetics in 
tumorigenesis, which often involve global changes in patterns of PTMs of histones, 
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DNA methylation and the expression profiles of chromatin-remodelling complexes in 
different types of cancers like myeloid and lymphoblastic leukaemia, breast, colon, 
liver, lung, skin and prostate cancers (Chi et al., 2010; Godley and Le Beau, 2012). 
Besides cancers, neurological disorders were also found to arise due to aberrant 
histone modifications like histone hypoacetylation and hypermethylation or 
hypomethylation of DNA. This includes neurodevelopmental disorders like Coffin-
Lowry syndrome, Rett syndrome and Rubinstein-Taybi syndrome, neurodegenerative 
diseases like Alzheimer's disease, Huntington's disease and Parkinson's disease, as 
well as neurological disorders like amyotrophic lateral sclerosis, epilepsy and multiple 
sclerosis (Urdinguio et al., 2009; Ghizzoni et al., 2011). In addition, aberrant 
epigenetic mechanisms, especially hypermethylation or hypomethylation of DNA, 
have been shown to lead to autoimmune diseases like rheumatoid arthritis, systemic 
lupus erythromatus and Type 1 diabetes mellitus (Meda et al., 2011; Villeneuve et al., 
2011). 
 
In particular, dysregulation of histone acetylation events by HATs and histone 
deacetylation events by HDACs have been shown to lead to a diverse range of 
diseases (Timmermann et al., 2001). For example, the disease mechanism in 
Huntington's disease has been proposed to be due to defects in the HAT activity of 
transcription factors, which arose via the interaction with the mutant Huntingtin 
protein that led to a down regulation of the expression of specific genes (Bithell et al., 
2009; Ross and Shoulson, 2009; Selvi et al., 2010). In a second example, acetylation 
of histone H4K8 and H4K12 was found to be significantly elevated in mice ulcerative 
colitis models (Tsaprouni et al., 2011). In a third example, the loss of acetylation at 
histone H4K16 together with trimethylation at histone H4K20 has been shown to be a 
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common hallmark of human cancer (Fraga et al., 2005; Cohen et al., 2011; Füllgrabe 
et al., 2011). In fact, acetylation at histone H4K16 was found to have profound effects 
on chromatin structure (Shogren-Knaak et al., 2006; Füllgrabe et al., 2011), where the 
loss of histone H4K16 acetylation was mediated by overexpressed or mutant HDACs 
in different cancer types (Shogren-Knaak and Peterson, 2006; Füllgrabe et al., 2011) 
that led to a global imbalance of histone acetylation and gene silencing. Even viral 
oncoprotein adenovirus-5 E1A has been shown to interact with HATs like 
p300/CREB-binding protein, which promotes oncogenic transformation of adenovirus 
infected human primary fibroblast (Frisch and Mymryk, 2002). 
 
Thus, it is of no surprise that the inhibition of HDACs is an emerging novel 
therapeutic strategy against cancer and neurological disorders like Alzheimer's disease 
and stroke (Chuang et al., 2009; Lane and Chabner, 2009; Di Marcotullio et al., 2011; 
Xu et al., 2011). Although the chemotherapeutic potential of HAT targets requires 
more validation, the anti-cancer effects of HDAC inhibitors are well known, with 
vorinostat approved for treatment of cutaneous T-cell lymphoma and other HDAC 
inhibitors like depsipeptide and MGCD0103 in the advanced stages of clinical 
development (Lane and Chabner, 2009; Sarfstein et al., 2011; Fujita et al., 2012). This 
study aims to further elucidate the molecular pathways at the transcriptional level, 
particularly on the effects of HATs, which could form the basis for the design of 


























































Phenotype testing of histone H4 mutant strains Y51A, E53A and Y98A
Suppression studies via over-expression for observable phenotypes of 
histone H4 mutant strains Y51A, E53A and Y98A
Transformation with genomic library YEp13 
Plate on control media Plate on selective media
Record number of primary transformants 
Focused on 3-AT sensitivity (AT), antimycin A sensitivity (AA) or temperature sensitivity (TS) phenotypes
Extraction of suppressor plasmid DNA — Yeast breaking
Amplification of suppressor plasmid DNA
Miniprep for purification of suppressor plasmid DNA from E. coli
Agarose gel electrophoresis  to ensure isolated suppressor plasmid DNA 
contains Sau3AI partially digested S. cerevisiae genomic DNA fragments
Sequencing reaction to identify each 
genomic DNA fragment
Testing of phenotype specificity and strain specificityQuantitative real-time PCR analysis
Sub-cloning to split the multiple ORFs found in each genomic DNA fragment
Identify the genes responsible for phenotypic suppression
Suppressor gene knock out studies






























Alanine-scanning mutagenesis of histone H4 tyrosine residues
Phenotype testing of histone H4 tyrosine residue mutant strains Y51A, Y88A and Y98A
Generation of S. cerevisiae histone mutant strains H4Y51A, H4Y72A, H4Y88A and H4Y98A — Plasmid shuffling
Characterisation of histone H4 tyrosine residue Y98
Phenotype testing of histone H4 mutant strains Y98A and Y98F
Focused on 3-AT sensitivity (AT) phenotype
Histone complementation assay — complement genomic deletion of histone H4
Generation of S. cerevisiae histone mutant strains H4Y98A, H4Y98D and H4Y98F — Plasmid shuffling
Histone complementation assay — complement genomic deletion of histone H4
Focused on 3-AT sensitivity (AT) phenotype
S. cerevisiae histone mutant protein H4Y72A could not complement genomic deletion of histone H4





































Suppression studies via over-expression of HATs for AT phenotype of 
histone H4 mutant strain Y98A
12 HATs were selected for directed screening of H4Y98A mutant strain but cloning was successful only for nine HATs 
Suppression of the AT phenotype of the H4Y98A mutant strain by the over-expression of HATs
HATs phenotype specificity and strain specificity
Suppressor gene knock out studies
GCN5, HPA1, HPA2 and HPA3 single gene knock out studies GCN5, HPA1, HPA2 and HPA3
double gene knock out studies
Suppression studies via over-expression in GCN5 and HPA1
single gene knock out mutant strains
Quantitative real-time PCR analysis
Over-expression of non-tagged and HA-tagged HATs in H4Y98A mutant strain 
Gcn5, Hpa1 and Hpa2 are multi-copy phenotypic suppressors for H4Y98A mutant strain’s AT phenotype, while Hpa3, Esa1, 
Hat1, Hat2, Rtt109 and Sas2 are not
Over-expression of non-tagged and HA-tagged HATs in H4Y51A and H4Y98A mutant strains
Over-expression of HA-tagged HATs in GCN5 and HPA1






















































Phenotype testing of an histone H4 N-terminal deletion strain
Single-point mutations
Alanine- and arginine-scanning mutagenesis of the histone H4 N-terminal 
lysine residues without or in combination with H4Y98A
Phenotype testing of histone H4 N-terminal lysine residue mutant strains 
without or in combination with H4Y98A
Double-point mutations Multiple point mutations
Suppression studies via over-expression of HATs for AT phenotype of histone H4 N-terminal 
lysine residue mutant strains without or in combination with H4Y98A
Acetylation status of histone H4 N-terminal K8 and K16 residues
Chromatin immunoprecipitation (ChIP)
Focused on 3-AT sensitivity (AT) phenotype
Acetylation status of H4K8 and H4K16 in WT histone H4 
strain and H4Y98A mutant strain
Acetylation status of H4K8 and H4K16 in H4Y98A mutant 





























Plasmid shuffling of histone H3 and H4
Complementation of histone H3 and H4 genomic deletion of cells expressing combinations of 
different histone H3 and histone H4 derivatives
Phenotype testing of cells expressing 
combinations of different histone H3 
derivatives and WT histone H4
Phenotype testing of cells expressing 
combinations of different histone H3 
derivatives and histone H4Y98A




3.2.1 E. coli strains 




DH5α F- Φ80dlacZ∆M15 ∆(lacZYA-argF)U169 





supE44 λ- thi-1 gyrA96 relA1 
Used for chemical 
transformation of plasmid 
DNA 
DH10β F- mcrA ∆(mrr-hsdRMS-mcrBC) 
Φ80dlacZ∆M15 ∆lacX74 deoR recA1 endA1 
araD139∆(ara,leu)7697 galU galK λ- rpsL 
nupG 
Used for electroporation of 
plasmid DNA as they are 
more electrocompetent 
 
3.2.2 S. cerevisiae strains 




BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 EUROSCARF 
BY4741∆W MATa his3∆1 leu2∆0 met15∆0 ura3∆0 
trp1::hisG 
Lab collection 
BY4741∆W::HIS3 MATa leu2∆0 met15∆0 ura3∆0 trp1::hisG Lab collection 
BY4742 MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 EUROSCARF 
BY4742∆W MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 
trp1::hisG 
Lab collection 
BY4742∆W::HIS3 MATα leu2∆0 lys2∆0 ura3∆0 trp1::hisG Lab collection 
 
The parental S. cerevisiae strains BY4741 and BY4742 were derived from 
EUROSCARF (http://web.uni-frankfurt.de/fb15/mikro/euroscarf/). The TRP1 gene 
was deleted with the help of NKY1009 (Alani et al., 1987) and the HIS3 gene was 
repaired with the help of a genomic BamHI fragment containing the entire HIS3 gene 







Table 3.3 S. cerevisiae knock out strains used 
S. cerevisiae knock 
out strain 
Source S. cerevisiae knock out 
strain 
Source 
BY4741∆HPA2 EUROSCARF BY4742∆GCN5 EUROSCARF 
BY4741∆KAR4 EUROSCARF BY4742∆HPA1 EUROSCARF 
BY4741∆MCK1 EUROSCARF BY4742∆HPA2 EUROSCARF 
BY4741∆MSC3 EUROSCARF BY4742∆HPA3 EUROSCARF 
BY4741∆SIP5 EUROSCARF BY4742∆W∆GAL4 Lab collection 
BY4741∆SKI8 EUROSCARF BY4742∆W∆GCN4 Lab collection 
BY4741∆SLH1 EUROSCARF BY4742∆W∆GCN5 This study 
BY4741∆YAP1 EUROSCARF BY4742∆W∆HPA1 This study 
BY4741∆YHR151C EUROSCARF BY4742∆W∆HPA2 This study 
BY4741∆YHR177W EUROSCARF BY4742∆W∆HPA3 This study 




The endogenous HHF1 and HHF2 genes in the S. cerevisiae strain 
BY4742∆W∆HHF1/2 + PactT316-HA-HHF1 were replaced by the HIS3 gene 
through homologous recombination, in the presence of PactT316-HA containing WT 
HHF1 gene flanked by 500 bp of promoter and terminator at their respective ends. 
 
Table 3.4 S. cerevisiae double knock out strains used 
S. cerevisiae double knock out strain Source 
BY4742∆W∆GCN5∆HPA1 This study 
BY4742∆W∆GCN5∆HPA2 This study 
BY4742∆W∆GCN5∆HPA3 This study 
BY4742∆W∆HHTF1/2 + YCplac33-HHTF2 Lab collection 
 
The endogenous HPA1 and HPA3 genes in the S. cerevisiae strain 
BY4742∆W∆GCN5 were deleted with the help of puc8+LEU2. The endogenous 
HPA2 gene in the S. cerevisiae strain BY4742∆W∆GCN5 was deleted with the help 
of NKY51 (Alani et al., 1987). The endogenous HHT2 and HHF2 genes in the  
S. cerevisiae strain BY4742∆W∆HHTF1/2 + YCplac33-HHTF2 were deleted with 
the help of NKY51 (Alani et al., 1987), after which the endogenous HHT1 and HHF1 
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genes were deleted with the help of puc8+HIS3 through homologous recombination, 
in the presence of YCplac33 containing WT HHTF2 gene flanked by 500 bp of 
promoter and terminator at their respective ends. 
 
3.2.3 Plasmids 
3.2.3.1 Plasmids used for gene targeting 
NKY51 (URA3 marked), NKY1009 (URA3 marked), puc8+HIS3 (HIS3 marked) and 
puc8+LEU2 (LEU2 marked) targeting vectors from laboratory collection were used 
(refer to section 3.3.2.4). 
 
3.2.3.2 Plasmids used for genetic interaction analysis 
Table 3.5 Plasmids used for genetic interaction analysis 
Plasmid Relevant characteristics Markers Source 














Bank 13 (YEp13) 








PactT424 Multi-copy vector where proteins are 
under the control of the ACT1 








— genes inserted 
(Appendix 8.2, 
Table 8.2) 
Multi-copy vector where proteins are 
under the control of the ACT1 






PactT424-HA Multi-copy vector where 
haemagglutinin (HA) fusion proteins 
are under the control of the ACT1 








— genes inserted 
(Appendix 8.2, 
Table 8.2) 
Multi-copy vector where 
haemagglutinin (HA) fusion proteins 
are under the control of the ACT1 








Plasmid Relevant characteristics Markers Source 























Single-copy vector containing HHF1 









— HHT1 and HHF1 
mutants (Appendix 
8.4, Table 8.4; 























BamHI site had been used to clone Sau3AI partially digested S. cerevisiae genomic 
DNA fragments to generate library plasmids Bank 366 (P. Heiter, ATCC 77162) and 





3.3.1 Generation of plasmids 
3.3.1.1 Polymerase chain reaction (PCR) 
PCR was carried out to amplify the desired gene, so that it could be inserted into a 
vector for genetic expression. For most genes, a one-step PCR was carried out using 
primers designed to anneal to the 5’atg and 3’stp ends of the desired gene (Table 3.6), 
where the ORF of the gene would be expressed under the control of different 
promoters and terminators. For some genes, a one-step PCR was carried out using 
primers designed to anneal to the 5’pro and 3’ter ends of the desired gene (Appendix 
8.7, Table 8.7), where the ORF of the gene would be expressed under the control of 
endogenous promoters and terminators. For knock out targeting vectors, a one-step 
PCR was carried out using primers designed to anneal to the selected gene promoter 
and terminator sequences (Table 3.7). All primers were synthesised by 1st BASE. 
 
Table 3.6 Primers used for amplification of selected histone acetyltransferases in 
one-step PCR 
Gene Primer name Sequence 
ESA1 5’ESA1atg-EcoRI GCCGAATTCATGTCCCATGACGGAAAA 
 3’ESA1stp-SalI GCCGTCGACTTACCAGGCAAAGCGTAA 
HAT1 5’HAT1atg-EcoRI GCCGAATTCATGTCTGCCAATGATTTC 
 3’HAT1stp-SalI GCCGTCGACTTAACCTTGAGATTTATTTAT 
HAT2 5’HAT2atg-EcoRI GCCGAATTCATGGAAAACCAAGAGAAAC 
 3’HAT2stp-SalI GCCGTCGACTTAGCTTATTATATCCTTGT 
HPA3 5’HPA3atg-EcoRI GCCGAATTCATGAAAAAGACCCCAGAC 
 3’HPA3stp-SalI GCCGTCGACTCAGTATCCGTTTCTCTT 
RTT109 5’RTT109atg-EcoRI GCCGAATTCATGTCACTGAATGACTTC 
 3’RTT109stp-SalI GCCGTCGACTCAAGTTTTAGGCAAGGC 
SAS2 5’SAS2atg-EcoRI GCCGAATTCATGGCAAGATCTTTAAGTC 






Table 3.7 Primers used for amplification of selected gene promoter and 
terminator sequences in one-step PCR 
Gene Primer name Sequence 
GCN5 5'Pgcn5-EcoRI GCCGAATTCAAGTACTGAGTACGTTAAC 
 3'Pgcn5-BglII GCCAGATCTAATGTAGAATACGAACC 
 5'Tgcn5-NsiIBamHI GCCATGCATGGATCCTGCGTAGAAGAAGCTTTT 
 3'Tgcn5-SalI GCCGTCGACTGGTTATCAACTTTTCCAT 
HPA1 5'Phpa1-EcoRI GCCGAATTCTCAAGCAGGAGGGCTG 
 3'Phpa1-BglII GCCAGATCTTTGTCAGGGTGTTCTT 
 5'Thpa1-NsiIBamHI GCCATGCATGGATCCAGGTAAATAGAACTTTTATG 
 3'Thpa1-SalI GCCGTCGACTTATTTATATGGAGGTGG 
HPA2 5'Phpa2-EcoRI GCCGAATTCATAGTTTTGTAAACGTATAT 
 3'Phpa2-BglII GCCAGATCTGCTACACAGAAAGGGCTGTT 
 5'Thpa2-BglII GCCAGATCTAAACACTAATTACCTCAGTA 
 3'Thpa2-SalI GCCGTCGACGGCACCGCTATCCTATGTTT 
 
For a one-step PCR carried out in a 200 µl PCR tube, 16.7 μl sterile water, 0.2 μl 
template DNA (either a known plasmid or the S. cerevisiae genomic library Bank 
366), 0.25 μl 5’ primer, 0.25 μl 3’ primer, 2 μl 10X Expand High Fidelity PCR Buffer, 
0.4 μl 10 mM dNTP, 0.2 μl Expand High Fidelity Polymerase were added in sequence 
and mixed. The Expand High Fidelity Polymerase (Roche) was used as it generates 
PCR products of high fidelity, due to its 3’-5’ exonuclease proofreading activity. 
 
For certain genes and HHF1 mutants, site-directed mutagenesis was carried out using 
either one-step or two-step PCR. In the two-step PCR for certain histone 
acetyltransferases, an additional pair of primers was designed such that the internal 
EcoRI site was mutated to allow for subsequent cloning, without changing the identity 
of the original amino acid — silent mutation based on the degeneracy of the genetic 
code (Table 3.8). In the two-step PCR for HHF1 mutants, an additional pair of 
primers was designed such that the original amino acid’s codon was changed by 
replacing the bases in the codon (Tables 3.9, 3.10, 3.11, 3.12, 3.13 and 3.14). In order 
to ensure sufficient specificity and sufficient binding strength of the designed primers, 
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12 to 15 complementing bases flanking both upstream and downstream of the 
mutation were added. All primers were synthesised by 1st BASE. 
 
Table 3.8 Primers used for amplification of selected histone acetyltransferases in 
two-step PCR 
Gene Primer name Sequence 
GCN5 5’GCN5atg-EcoRI GCCGAATTCATGGTCACAAAACATCAG 
 3’GCN5stp-SalI GCCGTCGACTTAATCAATAAGGTGAGAAT 
 GCN5+koEcoRI CTTTCGATAAGAGAGAGTTCGCAGAAATTGTTT 
 GCN5-koEcoRI AAACAATTTCTGCGAACTCTCTCTTATCGAAAG 
HPA1 5’HPA1atg-EcoRI GCCGAATTCATGGCTCGTCATGGAAAA 
 3’HPA1stp-SalI GCCGTCGACTTAAATTCTTTTCGACATGT 
 HPA1+koEcoRI ATACATATAGAAAAGAGTTCACCTCCCAGAGGA 
 HPA1-koEcoRI TCCTCTGGGAGGTGAACTCTTTTCTATATGTAT 
HPA2 5’HPA2atg-EcoRI GCCGAATTCATGTCCAACACTAGCGAA 
 3’HPA2stp-SalI GCCGTCGACTTAATATCCCTTCCTCTTG 
 HPA2+koEcoRI TCTCTATGTTGATGAAAATTCTAGGGTCAAA 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Site-directed mutagenesis was carried out using a two-step PCR and involved three 
separate PCR reactions. In the first step, two PCR reactions were carried out — one 
reaction containing the forward 5’ primer and the mutant negative (-) primer to 
replicate the DNA sequence upstream of the mutation and the other reaction 
containing the reverse 3’ primer and the mutant positive (+) primer to replicate the 
DNA sequence downstream of the mutation (Figure 3.1A). In the second step, the two 
PCR fragments generated from the first step were used as the template in a third PCR 
reaction containing the forward 5’ primer and reverse 3’ primer (Figure 3.1B). 
 
 
Figure 3.1 Schematic diagram of the two-step PCR. (A) Step 1 shows the generation of the DNA 
sequence upstream and downstream of the mutation. (B) Step 2 shows the generation of the complete 
DNA fragment containing the mutation. 
 
In the first step of the two-step PCR, the PCR reactions were carried out with a 
similar reaction mixture as in the one-step PCR (Tables 3.9, 3.10, 3.11, 3.12, 3.13 and 
3.14 for details on the template DNA used). In the second step, the PCR reaction was 

























PCR reaction 2 product
PCR reaction 1 product
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1 μl PCR reaction 2, 0.25 μl 5’ primer, 0.25 μl 3’ primer, 2 μl 10X Expand High 
Fidelity PCR Buffer, 0.4 μl 10 mM dNTP, 0.2 μl Expand High Fidelity Polymerase 
were added in sequence and mixed. 
 
For all of the above PCR reactions, the following cycling parameters were repeated 
for 20 cycles — 95°C for 30 s, x°C for 1 min and 72°C for y min, where x°C is 
dependent on primer annealing temperature and y min is dependent on length of the 
DNA sequence amplified (100 s for every 1 kb). The extension products were 
analysed through 1 % agarose gel electrophoresis to ensure amplification of the 
correct DNA sequence occurred before insertion into a vector. 
 
3.3.1.2 Purification of extension products 
For each 20 μl PCR reaction, 5 μl was used for analysis through 1 % agarose gel 
electrophoresis. The extension products in the remaining 15 μl PCR reaction were 
purified using Roche High Pure PCR Product Purification Kit (Boehringer Mannheim) 
following the manufacturer’s protocol. 
 
3.3.1.3 Cloning and sub-cloning 
In order to clone the desired genes into the plasmids, the PCR extension products and 
cloning vectors were cleaved with the same restriction enzymes or with restriction 
enzymes that generate compatible overhang DNA sequences. For sub-cloning of the 
candidate suppressor genes, two methods were carried out to generate the desired 
plasmids. In the first method, the candidate suppressor gene was isolated on YEp13 
through the use of restriction enzymes to cleave the unwanted fragments, then the 
plasmid DNA was re-ligated. In the second method, the candidate suppressor gene 
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was cleaved from YEp13 and ligated to YEplac181. 
 
Restriction digestion of PCR extension products was carried out in a 1.5 ml microtube, 
where 17.4 μl purified PCR extension products, 2 μl restriction digestion buffer, 
0.2 μl bovine serum albumin (BSA), 0.2 μl of each restriction enzyme were added in 
sequence and mixed. Restriction digestion of plasmid DNA was carried out using a 
similar mix, with the exception that 16.4 μl sterile water and only 1 μl plasmid DNA 
were added. The restriction digestion mixture was incubated at 37°C overnight to 
ensure complete digestion of DNA has taken place. 
 
3.3.1.4 Purification of restriction digested products 
The restriction digested products in each 20 μl reaction were purified using Roche 
High Pure PCR Product Purification Kit (Boehringer Mannheim) following the 
manufacturer’s protocol. 
 
3.3.1.5 DNA ligation 
In a 1.5 ml microtube, 4.8 μl sterile water, 1 μl 10X ligation buffer, 0.2 μl T4 DNA 
Ligase (Roche), 4 μl cut plasmid DNA or 2 μl cut plasmid DNA and 2 μl cut gene 
fragment were added and mixed. The ligation mixture was incubated at room 
temperature for 4 h or at 4°C overnight. 
 
3.3.1.6 Amplification of plasmid DNA 
Plasmid DNA can be transformed into competent E. coli for amplification through 
two methods — chemical transformation or electroporation. Chemical transformation 
of DH5α E. coli was used for amplification of ligated plasmid DNA or known 
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plasmid DNA. Electroporation of DH10β E. coli was used for amplification of 
plasmid DNA isolated from S. cerevisiae, where the more electrocompetent DH10β  
E. coli allows for a relatively higher transformation efficiency as S. cerevisiae 
genomic DNA present in the isolated plasmid DNA reduces transformation efficiency. 
 
3.3.1.6.1 Chemical transformation into DH5α E. coli 
DH5α E. coli was made competent by resuspending the cells in a calcium chloride 
(CaCl2) solution (Appendix 8.8), where the divalent cation Ca
2+
 creates pores in the 
plasma membrane, helps plasmid DNA to bind the plasma membrane and masks the 
negative charge of the plasmid DNA. In a 1.5 ml microtube, 20 μl DH5α E. coli was 
added to the 10 μl ligation mixture or 0.5 μl known plasmid DNA and mixed. The 
mixture was placed on ice for 15 min, followed by heat shock in a 42°C water bath 
for 1 min to force the plasmid DNA through the hydrophobic plasma membrane and 
into the cells. 160 µl Luria-Bertani (LB; Appendix 8.9) media was added immediately 
to ensure maximal recovery of transformants and mixed using a pipette. The mixture 
was incubated with rotation at 37°C for 1 h to allow for expression of the antibiotic 
resistance gene, then plated on LB+ampicillin or LB+chloramphenicol plate 
(Appendix 8.9) and incubated at 37°C for more than 12 h or overnight. 
 
Ampicillin inhibits synthesis of the bacterial cell wall, where ampicillin resistance 
relies on the production of beta-lactamase, which catalyses the degradation of the 
beta-lactam ring in the periplasmic space. Chloramphenicol binds the 50S subunit of 
ribosomes to prevent protein synthesis, where chloramphenicol resistance relies on 
the production of chloramphenicol acetyltransferase, which converts chloramphenicol 
into a form that cannot bind ribosomes. 
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3.3.1.6.2 Electroporation into DH10β E. coli 
DH10β E. coli was made competent by extensive washing to remove all salts 
(Appendix 8.10) to ensure that the electric current applied is not conducted through 
the media. The electric current should be applied across DH10β E. coli to create pores 
in the plasma membrane so as to force the plasmid DNA through the plasma 
membrane and into the cells. Electroporation cuvettes were prepared by treating with 
denatured EtOH overnight, then the contents were poured away and the cuvettes were 
dried in a laminar hood. The cuvettes were placed under ultraviolet (UV) for 10 min 
and chilled on ice for 5 min before use. In a 1.5 ml microtube, 40 µl DH10β E. coli 
was added to 4 µl isolated plasmid DNA and mixed on ice before transferring the 
mixture carefully into a prepared cuvette to avoid bubble formation. After 
electroporation at 1.8 kV using an E. coli Pulser (Bio-Rad), 400 µl LB was added 
immediately to ensure maximal recovery of transformants and mixed vigorously using 
a pipette. The mixture was transferred back into the 1.5 ml microtube and incubated 
with rotation at 37°C for 1 h to allow for expression of the antibiotic resistance gene. 
The mixture was plated on LB+ampicillin (Appendix 8.9) and incubated at 37°C for 
more than 12 h or overnight. 
 
3.3.1.7 Miniprep for purification of plasmid DNA from E. coli 
Larger colonies formed on LB+ampicillin or LB+chloramphenicol plate were picked 
for inoculation in 2 ml LB+ampicillin or LB+chloramphenicol media at 37°C for 
more than 12 h or overnight. The culture was transferred into a 1.5 ml microtube, 
centrifuged at 13000 rpm for 30 s and the supernatant was removed. The plasmid 
DNA was isolated using the alkaline lysis method (Ausubel et al., 2006), involving 
Miniprep Solution I (Appendix 8.11, Table 8.10), Miniprep Solution II (Appendix 
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8.11, Table 8.11) and Miniprep Solution III (Appendix 8.11, Table 8.12). The plasmid 
DNA pellet was dried under vacuum for 15 min, then resuspended in 50 μl sterile 
water and stored at -20°C. Restriction digestion of plasmid DNA was carried out in a 
1.5 ml microtube, where 12.7 μl sterile water, 5 µl plasmid DNA, 2 μl restriction 
digestion buffer, 0.1 μl BSA, 0.1 μl of each restriction enzyme were added in 
sequence and mixed. The restriction digestion mixture was incubated at 37°C for at 
least 2 h. This was followed by 1 % agarose gel electrophoresis and sequencing 
reaction to ensure that the plasmid generated was correct. 
 
Restriction digestion of integration plasmid DNA was carried out in a 1.5 ml 
microtube, where 34 µl sterile water, 10 μl integration plasmid DNA, 5 μl restriction 
digestion buffer, 0.5 μl BSA, 0.25 μl of each restriction enzyme were added in 
sequence and mixed. The restriction digestion mixture was incubated at 37°C 
overnight to ensure complete digestion of integration plasmid DNA has taken place. 
This was followed by 1 % agarose gel electrophoresis to ensure that the integration 
plasmid DNA has been completely cleaved. The restriction digestion mixture does not 
have to be purified and was used to transform competent S. cerevisiae directly (refer 
to section 3.3.2.2). 
 
3.3.1.8 Agarose gel electrophoresis 
1 % agarose gel was cast with 1 g agarose and 100 ml 1X Tris Borate EDTA (TBE) 
buffer, which was then microwaved for 2 min to melt the agarose. Different 
percentages of agarose gel were obtained by varying the amount of agarose added. 
Before pouring the gel mixture into a gel tray to cool and solidify, 3 μl ethidium 
bromide (Bio-Rad) was added to enable visualisation of DNA upon intercalation 
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between nucleic acid base pairs and exhibition of fluorescence under UV. Before 
loading the samples, 1 μl 10X loading dye (Appendix 8.12, Table 8.13) was added 
and mixed. The gel was electrophoresed at a constant 100 volts for 40 min, then 
viewed under UV. 
 
3.3.1.9 Sequencing reaction and purification of extension products 
In a 200 µl PCR tube, 6 μl sterile water, 1.5 μl plasmid DNA, 0.5 μl forward or 
reverse primer (Table 3.15), 2 μl BigDye Terminator Cycle reaction mix (Applied 
Biosystems) were added in sequence and mixed. The following cycling parameters 
were repeated for 25 cycles — 96°C for 30 s, 50°C for 15 s, 60°C for 4 min. 
Table 3.15 Primers used for sequencing reactions 
Sequencing template Primer name Sequence 
Bank 13 (YEp13) YEp13+ GCCACTATCGACTACGCG 
YEp13- GCGCCAGCAACCGCACCTGT 
Histone mutants 5'HHF1pro-70 CCGTCGCATTATTGTACTCT 
3'HHF1ter-70 TACACTCATATTTGTAGAAG 





In order to purify the extension products, the contents of the PCR tube was transferred 
into a 1.5 ml microtube containing 80 μl of ethanol/sodium acetate (EtOH/NaAc) 
solution, which is a mixture of 14.5 μl sterile water, 62.5 μl 100 % EtOH, 3 μl 3 M 
NaAc (pH4.6). The mixture was vortexed briefly and allowed to stand at room 
temperature for 15 min to precipitate the extension products. After centrifuging at 
13000 rpm for 10 min, the supernatant was carefully removed using a pipette. Upon 
addition of 500 μl 75 % EtOH to rinse the DNA pellet, the microtube was centrifuged 
at 13000 rpm for 5 min and the supernatant was removed. The DNA pellet was dried 
under vacuum for 15 min before sending the sample to a sequencing facility provided 
in Department of Microbiology, NUS. 
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3.3.2 Generation of S. cerevisiae strains 
3.3.2.1 Production of competent S. cerevisiae 
In order to generate competent cells for transformation, a preculture of the required  
S. cerevisiae strain was prepared by inoculating a single colony in 2 ml YPDA (Yeast 
extract Peptone Dextrose Adenine, Appendix 8.13) or other selective media 
(Appendix 8.14), then incubating at 28°C for more than 12 h or overnight. A suitable 
volume of the preculture was transferred into either 10 ml or 50 ml fresh media, 
depending on the amount of competent cells required for transformation, at a 50X 
dilution for fast growing strains or at a 25X dilution for slow growing strains. The 
culture was incubated at 28°C until OD600 = 1.0. The cells were made competent 
using the lithium acetate (LiAc, Appendix 8.15) method (Ausubel et al., 2006), 
followed by transformation or storage at 4°C for a maximum of one week. 
 
3.3.2.2 Transformation of competent S. cerevisiae 
Transformation of competent cells was carried out in a 1.5 ml microtube, where 2 μl 
fish sperm DNA (FS DNA, Roche), 1 μl plasmid DNA or cut integration plasmid 
DNA (refer to section 3.3.1.7), 5 μl competent cells and 50 μl 40 % polyethylene 
glycol (PEG, Appendix 8.16) were added in sequence and mixed. The transformation 
mixture was incubated at 28°C for 1 h, followed by heat shock in a 42°C water bath 
for 15 min to trigger DNA uptake. After centrifuging at 7000 rpm for 1 min, the 
supernatant was removed and the cells were resuspended in 10-15 μl sterile water. 
The cell resuspension was plated on the relevant selection plate to select for 





3.3.2.3 Generation of S. cerevisiae histone mutant strains — Plasmid shuffling 
The histone knock out strains bear chromosomal null mutations for the indicated 
histone genes, BY4742∆W∆HHF1/2 + PactT316-HA-HHF1 and 
BY4742∆W∆HHTF1/2 + YCplac33-HHTF2. Thus, they were maintained by the 
presence of URA3 marked PactT316-HA-HHF1 and YCplac33-HHTF2 respectively. 
URA3 is a widely used marker as it allows both positive and negative selections. 
URA3 encodes for the enzyme orotidine-5'-phosphate (OMP) decarboxylase, which is 
required for the de novo biosynthesis of uracil where it converts OMP into uridine 
monophosphate (UMP). Thus, cells containing URA3 marked plasmids can grow on 
media lacking uracil, i.e. positive selection (Figure 3.2A). However, the same enzyme 
encoded by URA3 converts 5-fluoro-orotic acid (5-FOA) into the toxic metabolite  
5-fluorouracil (5-FU), which inhibits thymidylate synthase (an enzyme involved in 
the synthesis of deoxy-thymidine monophosphate for DNA replication). Thus, cells 
containing URA3 marked plasmids cannot grow on media containing 5-FOA,  
i.e. negative selection (Figure 3.2B). 
 
 
Figure 3.2 Schematic diagram of the URA3 marker’s positive and negative selections. (A) The 
positive selection of the URA3 marker leads to cell growth. (B) The negative selection of the URA3 




















In order to elucidate the effects of various HHT1 and HHF1 mutants, plasmid 
shuffling was carried out to replace the URA3 marked plasmids carrying WT genes 
with the TRP1 or LEU2 marked plasmids carrying mutant genes (Figure 3.3A). 
Transformation was first carried out to introduce the plasmid carrying the mutant gene 
into the strain. For the single knock out HHF1/2 strain, single transformation was 
carried out as described in section 3.3.2.2. For the double knock out HHTF1/2 strain, 
double transformation was carried out by adding 1 µl of each desired plasmid into the 
transformation mixture. The transformants were titrated (refer to section 3.3.2.3.1) 
onto histidine-depleted selection plates containing 5-FOA (H- + FOA). Histidine-
depleted selection plates were used to select for the strains that have the chromosomal 
histone genes replaced by the HIS3 gene through homologous recombination. If the 
mutant histone gene encodes for a functional protein, the cells would lose the URA3 
marked plasmids carrying WT gene and colonies will be observed on the H- + FOA 
plates due to counter selection (Figure 3.3B). The histone mutant strains that grew 
were restreaked on H- + FOA plates for another generation, before testing for  
3-amino-1,2,4-triazole (3-AT) sensitivity (AT), antimycin A sensitivity (AA) or 





Figure 3.3 Schematic diagram of plasmid shuffling and URA3 marker’s counter selection 
involved. (A) The process of plasmid shuffling starts with a URA3 marked plasmid in the cell, 
followed by two plasmids after transformation. This eventually results in the presence of only the 
second plasmid after shuffling the URA3 marked plasmid out of the cell. (B) The schematic of counter 
selection of the URA3 marker, where the absence of the URA3 marked plasmid in the cell allows 
growth on media containing 5-FOA. 
 
3.3.2.3.1 Titration — Droplet growth assay 
Titration or droplet growth assay was carried out in a 96-well plate. A pipette tip was 
used to inoculate a scoop of cells into 90 μl sterile water, followed by tenfold serial 
dilutions of up to 10
-6
. A multi-channel pipette was used to load 5 μl from each well 
onto relevant control and selection plates, then the droplets were allowed to dry. The 
plates were incubated at 28°C or at 38°C (to test for TS phenotype) for three to six 
days and were scanned into a computer at regular intervals. 
 
3.3.2.4 Generation of S. cerevisiae mutant strains — Gene targeting 
In order to generate S. cerevisiae mutant strains, two methods of gene targeting were 




























NKY1009 targeting vectors (Alani et al., 1987). The hisG-URA3-hisG cassette can be 
flanked by approximately 500 bp of the targeted gene’s promoter and terminator 
(NKY51) or by approximately half of the targeted gene on either ends (NKY1009, 
Figure 3.4). Before the targeting vectors were transformed into the desired S. 
cerevisiae strain, they were linearised by restriction digestion (refer to section 3.3.1.7). 
 
 
Figure 3.4 Schematic diagram of gene targeting involving the hisG-URA3-hisG cassette present in 
NKY1009 targeting vector. The TRP1 gene was disrupted due to the presence of a hisG sequence in 
the middle of the gene after counter selection of the URA3 marker. TR: first half of TRP1 gene,  
P1: second half of TRP1 gene, U-: media lacking uracil, UW-: media lacking uracil and tryptophan,  
C-FOA: media containing complete amino acid mixture and 5-FOA. 
 
The second method involved the use of relevant selection markers with the help of 
differently marked targeting vectors — puc8+HIS3 and puc8+LEU2 (Figure 3.5). 
Before the targeting vectors were transformed into the desired S. cerevisiae strain, 
they were linearised by restriction digestion (refer to section 3.3.1.7). In order to 
confirm whether the targeted gene had been knocked out, yeast breaking to extract 
genomic DNA was carried out (refer to section 3.3.3.2), followed by PCR using 
hisG P1
Chromosome TRP1
hisG URA3 hisGTR P1Linearised vector
EcoRI BglII
Transformation plated on U-
hisG URA3 hisGTR P1Chromosome
Parallel restreak on U- and UW-
Correct transformants grow on U- plate and not on UW- plate
Single colony inoculation in 1ml 








primers designed to anneal to the 5’pro and 3’ter of the targeted gene (refer to section 
3.3.1.1). If the length of the targeted gene and the selected marker are different, 
analysis of the extension products through agarose gel electrophoresis was sufficient. 
If the length of the targeted gene and the selected marker are similar, a sequencing 
reaction was carried out using the extension products as template. 
 
 
Figure 3.5 Schematic diagram of gene targeting involving the LEU2 marker present in 
puc8+LEU2 targeting vector. The HPA1 gene was replaced by the LEU2 marker after homologous 
recombination of the promoter and terminator sequences of HPA1 gene on the chromosome and the 
linearised vector. Pro: promoter sequence of HPA1 gene, Ter: terminator sequence of HPA1 gene,  
L-: media lacking leucine. 
 
3.3.2.5 Generation of S. cerevisiae glycerol stock 
Once the S. cerevisiae mutant strains have been confirmed, glycerol stocks were 
generated. A preculture of each S. cerevisiae mutant strain was prepared by 
inoculating a single colony in 1 ml YPDA or other selective media, then incubating at 
28°C for more than 12 h or overnight. 400 µl of the preculture was mixed with 400 µl 
50 % glycerol to obtain a 25 % glycerol-cells mixture. The mixture was stored 
immediately at -80°C to avoid settling of the cells. 
 
3.3.3 Genomic library screening 
The S. cerevisiae histone H4 mutant strains Y51A, E53A and Y98A generated were 
Chromosome HPA1
Pro LEU2 TerLinearised vector
EcoRI SalI




Correct transformants grow on L- plate
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conferred with phenotypic deficiencies that arose most probably due to defective 
genetic interactions. A genomic library screen was carried out in order to identify the 
specific gene involved in the defective genetic interactions. 
 
3.3.3.1 Transformation of competent S. cerevisiae with YEp13 library plasmids 
Transformation of competent cells (refer to section 3.3.2.1) was carried out in a 1.5 ml 
microtube, where 25 μl FS DNA, 25 μl YEp13 library plasmids (concentration of 
0.5 µg/µl), 25 μl competent cells and 375 μl 40 % PEG were added in sequence and 
mixed. The transformation mixture was incubated at 28°C for 1 h, followed by heat 
shock in a 42°C water bath for 15 min to trigger DNA uptake. After centrifuging at 
7000 rpm for 1 min, the supernatant was removed and the cells were resuspended in 
250 μl sterile water. In a first protocol, the cell resuspension was plated directly on the 
selection plate and incubated at 28°C or at 38°C (to test for TS phenotype) for three 
days. In a second protocol, the cell resuspension was plated directly on L- plate and 
incubated at 28°C for three days. The colonies formed were washed off twice with 
5 ml sterile water each time, of which only 1 % was plated on the selection plate and 
incubated at 28°C or at 38°C for three days. The second protocol helped to increase 
the number of cells plated on the selection plate to improve the colony numbers 
obtained. The volumes of each transformation component and sterile water for 
resuspension were multiplied according to the number of selection plates used. 
 
The size of the S. cerevisiae genome is approximately 12000 kb with more than 6000 
genes, while the average fragment size of the genomic library is approximately 6 kb. 
Theoretically, there should be at least 2000 transformants on each transformation 
plate to cover the S. cerevisiae genome. However, in order to ensure a complete 
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coverage of the S. cerevisiae genome, a more practical number to aim for would be at 
least 10000 transformants on each transformation plate. This means that the  
S. cerevisiae genome would be covered about five times. Thus, to determine the 
number of primary transformants screened, two dilutions of the transformed cells 
were carried out, plated on L- plate and incubated at 28°C for six days. For the 1000X 
dilution, 6 μl cell resuspension and 54 μl sterile water were mixed, where only 50 μl 
was plated. For the 10000X dilution, 5 μl 1000X diluted cell resuspension and 45 μl 
sterile water were mixed, where only 50 μl was plated. The number of primary 
transformants was recorded twice, after three days and after six days of incubation. 
 
3.3.3.2 Extraction of genomic or plasmid DNA — Yeast breaking 
Yeast breaking was carried out to extract genomic DNA from S. cerevisiae mutant 
strains or to extract YEp13 library plasmids from transformants. A single colony was 
inoculated in 5 ml YPDA or other selective media and incubated at 28°C  
(S. cerevisiae mutant strains or AT and AA phenotype suppressors) or 38°C  
(TS phenotype suppressors) until OD600 = 1.0. The DNA was isolated using the 
phenol-chloroform extraction method (Ausubel et al., 2006), which involves the use 
of yeast breaking buffer (Appendix 8.17, Table 8.18). The DNA pellet was dried 
under vacuum for 30 min, then resuspended in 50 μl sterile water and stored at -20°C. 
 
After the YEp13 library plasmids were extracted from the transformants, they were 
amplified in DH10β E. coli and restriction digestion was carried out to ensure that the 
plasmids contained an insert. The isolated plasmids were transformed into their 
respective S. cerevisiae histone mutant strains and also cross transformed into other  
S. cerevisiae histone mutant strains conferred with the phenotype suppressed by the 
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isolated plasmids. The same isolated plasmids were also transformed into 
BY4742∆W∆HHF1/2 + PactT316-HA-HHF1 strain. Titration was carried out on 
selection plates to retest suppression efficiency of the isolated plasmids and on  
H-FOA plates to ensure that the isolated plasmids did not encode WT HHF1. The 
isolated plasmids that suppressed the phenotypes conferred by the HHF1 mutations 
and failed to complement HHF1 deletion were sequenced. 
 
3.3.4 Quantitative real-time PCR analysis 
Real-time PCR involves the monitoring of the progress of a PCR reaction as it occurs. 
Data is collected throughout the PCR reaction, rather than at the end of the reaction. A 
PCR reaction is characterised by the point in time during cycling when the 
amplification of a target is first detected. 
 
3.3.4.1 Purification of total ribonucleic acid (RNA) 
Cells were grown for total RNA purification using two methods — broth method and 
plate method. In the broth method, the required S. cerevisiae strain was inoculated in 
40 ml glucose complete media or other selective media. The culture was incubated at 
28°C until OD600 = 1.0, before splitting it into two 20 ml cultures. For one culture, 
after centrifuging at 4000 rpm for 5 min, the supernatant was removed and the cells 
were washed in 20 ml sterile water. After centrifuging at 4000 rpm for 5 min, the 
supernatant was removed and a 2 h induction in 20 ml media containing 3-AT was 
carried out. After centrifuging at 4000 rpm for 5 min, the supernatant was removed 
and the cells from both cultures were washed in 1 ml sterile water. The resuspension 
was transferred into a 1.5 ml microtube. After centrifuging at 7000 rpm for 1 min, the 
supernatant was completely removed in order to prevent lysis inhibition or lysate 
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dilution, both of which could reduce RNA yield. 
 
In the plate method, the required S. cerevisiae strain was inoculated in 5 ml glucose 
complete media or other selective media and incubated at 28°C until OD600 = 1.0. 
After centrifuging at 4000 rpm for 5 min, the supernatant was removed and the cells 
were washed in 1 ml sterile water. The resuspension was transferred into a 1.5 ml 
microtube. After centrifuging at 7000 rpm for 1 min, the supernatant was removed 
and the cells were resuspended in 100 μl sterile water. Serial dilutions of up to 10-6 
were carried out and plated on control plates and plates containing 3-AT, then 
incubated at 28°C for four days. The colonies formed from the most diluted diluent 
that survived on the 3-AT plate and the corresponding control plate were harvested by 
washing off with 10 ml sterile water (5 ml sterile water twice). After centrifuging at 
4000 rpm for 5 min, the supernatant was removed and the cells were washed in 1 ml 
sterile water. The resuspension was transferred into a 1.5 ml microtube. After 
centrifuging at 7000 rpm for 1 min, the supernatant was completely removed. 
 
Mechanical disruption was used to homogenise the harvested cells and total RNA was 
purified using the RNeasy
®
 Mini Kit (Qiagen) following the manufacturer’s protocol 
in the RNeasy
®
 Mini Kit Handbook. RNA was eluted from the RNeasy
®
 spin column 
with 60 μl RNase-free water and stored at -80°C. 
 
3.3.4.2 Quantitation of total RNA 
Quantitation of total RNA was carried out using a nanodrop machine, where 2 µl of 
the purified total RNA was pipetted onto the end of a fibre optic cable. The following 
values were recorded to determine the integrity of the total RNA purified: 
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 ng/µl: sample concentration based on absorbance at 260 nm, which was used to 
calculate the amount of RNA added in a reverse transcription reaction 
 260/280: ratio of sample absorbance at 260 nm and 280 nm, which indicates the 
purity of RNA (a ratio of ~2.0 indicates a pure RNA sample) 
 260/230: ratio of sample absorbance at 260 nm and 230 nm, which is a secondary 
indication of the purity of nucleic acids (a ratio of 2.0–2.2 indicates a pure nucleic 
acid sample) 
 
3.3.4.3 Formaldehyde agarose (FA) gel electrophoresis of total RNA 
In order to determine the integrity and size distribution of total RNA purified, FA 
(denaturing) gel electrophoresis was carried out. Intact total RNA run on a denaturing 
gel will display sharp 28S (4718 bp) and 18S rRNA (1874 bp) bands, where the 28S 
rRNA band should be approximately twice as intense as the 18S rRNA band. This 
indicates that the rRNA and mRNA purified were not degraded during the extraction 
procedure. 
 
1.2 % FA gel was cast with 1.2 g agarose, 10 ml 10X FA gel buffer (Appendix 8.18, 
Table 8.19) and 90 ml RNase-free water, which was then microwaved for 2 min to 
melt the agarose. Before pouring the gel mixture into a gel tray to cool and solidify, 
the gel mixture was cooled to 65°C, after which 1 μl ethidium bromide and 1.8 ml 37 % 
formaldehyde was added. The FA gel was equilibrated in 1X FA gel running buffer 
(Appendix 8.18, Table 8.20) for at least 30 min. The total RNA sample was prepared 
for FA gel electrophoresis by mixing 3 μl total RNA sample with 3 μl 2X RNA 
loading buffer. The mixture was incubated at 65°C for 5 min and chilled on ice before 
loading onto the equilibrated FA gel. After loading 4 μl RiboRuler RNA Ladder High 
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Range (Fermentas), the FA gel was electrophoresed at a constant 80 volts for 1 h, then 
viewed under UV. Preparation and electrophoresis of the FA gel was carried out in a 
fume hood due to the usage of formaldehyde. 
 
3.3.4.4 DNaseI treatment of DNA contaminants 
The purified total RNA samples were treated with DNaseI to degrade genomic DNA 
that could otherwise result in false positive signals during real-time PCR. A dilution 
using RNase-free water was carried out to obtain 4 μg purified total RNA in a 
reaction volume of 35 μl. 3.5 μl 10X DNaseI buffer (Ambion) and 1 μl Turbo DNaseI 
(Ambion) were added in sequence and mixed, then the mixture was incubated at 37°C 
for 2 h. Upon addition of 1.2 μl Turbo DNaseI, the mixture was again incubated at 
37°C for 2 h. Upon addition of 4 μl DNaseI inactivation reagent (Ambion), the 
mixture was incubated at room temperature for 5 min with occasional mixing to 
ensure the effective sequestering of DNaseI and divalent cations. After centrifuging at 
13000 rpm for 2 min, the supernatant was transferred into a new 1.5 ml microtube and 
stored at -80°C. 
 
In order to ensure that there was no detectable DNA contamination, a PCR reaction 
was carried out in a 200 µl PCR tube, where 10.9 μl RNase-free water, 5 μl DNaseI 
treated purified total RNA, 1 μl 5’ primer (Table 3.16), 1 μl 3’ primer (Table 3.16), 
5 μl 5X PCR buffer (Promega), 1.5 μl 25 mM MgCl2, 0.5 μl 10 mM dNTP, 0.1 μl Taq 
polymerase (Promega) were added in sequence and mixed. The following cycling 
parameters were repeated for 40 cycles — 95°C for 30 s, 50°C for 30 s and 72°C for 
30 s. The extension products were analysed through 2.5 % agarose gel electrophoresis 
to ensure that there was no detectable DNA band. 
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3.3.4.5 Reverse transcription (RT) PCR 
In order to generate complementary DNA (cDNA) from the DNaseI treated purified 
total RNA samples, a RT-PCR reaction was carried out using the TaqMan
®
 
MicroRNA reverse transcription kit (Roche). In a 200 µl PCR tube, 5.55 μl RNase-
free water, 6 μl DNaseI treated purified total RNA, 1.5 μl 50 μM random hexamer, 
3 μl 10X RT buffer, 6.6 μl 25 mM MgCl2, 6 μl 10 mM dNTP, 0.6 μl RNase inhibitor, 
0.75 μl reverse transcriptase were added in sequence and mixed. The following 
cycling parameters were carried out — 25°C for 5 min, 42°C for 60 min and 70°C for 
5 min. In order to analyse the quality of cDNA generated, a PCR reaction and 2.5 % 
agarose gel electrophoresis were carried out to ensure that there was a defined DNA 
band (refer to section 3.3.4.4). 
 
3.3.4.6 Quantitative real-time PCR 
For quantitative real-time PCR, two sets of triplicates that contained different primers 
(Table 3.16) were prepared for each DNaseI treated purified total RNA sample. One 
set contained HIS3 ORF 5’ and 3’ primers, while the second set contained primers for 
the reference gene (ACT1 ORF 5’ and 3’ primers for samples grown in broth and 18S 
rRNA 5’ and 3’ primers for samples grown on plates). For HIS3 and ACT1 ORF 
primers, 6.5 μl RNase-free water, 5 μl 1:10 diluted cDNA obtained from RT-PCR, 
0.5 μl 10 µM 5’ primer, 0.5 μl 10 µM 3’ primer, 12.5 μl 2X Maxima® SYBR 
Green/ROX qPCR Master Mix (Fermentas) were added in sequence and mixed. For 
18S rRNA primers, 11 μl RNase-free water and 0.5 μl 1:10 diluted cDNA obtained 
from RT-PCR were used instead. A non-template control to verify amplification 
quality was included for each pair of primers used. The ABI PRISM
®
 7000 sequence 
detection system (Applied Biosystems) was used to carry out real-time PCR using 
 87 
 
standard thermal cycling parameters. 
 
Table 3.16 Primers used for quantitative real-time PCR 
Gene Primer name Sequence 
Target gene HIS3 ORF 5’ CTTACACATAGACGACCATCAC 
HIS3 ORF 3’ GCAAATCCTGATCCAAACCT 
Reference gene ACT1 ORF 5’ GACCAAACTACTTACAACTCCA 
ACT1 ORF 3’ CATTCTTTCGGCAATACCTG 
18S rRNA 5’ ATTCCTAGTAAGCGCAAGTCATCAG 
18S rRNA 3’ GACGGGCGGTGTGTACAAA 
 
The amount of HIS3 mRNA relative to ACT1 mRNA was determined by quantitative 
real-time PCR. The relative expression level of HIS3 mRNA was calculated using the 
comparative delta Ct (threshold cycle number) method. ∆Ct values were first obtained 
by taking the difference between the average HIS3 Ct values and the average ACT1 Ct 
values. 2
-∆Ct
 values were calculated, where the values obtained were then calculated 
relative to the uninduced WT histone H4 strain containing the PactT424-HA empty 
vector that was set as 1. The results are means ± S.D. for three replicate experiments. 
 
3.3.5 Protein analysis 
3.3.5.1 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins in the samples were separated using SDS-PAGE, where each SDS 
polyacrylamide denaturing gel was cast with a 4 % stacking gel (Appendix 8.19, 
Table 8.21) overlaying a 10–18 % resolving gel (Appendix 8.19, Table 8.22) for 
separating proteins of different sizes. Before loading the samples, they were mixed 
with equal volume 2X loading dye (Bio-Rad Laemmli sample buffer with 5 %  
β-mercaptoethanol) and the proteins in the samples were denatured by heating at 95°C 
for 5 min. A protein ladder (Bio-Rad or Genedirex) was loaded together with the 
samples, where the proteins in the samples were allowed to stack at a constant 
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100 volts in 1X Tris-glycine SDS running buffer. When the dye front had reached the 
resolving gel, the voltage was increased to a constant 120 volts for separation of the 
proteins in the samples. 
 
3.3.5.2 Western blot 
Separated proteins on the gel were transferred onto a nitrocellulose membrane (Bio-
Rad) using the Semi-Dry Electrophoretic Transfer Cell system (Bio-Rad). The 
transfer for two gels was carried out at 0.23 A for 75 min in freshly prepared 1X 
transfer buffer, which is a mixture of 30 ml sterile water, 10 ml methanol and 10 ml 
5X transfer buffer (Appendix 8.20, Table 8.23). The membrane was blocked with 
either 5 % skim milk (for detection of most proteins) or 3 % BSA (for detection of 
histones) in Tris-buffered Saline Tween-20 (TBST, Appendix 8.21, Table 8.24) for 
2 h. After blocking the membrane, the blocking solution was removed and primary 
antibodies (Table 3.17) were added using TBST as diluent, then incubated at 4°C 
overnight. After incubation, the solution was removed and the membrane was washed 
three times with TBST for 15 min each. Secondary antibodies (Table 3.17) were 
added using TBST as diluent, then incubated at 4°C for 2 h. After incubation, the 
solution was removed and the membrane was washed three times with TBST for 
15 min each. 
Table 3.17 Primary and secondary antibodies used in Western blotting 














Rabbit α-H4K8ac (Millipore) 1:10000 






Chemiluminescence detection was carried out using Amersham ECL Plus WB 
Detection Reagents (GE Healthcare) and Amersham ECL Advanced WB Detection 
Kit (GE Healthcare) on films for the various indicated exposure time. In order to 
determine the loading control, Coomassie Blue staining of the membrane was carried 
out after stripping the membrane with 0.2 M NaOH for 5 min. The membrane was 
washed with distilled water for 5 min, both before and after stripping the membrane 
with 0.2 M NaOH. The membrane was incubated in Coomassie Blue (Sigma-Aldrich) 
staining solution (Appendix 8.22, Table 8.25) until it turned dark blue, then incubated 
in destaining solution until the protein bands were clearly discernible (Appendix 8.22, 
Table 8.26). 
 
3.3.6 Chromatin immunoprecipitation (ChIP) 
As discussed earlier (refer to section 1.2.5), ChIP is an immunoprecipitation 
experimental technique that allows the study of interactions between proteins and 
DNA in a cell. 37 % formaldehyde is used to crosslink the proteins to the DNA, while 
2.5 M glycine is used to quench the 37 % formaldehyde and stop the crosslinking 
reaction. Chromatin is isolated and antibodies against the protein or histone 
modification-of-interest are used to determine whether the target binds to a specific 
region of the genome. 
 
3.3.6.1 Culturing and crosslinking of sample 
Cells were grown for ChIP using the broth method, where the required S. cerevisiae 
strain was inoculated in 100 ml glucose complete media or other selective media. The 
culture was incubated at 28°C until OD600 = 1.0, before splitting it into two 50 ml 
cultures. For one culture, after centrifuging at 4000 rpm for 5 min, the supernatant 
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was removed and the cells were washed in 50 ml sterile water. After centrifuging at 
4000 rpm for 5 min, the supernatant was removed and a 2 h induction in 50 ml media 
containing 3-AT was carried out. 1.5 ml 37 % formaldehyde was added to each 
culture and crosslinking was carried out for 20 min with gentle agitation at 28°C. 3 ml 
2.5 M glycine was added to each culture and termination of the crosslinking reaction 
was carried out for 5 min with gentle agitation at 28°C. After centrifuging at 
4000 rpm for 5 min, the supernatant was discarded into a formaldehyde waste bottle 
and the cells were washed in 50 ml ice cold sterile water. After centrifuging at 
4000 rpm for 5 min, the supernatant was removed and the cells were washed again in 
50 ml ice cold sterile water. After centrifuging at 4000 rpm for 5 min, the supernatant 
was removed and the cells were washed in 1 ml ice cold sterile water. The 
resuspension was transferred into a 1.5 ml microtube. After centrifuging at 7000 rpm 
for 1 min, the supernatant was completely removed and the cell pellet was stored at  
-80°C. 
 
3.3.6.2 Cell lysis and sonication 
The cell pellet was resuspended in 1 ml ice cold yeast lysis buffer (Appendix 8.23, 
Table 8.27) containing 10 µl 200 mM phenylmethanesulphonylfluoride (PMSF), 
before transferring to a 2 ml screw cap tube containing 500 μl glass beads. In a bead 
beater (BioSpec Products), the cells were homogenised at top speed for 1 min four 
times, with 1 min rest on ice in between. The top and bottom of the 2 ml screw cap 
tube were punctured using a 25 g needle. The tube was assembled on top of the flared 
portion of an adaptor, which was prepared from a 5 ml syringe, then the set-up was 
rested on top of a 15 ml falcon tube. After centrifuging at 1000 rpm for 1 min, the 
flow through was transferred into a 1.5 ml microtube. After centrifuging at 13000 rpm 
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for 30 min at 4°C, the supernatant was removed and the cell lysate was carefully 
resuspended completely in 500 µl ice cold yeast lysis buffer containing 5 µl 200 mM 
PMSF. The cell lysate was sonicated using a microtip sonicator (Sanyo Soniprep 150). 
The ultrasonic probe was first cleaned with 70 % ethanol, then inserted into the lysate 
suspension, close to the bottom of the 1.5 ml microtube. The lysate suspension was 
sonicated at a continuous power output of 50 % for 15 s six times, with 1 min rest on 
ice in between. It is important to take note that the cell lysate should be sonicated over 
a time course to identify the optimum sonication conditions to be used for the 
remaining samples. After centrifuging at 13000 rpm for 15 min at 4°C, the 
supernatant (chromatin solution) was transferred into a new 1.5 ml microtube and 
stored at -80°C. 
 
3.3.6.3 Analysis of chromatin fragment size 
In order to ensure that the sonicated cell lysate contained DNA sheared to the desired 
fragment sizes of 100–500 bp, 50 µl of the chromatin solution was used for reversal 
of crosslinks. In a 500 µl PCR tube, 50 µl chromatin solution, 140 µl pronase working 
buffer (Appendix 8.24, Table 8.28) and 10 µl pronase (20 µg/µl) were added in 
sequence and mixed. Pronase contains various proteolytic components and is used to 
degrade proteins both extensively and completely in order to aid DNA purification. 
For the reversal of crosslinks, the mixture was incubated at 42°C for 2 h, then 65°C 
for 6 h, before being transferred into a 1.5 ml microtube. Upon addition of 200 μl 
phenol:chloroform 5:1 (pH4.7, Sigma-Aldrich), the mixture was vortexed at high 
speed for 5 min. After centrifuging at 13000 rpm for 10 min, the mixture was 
separated into two phases — aqueous DNA at the top and phenol at the bottom. 
Without disturbing the other phase, the top aqueous DNA phase was carefully 
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extracted and transferred into a new 1.5 ml microtube. Upon addition of 200 μl 0.3 M 
NaAc and 1 µl glycogen, the microtube was vortexed briefly to mix the contents. 
Upon addition of 1 ml 100 % EtOH, the microtube was vortexed briefly to mix the 
contents. The mixture was incubated at -80°C for 2 h to precipitate the DNA. After 
centrifuging at 13000 rpm for 10 min, the supernatant was removed. Upon addition of 
700 μl 70 % EtOH, the mixture was centrifuged at 13000 rpm for 5 min and the 
supernatant was removed. The DNA pellet was dried under vacuum for 15 min, then 
resuspended in 50 μl sterile water and stored at -20°C. 10 μl of the input DNA 
resuspension was analysed through 1.5 % agarose gel electrophoresis to check the 
DNA fragment sizes, while 2 μl of the input DNA resuspension was used for the 
quantitation of DNA carried out using a nanodrop machine (refer to section 3.3.4.2). 
 
3.3.6.4 Immunoprecipitation 
For each immunoprecipitation reaction, an equal mix of rProtein A Sepharose
TM
 Fast 
Flow beads (GE Healthcare) and Protein G Sepharose
TM
 4 Fast Flow beads (GE 
Healthcare) were used. 10 µl protein A/G beads mixture was washed with 250 µl 
yeast lysis buffer. After centrifuging at 5000 rpm for 1 min, the supernatant was 
removed. Upon addition of 250 µl yeast lysis buffer, the protein A/G beads mixture 
was incubated at 4°C for 1 h for equilibration. After centrifuging at 5000 rpm for 
1 min, the supernatant was removed. Upon addition of 400 µl yeast lysis buffer, 5 µl 
200 mM PMSF, 100 µl chromatin solution and the desired antibody (Table 3.18), the 
mixture was incubated with rotation at 4°C for 2 h. A no-antibody control was 





Table 3.18 Antibodies used in immunoprecipitation 
Antibody Volume used 
Rabbit α-H4 (Millipore) 4 µl 
Rabbit α-H4K16ac (Active Motif) 8 µl 
Rabbit α-GCN5 (Santa Cruz) 8 µl 
 
After incubation, the mixture was centrifuged at 5000 rpm for 1 min, where the 
supernatant was kept for subsequent protein analysis to check protein stability and 







 polypropylene centrifuge tube filters (Sigma-Aldrich). 
The protein A/G beads mixture was washed three times for 10 min each with yeast 
lysis buffer, two times for 10 min each with yeast lysis buffer with 0.5 M NaCl 
(Appendix 8.25, Table 8.29), once for 15 min with ChIP wash buffer (Appendix 8.25, 
Table 8.30), then once for 15 min with 1X TE buffer (Appendix 8.25, Table 8.31). 
Each wash was incubated with rotation at 4°C, before centrifuging at 5000 rpm for 
1 min. After centrifuging at 5000 rpm for 1 min again to ensure dryness of the filter, 
the filter portion of the centrifuge tube filter was transferred to a 1.5 ml microtube. 
Upon addition of 120 µl ChIP elution buffer (Appendix 8.25, Table 8.32), the proteins 
bound to the beads were eluted by heating at 65°C for 10 min. After centrifuging at 
6000 rpm for 1 min, 80 µl of the flow through was used for reversal of crosslinks. In a 
500 µl PCR tube, 80 µl flow through, 110 µl 1X TE buffer and 10 µl pronase 
(20 µg/µl) were added in sequence and mixed. The subsequent steps were the same as 
that described before (refer to section 3.3.6.3). The DNA pellet was dried under 
vacuum for 15 min, then resuspended in 20 μl sterile water and stored at -20°C. 
 
3.3.6.5 PCR and quantitative real-time PCR analysis 
In order to check both input DNA resuspension and immunoprecipitated DNA 
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resuspension for presence of DNA before real-time PCR, a PCR reaction was carried 
out in a 200 µl PCR tube, where 11.8 μl sterile water, 1 μl 1:10 diluted input DNA 
resuspension or 1 µl neat immunoprecipitated DNA resuspension, 0.5 μl 5’ primer 
(Table 3.19), 0.5 μl 3’ primer (Table 3.19), 4 μl 5X PCR buffer (Promega), 1.5 μl 
25 mM MgCl2, 0.5 μl 10 mM dNTP, 0.2 μl Taq polymerase (Promega) were added in 
sequence and mixed. The following cycling parameters were repeated for 40 cycles 
— 95°C for 30 s, 50°C for 30 s and 72°C for 30 s. The extension products were 
analysed through 2.5 % agarose gel electrophoresis. Quantitative real-time PCR was 
carried out as previously described (refer to section 3.3.4.6) using various pairs of 
primers that amplify the indicated DNA fragments (Table 3.19). 
 
Table 3.19 Primers used for PCR and quantitative real-time PCR 








HIS3 Pro 3’ TTGCCTTCGTTTATCTTGCC 




HIS3 ORF 3’ GCAAATCCTGATCCAAACCT 
 
In order to calculate the relative percent IP, ∆Ct values were first obtained by taking 
the difference between the average IP Ct values and the average input Ct values.  
2
-∆Ct
 values were calculated, followed by the ratio of Input:IP. The values were 
normalised to the input DNA sample and the no-antibody control for each strain after 
factoring the 50-fold dilution into the calculations. The values obtained were then 
calculated relative to the uninduced WT histone H4 strain that was set as 1. The 
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Genomic library screening of 
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4I.1 Phenotype testing of histone H4 mutant strains Y51A, E53A and Y98A 
Previous studies had shown that alanine-scanning mutagenesis of histone H4 amino 
acid residues Y51, E53 and Y98 conferred observable phenotypes, where phenotype 
testing was focused on 3-AT sensitivity that arose due to defects in transcriptional 
activation of the HIS3 gene by Gcn4 (AT), antimycin A sensitivity that arose due to 
defects in transcriptional activation of the GAL genes by Gal4 (AA) or temperature 
sensitivity that arose due to general transcriptional defects (TS) phenotypes (refer to 
section 1.2.3; Lee, 2007). 
 
On histidine-depleted media containing 3-AT, the H4Y51A and H4Y98A mutant 
strains exhibited reduced growth as compared to the positive control WT histone H4 
strain (Figure 4.1, second panel, compare lanes 2 and 4 to lane 1). In fact, the 
H4Y98A mutant strain exhibited a more severe AT phenotype as compared to the 
H4Y51A mutant strain (Figure 4.1, second panel, compare lane 2 to lane 4). However, 
unlike the negative control ∆GCN4 deletion strain, there was some background 
growth of the H4Y51A and H4Y98A mutant strains (Figure 4.1, second panel, 
compare lanes 2 and 4 to lane 6). This was most likely due to the use of different 
batches of plates, so both a positive control and a negative control were included on 
each plate as far as possible. 
 
At the non-permissive temperature of 38°C, the growth of the H4Y51A, H4E53A and 
H4Y98A mutant strains was completely inhibited as compared to the WT histone H4 
strain (Figure 4.1, third panel, compare lanes 2, 3 and 4 to lane 1). 
 
On galactose media containing antimycin A, the H4Y98A mutant strain exhibited 
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reduced growth as compared to the WT histone H4 strain (Figure 4.1, fourth panel, 
compare lane 4 to lane 1). However, unlike the negative control ∆GAL4 deletion 
strain, there was some background growth of the H4Y98A mutant strain (Figure 4.1, 
fourth panel, compare lane 4 to lane 5). 
 
 
Figure 4.1 Observable phenotypes of the H4Y51A, H4E53A and H4Y98A mutant strains. The 
histone H4 deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 served as the positive 
control, while the ∆GCN4 and ∆GAL4 deletion strains served as the negative controls for AT and AA 
phenotypes, respectively. The H- plate served as the loading control. Tenfold serial dilutions were 
titrated onto the indicated plates and incubated at 28°C for six days, unless otherwise indicated.  
H-: media lacking histidine, AT: 3-amino-1,2,4-triazole, Gal: galactose, AA: Antimycin A. 
 
Thus, the H4Y51A mutant strain exhibited the AT and TS phenotypes, the H4E53A 
mutant strain exhibited the TS phenotype, and the H4Y98A mutant strain exhibited 
the AT, TS and AA phenotypes (Table 4.1). 
 
Table 4.1 Tabulation of observable phenotypes of the H4Y51A, H4E53A and 
H4Y98A mutant strains 
Histone H4 mutant strain AT phenotype TS phenotype AA phenotype 
H4Y51A √ √ × 
H4E53A × √ × 
H4Y98A √ √ √ 
 
4I.2 Suppression studies via over-expression for observable phenotypes of histone H4 
mutant strains Y51A, E53A and Y98A 
As the average fragment size of the genomic library YEp13 is approximately 6 kb, at 
least 10,000 transformants on each transformation plate had to be obtained in order to 
ensure coverage of the approximately 12,000 kb S. cerevisiae genome for about five 
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times. For the H4Y51A, H4E53A and H4Y98A mutant strains, the number of primary 
transformants obtained was 63,000 primary transformants, 45,000 primary 
transformants and 56,000 primary transformants, respectively (Lee, 2007). 
 
Different numbers of YEp13 suppressor plasmids were isolated for each of the 
observable phenotypes of the histone H4 mutant strains Y51A, E53A and Y98A 
(Table 4.2). However, no YEp13 suppressor plasmids were isolated for the TS 
phenotype of the H4Y51A mutant strain and for the TS and AA phenotypes of the 
H4Y98A mutant strain despite repeated attempts (Lee, 2007). 
 
The isolated YEp13 suppressor plasmids were transformed into the ∆HHF1/2 deletion 
strain and a histone complementation assay was carried out to ensure that the isolated 
YEp13 suppressor plasmids did not encode WT histone H4 (Lee, 2007). The plasmids 
were also transformed back into the original histone mutant strain for which they were 
determined to be multi-copy phenotypic suppressors, in order to establish plasmid 
linkage of phenotypic suppression. It was found that phenotypic suppression by the 
isolated YEp13 suppressor plasmids was 100 % plasmid linked (Lee, 2007). 
 
In addition, the isolated YEp13 suppressor plasmids were tested for phenotype 
specificity and strain specificity (Table 4.2). For phenotype specificity, the isolated 
YEp13 suppressor plasmids were transformed into the original histone mutant strain 
for which they were determined to be multi-copy phenotypic suppressors and tested 
for their ability to suppress the other phenotypes of the original histone mutant strain 
(Lee, 2007). For example, the five YEp13 suppressor plasmids isolated as suppressors 
for the AT phenotype of the H4Y98A mutant strain were tested for their ability to 
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suppress the TS and AA phenotypes of the H4Y98A mutant strain (Table 4.2). For 
strain specificity, the isolated YEp13 suppressor plasmids were cross transformed into 
the other histone mutant strains that exhibited the same phenotype as the original 
histone mutant strain (Lee, 2007). For example, the 11 YEp13 suppressor plasmids 
isolated as suppressors for the TS phenotype of the H4E53A mutant strain were tested 
for their ability to suppress the TS phenotype of the H4Y51A and H4Y98A mutant 
strains (Table 4.2). 
 
Table 4.2 Details of YEp13 suppressor plasmids isolated for each of the 




Number of suppressor plasmids isolated 
AT phenotype TS phenotype AA 
phenotype 
H4Y51A 9 
 AT phenotype specific 
 3 suppressor plasmids 
not strain specific, 




H4E53A NA 11 
 TS phenotype specific 
 11 suppressor plasmids 
not strain specific, could 
partially suppress 




 AT phenotype specific 
 Strain specific 
0 0 
 
In order to identify the genomic DNA fragments contained in the isolated YEp13 
suppressor plasmids, sequencing results were analysed using the Basic Local 
Alignment Search Tool (BLAST). Coupled with sub-cloning to split the multiple 
ORFs found in each genomic DNA fragment (Appendix 8.1, Table 8.1; Appendix 8.6, 
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Table 8.6), the identities of the genes responsible for suppression of the AT phenotype 
of the H4Y51A mutant strain (Table 4.3), the TS phenotype of the H4E53A mutant 
strain (Table 4.4) and the AT phenotype of the H4Y98A mutant strain (Table 4.5) 























Table 4.3 Suppressors identified from H4Y51A AT phenotype suppression 
studies (Table adapted from Saccharomyces Genome Database) 








Subunit of the cytosolic chaperonin Cct ring 
complex, related to Tcp1p, essential protein that 
is required for the assembly of actin and tubulins 




Transcription factor required for gene regulation 
in response to pheromones; also required during 
meiosis; exists in two forms, a slower-migrating 
form more abundant during vegetative growth 






specificity) kinase involved in control of 
chromosome segregation and in regulating entry 
into meiosis; related to mammalian glycogen 




Protein of unknown function, green fluorescent 
protein (GFP)-fusion protein localizes to the cell 
periphery; msc3 mutants are defective in 
directing meiotic recombination events to 





Protein of unknown function; mtc6 is 




Proline tRNA (tRNA-Pro), predicted by 
tRNAscan-SE analysis; can mutate to suppress 




Basic leucine zipper (bZIP) transcription factor 
required for oxidative stress tolerance; activated 
by H2O2 through the multistep formation of 
disulfide bonds and transit from the cytoplasm to 
the nucleus; mediates resistance to cadmium 
72,532 Viable 
YDR187C Dubious open reading frame unlikely to encode 
a protein, based on available experimental and 
comparative sequence data; partially overlaps 
the verified, essential ORF CCT6/YDR188W 
18,444 Inviable 
YHR177W Putative protein of unknown function; 






Table 4.4 Suppressors identified from H4E53A TS phenotype suppression 
studies (Table adapted from Saccharomyces Genome Database) 






Centromere protein that resembles histone 
H3, required for proper kinetochore 
function; homolog of human CENP-A; 




Table 4.5 Suppressors identified from H4Y98A AT phenotype suppression 
studies (Table adapted from Saccharomyces Genome Database) 







Tetrameric histone acetyltransferase with 
similarity to Gcn5p, Hat1p, Elp3p, and Hpa3p; 
acetylates histones H3 and H4 in vitro and 




Protein of unknown function; interacts with 





Ski complex component and WD-repeat 
protein, mediates 3'-5' RNA degradation by the 
cytoplasmic exosome; also required for 
meiotic double-strand break recombination; 




Putative RNA helicase related to Ski2p, 
involved in translation inhibition of non-
poly(A) mRNAs; required for repressing 
propagation of dsRNA viruses 
224,849 Viable 
YMR141C Dubious open reading frame unlikely to 
encode a functional protein, based on available 
experimental and comparative sequence data 
12,108 Viable 
YOR314W Dubious open reading frame unlikely to 
encode a protein, based on available 
experimental and comparative sequence data 
12,523 Viable 
 
4I.3 Suppressor gene knock out studies 
The screening of the three conditional histone H4 mutant strains Y51A, E53A and 
Y98A for multi-copy phenotypic suppressors was a tool to understand how histones 
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regulate gene expression in WT cells. Thus, it was important to determine whether 
gene knock out strains of the genes identified as multi-copy phenotypic suppressors 
could phenocopy the conditional histone H4 mutant alleles. However, gene knock out 
strains could not be obtained for those genes identified where the null mutant was 
inviable (Tables 4.3 and 4.4), such as CCT6 and YDR187C that suppressed the AT 
phenotype of the H4Y51A mutant strain and CSE4 that suppressed the TS phenotype 
of the H4E53A mutant strain. In addition, gene knock out strains were obtained only 
for those genes identified that encoded for functional proteins and not for those genes 
identified that were unlikely to encode for functional proteins (Table 4.5), such as 
YMR141C and YOR314W that suppressed the AT phenotype of the H4Y98A mutant 
strain. 
 
On histidine-depleted media containing 3-AT, the ∆SKI8, ∆YAP1 and ∆MCK1 
deletion strains exhibited a slight AT phenotype (Figure 4.2, second panel, compare 
lanes 4, 10 and 13 to lanes 1 and 8). This indicated that these genes encode for 
proteins that could play a minor role in the Gcn4-mediated transcriptional activation 
of the HIS3 gene. 
 
On the other hand, the ∆HPA2, ∆SLH1, ∆SIP5, ∆YHR151C, ∆MSC3, ∆KAR4 and 
∆YHR177W deletion strains did not exhibit the AT phenotype (Figure 4.2, second 
panel, compare lanes 3, 5, 6, 7, 11, 12 and 14 to lanes 1 and 8). This indicated that 
these genes do not encode for proteins involved in the Gcn4-mediated transcriptional 
activation of the HIS3 gene. A second reason to explain the absence of an AT 
phenotype is functional redundancy, where a different protein possessing similar 




Figure 4.2 Observable phenotypes of gene knock out strains of the genes identified as multi-copy 
phenotypic suppressors. The WT BY4741∆W strain served as the positive control, while the ∆GCN4 
deletion strain served as the negative control for AT phenotype. The H- plate served as the loading 
control. Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C for six 










4II.1 Alanine-scanning mutagenesis of histone H4 tyrosine residues 
As alanine-scanning mutagenesis of histone H4 tyrosine residues Y51 and Y98 
conferred observable phenotypes (refer to section 4I.1), it was of interest to determine 
whether site-directed alanine mutagenesis of the other two histone H4 tyrosine 
residues Y72 and Y88 would confer similar observable phenotypes. 
 
The histone H4 tyrosine-alanine single-point mutant proteins each expressed from a 
LEU2-marked YCplac111 vector were transformed into the histone H4 deletion strain 
BY4742∆W∆HHF1/2, which was dependent on a stable and essential episomal source 
of WT histone H4 expressed from a URA3-marked PactT316 vector. As cells 
containing URA3-marked plasmids cannot grow on media containing 5-FOA, 
negative selection was used to shuffle out the URA3-marked PactT316 vector, such 
that the histone H4 deletion strain BY4742∆W∆HHF1/2 contained only the LEU2-
marked YCplac111 vector expressing non-lethal histone H4 tyrosine-alanine single-
point mutant proteins (refer to section 3.3.2.3). 
 
On media containing 5-FOA, the H4Y51A and H4Y98A mutant strains exhibited 
reduced growth as compared to the positive control WT histone H4 strain (Figure 4.3, 
second panel, compare lanes 3 and 4 to lane 1). In fact, the H4Y98A mutant strain 
exhibited less growth as compared to the H4Y51A mutant strain (Figure 4.3, second 
panel, compare lane 3 to lane 4). The H4Y88A mutant strain exhibited growth 
comparable to the positive control WT histone H4 strain (Figure 4.3, second panel, 
compare lane 6 to lane 1). This indicated that these three histone H4 mutant proteins 
could complement the genomic deletion of histone H4, although to different degrees, 
where the H4Y88A mutant protein complemented fully, while the H4Y98A mutant 
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protein complemented only partially. On the other hand, the growth of the H4Y72A 
mutant strain was completely inhibited as compared to the WT histone H4 strain 
(Figure 4.3, second panel, compare lane 5 to lane 1). This indicated that the H4Y72A 
mutant protein was unable to complement the genomic deletion of histone H4, 
indicating that this residue may be essential for cell viability. 
 
The growth of the negative control YCplac111 empty vector was completely inhibited 
as compared to the WT histone H4 strain (Figure 4.3, second panel, compare lane 2 to 
lane 1). This indicated that the plasmid shuffling procedure was efficient in shuffling 
out the URA3-marked PactT316 vector expressing WT histone H4 and that the growth 




Figure 4.3 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 tyrosine-alanine single-point mutant proteins. The WT histone H4 expressed 
from YCplac111 served as the positive control, while the YCplac111 empty vector served as the 
negative control. The L- plate served as the loading control. Tenfold serial dilutions were titrated onto 
the indicated plates and incubated at 28°C for three days. L-: media lacking leucine, H-: media lacking 
histidine, FOA: 5-FOA. 
 
4II.1.1 Phenotype testing of histone H4 tyrosine residue mutant strains Y51A, Y88A 
and Y98A 
As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
3-AT, the H4Y51A and H4Y98A mutant strains exhibited the AT phenotype (Figure 
4.4, second panel, compare lanes 2 and 3 to lane 1). However, the H4Y88A mutant 
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strain did not exhibit the AT phenotype as it exhibited growth comparable to the 
positive control WT histone H4 strain (Figure 4.4, second panel, compare lane 4 to 
lane 1). This indicated that the histone H4 tyrosine residues Y51 and Y98 were likely 
to be involved in the Gcn4-mediated transcriptional activation of the HIS3 gene, while 
the histone H4 tyrosine residue Y88 was not. 
 
 
Figure 4.4 Observable phenotypes of the H4Y51A, H4Y88A and H4Y98A mutant strains. The 
histone H4 deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 served as the positive 
control. The L- plate served as the loading control. Tenfold serial dilutions were titrated onto the 
indicated plates and incubated at 28°C for six days, unless otherwise indicated. L-: media lacking 
leucine, H-: media lacking histidine, AT: 3-amino-1,2,4-triazole. 
 
4II.2 Characterisation of histone H4 tyrosine residue Y98 
As tyrosine residues can be phosphorylated upon PTM of histones (Singh and Gunjan, 
2011), it was of interest to determine whether histone H4 is phosphorylated at tyrosine 
residue Y98 or whether other factors come into play during the Gcn4-mediated 
transcriptional activation of the HIS3 gene. 
 
In addition to the original site-directed alanine mutagenesis of histone H4 Y98, 
histone H4 Y98 tyrosine-phenylalanine and tyrosine-aspartic acid single-point 
mutants were generated. Phenylalanine (F) resembles tyrosine (Y) structurally, except 
that the hydroxyl group of the aromatic ring is absent, which prevents 
phosphorylation from taking place. Unlike the hydrophobic tyrosine, aspartic acid (D) 
is a negatively charged residue, where this single-point mutation allows the study of 
whether hydrophobicity at histone H4 position 98 is required for the Gcn4-mediated 
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transcriptional activation of the HIS3 gene. 
 
On media containing 5-FOA, the H4Y98F mutant strain exhibited growth comparable 
to the positive control WT histone H4 strain (Figure 4.5, second panel, compare lane 
5 to lane 1). In fact, the H4Y98A mutant strain exhibited less growth as compared to 
the H4Y98F mutant strain (Figure 4.5, second panel, compare lane 3 to lane 5). This 
indicated that these two histone H4 mutant proteins could complement the genomic 
deletion of histone H4, although to different degrees, where the H4Y98F mutant 
protein complemented fully, while the H4Y98A mutant protein complemented only 
partially. On the other hand, the growth of the H4Y98D mutant strain was completely 
inhibited as compared to the WT histone H4 strain (Figure 4.5, second panel, compare 
lane 4 to lane 1). This indicated that the H4Y98D mutant protein was unable to 
complement the genomic deletion of histone H4. 
 
 
Figure 4.5 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 tyrosine-phenylalanine and tyrosine-aspartic acid single-point mutant 
proteins. The WT histone H4 expressed from YCplac111 served as the positive control, while the 
YCplac111 empty vector served as the negative control. The L- plate served as the loading control. 
Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C for three days.  
L-: media lacking leucine, H-: media lacking histidine, FOA: 5-FOA. 
 
Similar results were also obtained when the histone H4 tyrosine-phenylalanine and 
tyrosine-aspartic acid single-point mutant proteins were each expressed from the 
TRP1-marked PactT424-HA vector (Figure 4.6, second panel, compare lanes 4, 5, and 





Figure 4.6 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 tyrosine-phenylalanine and tyrosine-aspartic acid single-point mutant 
proteins. The WT histone H4 expressed from PactT424-HA served as the positive control, while the 
PactT424-HA empty vector served as the negative control. The W- plate served as the loading control. 
Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C for three days.  
W-: media lacking tryptophan, H-: media lacking histidine, FOA: 5-FOA. 
 
4II.2.1 Phenotype testing of histone H4 mutant strains Y98A and Y98F 
As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
3-AT, the H4Y98A mutant strain exhibited the AT phenotype (Figure 4.7, second 
panel, compare lane 2 to lane 1). However, the H4Y98F mutant strain did not exhibit 
the AT phenotype as it showed growth comparable to the positive control WT histone 
H4 strain (Figure 4.7, second panel, compare lane 3 to lane 1). This indicated that 
histone H4Y98 phosphorylation plays no role in the Gcn4-mediated transcriptional 
activation of the HIS3 gene. Rather, either hydrophobicity or the steric effect of the 
aromatic ring at histone H4 position 98 is required for the Gcn4-mediated 
transcriptional activation of the HIS3 gene. 
 
 
Figure 4.7 Observable phenotypes of the H4Y98A and H4Y98F mutant strains. The histone H4 
deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 served as the positive control. The L- 
plate served as the loading control. Tenfold serial dilutions were titrated onto the indicated plates and 
incubated at 28°C for six days, unless otherwise indicated. L-: media lacking leucine, H-: media 





Directed screening of 




4III.1 Suppression studies via over-expression of HATs for AT phenotype of histone 
H4 mutant strain Y98A 
As discussed earlier (refer to section 4I.2), on histidine-depleted media containing  
3-AT, the H4Y98A mutant strain exhibited the AT phenotype that was suppressed by 
the over-expression of the HAT Hpa2. However, the ∆HPA2 deletion strain could not 
phenocopy the conditional histone H4Y98A mutant allele (refer to section 4I.3). This 
indicated the possibility of functional redundancy, where a different protein 
possessing similar functions could be present in the cell. Thus, a second, directed 
screening of the H4Y98A mutant strain was carried out with the focus on HATs. 
 
Although 12 HATs were selected for the directed screening of the H4Y98A mutant 
strain, cloning was successful only for nine HATs (Table 4.6). In addition, the over-
expression of the HATs was analysed in the H4Y98A mutant strain to ensure that the 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.8 Over-expression of the HATs in the H4Y98A mutant strain. The H4Y98A mutant strain 
over-expressing the HATs Gcn5, Hpa1, Hpa2, Hpa3, Esa1, Hat1, Hat2, Rtt109 and Sas2 were grown in 
tryptophan-depleted liquid media to an OD600 value of 1. All the HATs were expressed from  
PactT424-HA. The H4Y98A mutant strain containing the PactT424-HA empty vector served as the 
negative control. Y98A: BY4742∆W∆HHF1/2 + YCplac111-HHF1 Y98A. 
 
4III.1.1 Suppression of the AT phenotype of the H4Y98A mutant strain by the over-
expression of HATs 
On histidine-depleted media containing different concentrations of 3-AT, the 
H4Y98A mutant strain over-expressing non-tagged and HA-tagged Gcn5 exhibited 
increased growth as compared to the negative controls PactT424 and PactT424-HA 
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empty vectors (Figure 4.9, second and third panels, compare lanes 5, 6, 7 and 8 to 
lanes 3 and 4). At the lower concentration of 3-AT (50 mM), both non-tagged and 
HA-tagged Gcn5 suppressed the AT phenotype of the H4Y98A mutant strain such 
that it exhibited growth comparable to the positive control WT histone H4 strain 
(Figure 4.9, second panel, compare lanes 5, 6, 7 and 8 to lanes 1 and 2). At the higher 
concentration of 3-AT (100 mM), both non-tagged and HA-tagged Gcn5 could 
suppress the AT phenotype of the H4Y98A mutant strain, but not as efficiently as 
compared to the lower concentration of 3-AT (Figure 4.9, third panel, compare lanes 
5, 6, 7 and 8 to lanes 1 and 2). 
 
 
Figure 4.9 Gcn5 suppression of the AT phenotype of the H4Y98A mutant strain. The WT histone 
H4 strain containing PactT424 and PactT424-HA empty vectors served as the positive controls, while 
the H4Y98A mutant strain containing PactT424 and PactT424-HA empty vectors served as the 
negative controls. The W- plate served as the loading control. Tenfold serial dilutions were titrated onto 
the indicated plates and incubated at 28°C for six days. W-: media lacking tryptophan, HW-: media 
lacking histidine and tryptophan, AT: 3-amino-1,2,4-triazole. 
 
On histidine-depleted media containing different concentrations of 3-AT, the 
H4Y98A mutant strain over-expressing non-tagged and HA-tagged Hpa1 and Hpa2 
exhibited increased growth as compared to the negative controls PactT424 and 
PactT424-HA empty vectors (Figure 4.10, second and third panels, compare lanes 5, 6, 
7 and 8 to lanes 3 and 4). At the lower concentration of 3-AT, both non-tagged and 
HA-tagged Hpa1 and Hpa2 suppressed the AT phenotype of the H4Y98A mutant 
strain such that it exhibited growth comparable to the positive control WT histone H4 
strain (Figure 4.10, second panel, compare lanes 5, 6, 7 and 8 to lanes 1 and 2). At the 
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higher concentration of 3-AT, both non-tagged and HA-tagged Hpa1 and Hpa2 could 
suppress the AT phenotype of the H4Y98A mutant strain, but not as efficiently as 
compared to the lower concentration of 3-AT (Figure 4.10, third panel, compare lanes 
5, 6, 7 and 8 to lanes 1 and 2). 
 
Figure 4.10 Hpa1 and Hpa2 suppression of the AT phenotype of the H4Y98A mutant strain. The 
WT histone H4 strain containing PactT424 and PactT424-HA empty vectors served as the positive 
controls, while the H4Y98A mutant strain containing PactT424 and PactT424-HA empty vectors 
served as the negative controls. The W- plate served as the loading control. Tenfold serial dilutions 
were titrated onto the indicated plates and incubated at 28°C for six days. W-: media lacking 
tryptophan, HW-: media lacking histidine and tryptophan, AT: 3-amino-1,2,4-triazole. 
 
Hpa2 and Hpa3 are close homologues, as they were found to share a 49 % DNA 
sequence identity and 81 % amino acid sequence identity (Angus-Hill et al., 1999). 
However, on histidine-depleted media containing different concentrations of 3-AT, 
the H4Y98A mutant strain over-expressing non-tagged and HA-tagged Hpa3 
exhibited growth comparable to the negative controls PactT424 and PactT424-HA 
empty vectors (Figure 4.11, second and third panels, compare lanes 5, 6, 7 and 8 to 
lanes 3 and 4). 
 
Figure 4.11 Hpa3 non-suppression of the AT phenotype of the H4Y98A mutant strain. The WT 
histone H4 strain containing PactT424 and PactT424-HA empty vectors served as the positive controls, 
while the H4Y98A mutant strain containing PactT424 and PactT424-HA empty vectors served as the 
negative controls. The W- plate served as the loading control. Tenfold serial dilutions were titrated onto 
the indicated plates and incubated at 28°C for six days. W-: media lacking tryptophan, HW-: media 
lacking histidine and tryptophan, AT: 3-amino-1,2,4-triazole. 
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Similarly, on histidine-depleted media containing different concentrations of 3-AT, 
the H4Y98A mutant strain over-expressing non-tagged and HA-tagged Esa1, Hat1, 
Hat2, Rtt109 and Sas2 exhibited growth comparable to the negative controls 
PactT424 and PactT424-HA empty vectors (Figure 4.12, second and third panels, 
compare lanes 5–14 to lanes 3 and 4). This indicated that the HATs Gcn5, Hpa1 and 
Hpa2 are multi-copy phenotypic suppressors of the AT phenotype of the H4Y98A 
mutant strain, while the HATs Hpa3, Esa1, Hat1, Hat2, Rtt109 and Sas2 are not. 
 
 
Figure 4.12 Esa1, Hat1, Hat2, Rtt109 and Sas2 non-suppression of the AT phenotype of the 
H4Y98A mutant strain. The WT histone H4 strain containing PactT424 and PactT424-HA empty 
vectors served as the positive controls, while the H4Y98A mutant strain containing PactT424 and 
PactT424-HA empty vectors served as the negative controls. The W- plate served as the loading 
control. Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C for six 
days. W-: media lacking tryptophan, HW-: media lacking histidine and tryptophan, AT: 3-amino-1,2,4-
triazole. 
 
4III.1.2 HATs phenotype specificity and strain specificity 
In addition, the HATs were tested for phenotype specificity and strain specificity. For 
phenotype specificity, the nine HATs were transformed into the H4Y98A mutant 
strain and tested for their ability to suppress the TS and AA phenotypes of the 
H4Y98A mutant strain. At the non-permissive temperature of 38°C, the growth of the 
H4Y98A mutant strain over-expressing HA-tagged HATs was completely inhibited as 
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compared to the WT histone H4 strain (Figure 4.13, second panel, compare lanes 3–5 
and 8–13 to lanes 1 and 6). On galactose media containing antimycin A, the H4Y98A 
mutant strain over-expressing HA-tagged HATs exhibited reduced growth as 
compared to the WT histone H4 strain (Figure 4.13, third panel, compare lanes 3–5 
and 8–13 to lanes 1 and 6). This indicated that the nine HATs, in particular the HATs 
Gcn5, Hpa1 and Hpa2, were phenotype-specific suppressors for the AT phenotype of 
the H4Y98A mutant strain. 
 
 
Figure 4.13 HATs phenotype specificity to the AT phenotype of the H4Y98A mutant strain. The 
WT histone H4 strain containing PactT424-HA empty vector served as the positive control, while the 
H4Y98A mutant strain containing PactT424-HA empty vector served as the negative control. The W- 
plate served as the loading control. Tenfold serial dilutions were titrated onto the indicated plates and 
incubated at 28°C for six days, unless otherwise indicated. W-: media lacking tryptophan,  
Gal: galactose, AA: Antimycin A. 
 
For strain specificity, the HATs Gcn5, Hpa1 and Hpa2 were transformed into the 
H4Y51A mutant strain and tested for their ability to suppress the AT and TS 
phenotypes of the H4Y51A mutant strain. On histidine-depleted media containing 
different concentrations of 3-AT, the H4Y51A mutant strain over-expressing HA-
tagged Gcn5, Hpa1 and Hpa2 exhibited growth comparable to the negative control 
PactT424-HA empty vector (Figure 4.14, second and third panels, compare lanes 4, 5 
and 6 to lane 3). At the non-permissive temperature of 38°C, the growth of the 
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H4Y51A mutant strain over-expressing HA-tagged Gcn5, Hpa1 and Hpa2 was 
completely inhibited as compared to the WT histone H4 strain (Figure 4.14, second 
and third panels, compare lanes 4, 5 and 6 to lane 1). This indicated that the HATs 
Gcn5, Hpa1 and Hpa2 were both strain-specific and phenotype-specific suppressors 
for the AT phenotype of the H4Y98A mutant strain. 
 
 
Figure 4.14 Gcn5, Hpa1 and Hpa2 strain specificity and phenotype specificity. The WT histone H4 
strain containing PactT424-HA empty vector served as the positive control, while the H4Y51A mutant 
strain containing PactT424-HA empty vector served as the negative control. The W- plate served as the 
loading control. Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C 
for six days, unless otherwise indicated. W-: media lacking tryptophan, HW-: media lacking histidine 
and tryptophan, AT: 3-amino-1,2,4-triazole. 
 
4III.2 Suppressor gene knock out studies 
4III.2.1 GCN5, HPA1, HPA2 and HPA3 single gene knock out studies 
On histidine-depleted media containing lower concentration of 3-AT, the ∆GCN5 and 
∆HPA1 deletion strains exhibited the AT phenotype (Figure 4.15, second panel, 
compare lanes 3 and 4 to lane 1), while the ∆HPA2 and ∆HPA3 deletion strains did 
not (Figure 4.15, second panel, compare lanes 5 and 6 to lane 1). On histidine-
depleted media containing higher concentration of 3-AT, the ∆GCN5, ∆HPA1 and 
∆HPA3 deletion strains exhibited the AT phenotype (Figure 4.15, third panel, 
compare lanes 3, 4 and 6 to lane 1), while the ∆HPA2 deletion strain did not (Figure 
4.15, third panel, compare lane 5 to lane 1). Interestingly, at the higher concentration 
of 3-AT, the ∆GCN5 and ∆HPA3 deletion strains exhibited an AT phenotype as 
severe as that of the negative control ∆GCN4 deletion strain (Figure 4.15, third panel, 
compare lanes 3 and 6 to lane 2). On the other hand, the ∆HPA1 deletion strain 
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exhibited a similar AT phenotype at both concentrations of 3-AT (Figure 4.15, second 
and third panels, compare lane 5 to lane 2). 
 
 
Figure 4.15 Observable AT phenotype of the ∆GCN5, ∆HPA1, ∆HPA2 and ∆HPA3 deletion 
strains. The WT BY4742∆W strain served as the positive control, while the ∆GCN4 deletion strain 
served as the negative control for AT phenotype. The H- plate served as the loading control. Tenfold 
serial dilutions were titrated onto the indicated plates and incubated at 28°C for six days. H-: media 
lacking histidine, AT: 3-amino-1,2,4-triazole. 
 
4III.2.1.1 Suppression studies via over-expression in GCN5 and HPA1 single gene 
knock out mutant strains 
As discussed earlier (refer to section 4III.1.3), on histidine-depleted media containing 
3-AT, the ∆GCN5 and ∆HPA1 deletion strains exhibited the AT phenotype. In respect 
to the issue of redundancy, it was of interest to determine whether over-expression of 
any HAT could restore the growth of the deletion strains. 
 
On histidine-depleted media containing 3-AT, the ∆GCN5 deletion strain over-
expressing HA-tagged Gcn5 exhibited increased growth as compared to the negative 
control PactT424-HA empty vector (Figure 4.16, second panel, compare lane 2 to 
lane 1), while the ∆GCN5 deletion strain over-expressing HA-tagged Hpa1, Hpa2 and 
Hpa3 exhibited growth comparable to the negative control PactT424-HA empty 
vector (Figure 4.16, second panel, compare lanes 3, 4 and 5 to lane 1). This indicated 
that the function of Gcn5 in the Gcn4-mediated transcriptional activation of the HIS3 




Figure 4.16 HATs over-expression in the ∆GCN5 deletion strain. The PactT424-HA empty vector 
served as the negative control. The HW- plate served as the loading control. Tenfold serial dilutions 
were titrated onto the indicated plates and incubated at 28°C for six days. HW-: media lacking histidine 
and tryptophan, AT: 3-amino-1,2,4-triazole. 
 
On histidine-depleted media containing 3-AT, the ∆HPA1 deletion strain over-
expressing HA-tagged Hpa1 exhibited increased growth as compared to the negative 
control PactT424-HA empty vector (Figure 4.17, second panel, compare lane 3 to 
lane 1), while the ∆HPA1 deletion strain over-expressing HA-tagged Gcn5 and Hpa2 
exhibited growth comparable to the negative control PactT424-HA empty vector 
(Figure 4.17, second panel, compare lanes 2 and 4 to lane 1). Interestingly, the 
∆HPA1 deletion strain over-expressing HA-tagged Hpa3 exhibited decreased growth 
as compared to the negative control PactT424-HA empty vector (Figure 4.17, second 
panel, compare lane 5 to lane 1). This indicated that the HATs Gcn5, Hpa1, Hpa2 and 
Hpa3 likely do not function redundantly as HATs. 
 
 
Figure 4.17 HATs over-expression in the ∆HPA1 deletion strain. The PactT424-HA empty vector 
served as the negative control. The HW- plate served as the loading control. Tenfold serial dilutions 
were titrated onto the indicated plates and incubated at 28°C for six days. HW-: media lacking histidine 




4III.2.2 GCN5, HPA1, HPA2 and HPA3 double gene knock out studies 
On histidine-depleted media containing lower concentration of 3-AT, the ∆GCN5, 
∆GCN5∆HPA1 and ∆GCN5∆HPA3 deletion strains exhibited the AT phenotype 
(Figure 4.18, second panel, compare lanes 3, 4 and 6 to lane 1), while the 
∆GCN5∆HPA2 double deletion strain did not (Figure 4.18, second panel, compare 
lane 5 to lane 1). In fact, the ∆GCN5∆HPA1 and ∆GCN5∆HPA3 double deletion 
strains exhibited a more severe AT phenotype as compared to the ∆GCN5 single 
deletion strain (Figure 4.18, second panel, compare lanes 4 and 6 to lane 3). 
Interestingly, at the higher concentration of 3-AT, the ∆GCN5, ∆GCN5∆HPA1, 
∆GCN5∆HPA2 and ∆GCN5∆HPA3 deletion strains exhibited an AT phenotype as 
severe as that of the negative control ∆GCN4 deletion strain (Figure 4.18, second 
panel, compare lanes 3, 4, 5 and 6 to lane 2). 
 
 
Figure 4.18 Observable AT phenotype of the ∆GCN5, ∆GCN5∆HPA1, ∆GCN5∆HPA2 and 
∆GCN5∆HPA3 deletion strains. The WT BY4742∆W strain served as the positive control, while the 
∆GCN4 deletion strain served as the negative control for AT phenotype. The H- plate served as the 
loading control. Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C 
for six days. H-: media lacking histidine, AT: 3-amino-1,2,4-triazole. 
 
4III.3 Quantitative real-time PCR analysis 
In order to quantitate the activation level of the HIS3 gene by Gcn4 in the presence of 
each multi-copy phenotypic suppressor, quantitative real-time PCR analysis was 
carried out. Before carrying out quantitative real-time PCR analysis, the integrity and 
size distribution of total RNA purified had to be determined through formaldehyde 
(denaturing) agarose gel electrophoresis. Intact total RNA run on a denaturing gel was 
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shown to display sharp 28S (4718 bp) and 18S rRNA (1874 bp) bands (Figure 4.19, 
lanes 1 and 2; results were representative of all the samples), where the 28S rRNA 
band was more intense as compared to the 18S rRNA band (Figure 4.19, lanes 1 and 2, 
compare the upper 28S rRNA band to the lower 18S rRNA band). This indicated that 
the purified RNA was intact after the extraction procedure. In addition, the optimum 
3-AT induction period for the strains used in this study was determined to be 2 h (Lee, 
2007), after which accumulated transcripts were likely to be subsequently processed 
or degraded by the cellular machinery. 
 
Figure 4.19 Integrity and size distribution of total RNA purified after the extraction procedure. 
Samples were separated on a 1.2 % FA gel, where the sharp 28S (4718 bp) and 18S rRNA (1874 bp) 
bands indicated that the rRNA and mRNA purified were not degraded during the extraction procedure. 
 
When the WT histone H4 strain containing the PactT424-HA empty vector was 
induced in histidine-depleted media containing 3-AT for 2 h, HIS3 mRNA expression 
levels increased by approximately 4-fold as compared to the uninduced WT histone 
H4 strain containing the PactT424-HA empty vector (Figure 4.20, compare lane 2 to 
lane 1). On the other hand, there were no significant differences in HIS3 mRNA 
expression levels when the H4Y98A mutant strain containing the PactT424-HA 
empty vector was induced in histidine-depleted media containing 3-AT for 2 h as 
compared to the uninduced H4Y98A mutant strain containing the PactT424-HA 
empty vector (Figure 4.20, compare lane 4 to lane 3). This indicated that the histone 
H4 tyrosine residue Y98 is likely to be involved in the Gcn4-mediated transcriptional 
activation of the HIS3 gene. These results also correlated with the growth of the 
positive control WT histone H4 strain and the reduced growth of the H4Y98A mutant 
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strain on histidine-depleted media containing 3-AT (Figure 4.1). 
 
Upon over-expression of Gcn5, HIS3 mRNA expression levels increased by 
approximately 2.7-fold for the induced strain as compared to the uninduced strain 
(Figure 4.20, compare lane 6 to lane 5). Upon over-expression of Hpa1, there were no 
significant differences in HIS3 mRNA expression levels for the induced strain as 
compared to the uninduced strain (Figure 4.20, compare lane 8 to lane 7). Upon over-
expression of Hpa2, HIS3 mRNA expression levels increased by approximately  
1.8-fold for the induced strain as compared to the uninduced strain (Figure 4.20, 
compare lane 10 to lane 9). This indicated that over-expression of Gcn5 led to the 
highest activation level of the HIS3 gene, while over-expression of Hpa1 led to the 
lowest activation level of the HIS3 gene (Figure 4.20, compare lanes 6, 8 and 10). 
These results also correlated with the suppression of the AT phenotype of the 
H4Y98A mutant strain by the over-expression of Gcn5, Hpa1 and Hpa2 on histidine-
depleted media containing 3-AT (Figures 4.9 and 4.10). 
 
However, it is important to take note that over-expression of Gcn5, Hpa1 and Hpa2 
did not increase the activation level of the HIS3 gene to that of the WT histone H4 
strain containing the PactT424-HA empty vector (Figure 4.20, compare lanes 6, 8 and 
10 to lane 2), although over-expression of Hpa1 increased the activation level of the 
HIS3 gene even for the uninduced strain as compared to the uninduced WT histone 
H4 strain containing the PactT424-HA empty vector (Figure 4.20, compare lane 7 to 
lane 1). 
 
Interestingly, upon over-expression of Hpa3, HIS3 mRNA expression levels increased 
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by approximately 1.1-fold for the induced strain as compared to the uninduced strain 
(Figure 4.20, compare lane 12 to lane 11), although the overall activation level of the 
HIS3 gene was comparable to that of the H4Y98A mutant strain containing the 
PactT424-HA empty vector (Figure 4.20, compare lane 12 to lane 4). In fact, upon 
over-expression of Hpa3, HIS3 mRNA expression levels decreased by approximately 
1.7-fold for the uninduced strain as compared to the uninduced H4Y98A mutant strain 
containing the PactT424-HA empty vector (Figure 4.20, compare lane 11 to lane 3). 
These results also correlated with the non-suppression of the AT phenotype of the 
H4Y98A mutant strain by the over-expression of Hpa3 on histidine-depleted media 
containing 3-AT (Figure 4.11). 
 
Figure 4.20 Over-expression of multi-copy phenotypic suppressors and the correlation to the 
activation level of the HIS3 gene. Samples were grown in tryptophan-depleted liquid media to an 
OD600 value of 1 and induced in histidine-depleted liquid media containing 3-AT for the indicated 
number of hours. Total RNA was isolated and the amount of HIS3 mRNA relative to ACT1 mRNA was 
determined by quantitative real-time PCR. The results are means ± S.D. for three replicate experiments, 
where the values are relative to the uninduced WT histone H4 strain containing the PactT424-HA 
empty vector that was set as 1 (Appendix 8.26, Table 8.33). WT: BY4742∆W∆HHF1/2 + YCplac111-
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4IV.1 Phenotype testing of an histone H4 N-terminal deletion strain 
As discussed earlier (refer to section 4III.1.1), on histidine-depleted media containing 
3-AT, the H4Y98A mutant strain exhibited the AT phenotype that was suppressed by 
the over-expression of the HATs Gcn5, Hpa1 and Hpa2. Previous reports have shown 
that the HATs Gcn5, Hpa1 and Hpa2 target core histones for acetylation, particularly 
at the N-terminal histone tails (Table 4.7). Thus, it was of interest to determine 
whether an histone H4 N-terminal deletion strain could phenocopy the histone 
H4Y98A mutant strain. 
 
Table 4.7 Acetylation of core histones carried out by the HATs Gcn5, Hpa1 and 
Hpa2 (Table adapted from Sterner and Berger, 2000; He and Lehming, 2003; 
Peterson and Laniel, 2004) 
Histone PTM Histone modifying enzyme 
H2B K11ac Gcn5 
K16ac Gcn5 
H3 K4ac Hpa2 
K9ac Gcn5 




H4 K5ac Hpa2 




As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
3-AT, the H4Y98A mutant strain exhibited the AT phenotype (Figure 4.21, second 
panel, compare lane 2 to lane 1). Similarly, a mutant strain expressing a histone H4 
deletion derivative lacking the first 19 amino acid residues also exhibited the AT 
phenotype (Figure 4.21, second panel, compare lane 3 to lane 1). In fact, the mutant 
strain expressing a histone H4 deletion derivative lacking the first 19 amino acid 
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residues exhibited a more severe AT phenotype as compared to the H4Y98A mutant 
strain (Figure 4.21, second panel, compare lane 3 to lane 2). This indicated that both 
the histone H4 tyrosine residue Y98 and the N-terminal 19 amino acid residues were 
likely to be involved in the Gcn4-mediated transcriptional activation of the HIS3 gene. 
 
 
Figure 4.21 Observable AT phenotype of an histone H4 N-terminal deletion strain. The histone 
H4 deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 served as the positive control. The 
L- plate served as the loading control. Tenfold serial dilutions were titrated onto the indicated plates 
and incubated at 28°C for six days, unless otherwise indicated. L-: media lacking leucine, H-: media 
lacking histidine, AT: 3-amino-1,2,4-triazole. 
 
4IV.2 Alanine- and arginine-scanning mutagenesis of the histone H4 N-terminal 
lysine residues 
As deletion of histone H4 N-terminal 19 amino acid residues conferred an observable 
AT phenotype (refer to section 4IV.1), it was of interest to determine whether site-
directed alanine and arginine mutagenesis of the histone H4 N-terminal lysine 
residues would confer a similar AT phenotype. Lysine to alanine single-point 
mutations do not impose electrostatic or steric effects on a protein, as alanine does not 
undergo covalent modifications, will not alter the main chain conformation and 
eliminates side chains beyond the β carbon (Lefèvre et al., 1997). Lysine to arginine 
single-point mutations mimic unacetylated lysine residues and allow the study of 
whether positive charges at histone H4 position 5, 8, 12, 16 and 20 are required for 
the Gcn4-mediated transcriptional activation of the HIS3 gene. 
 
On media containing 5-FOA, the H4K5A, H4K8A, H4K12A, H4K16A and H4K20A 
mutant strains exhibited growth comparable to the positive control WT histone H4 
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strain (Figure 4.22, second panel, compare lanes 2, 3, 4, 5 and 6 to lane 1).This 
indicated that these five histone H4 mutant proteins complemented the genomic 
deletion of histone H4 as well as the positive control WT histone H4 protein. 
 
 
Figure 4.22 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 N-terminal lysine to alanine single-point mutant proteins. The WT histone 
H4 expressed from YCplac111 served as the positive control. The L- plate served as the loading control. 
Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C for three days.  
L-: media lacking leucine, H-: media lacking histidine, FOA: 5-FOA. 
 
Similarly, on media containing 5-FOA, the H4K5R, H4K8R, H4K12R, H4K16R and 
H4K20R mutant strains exhibited growth comparable to the positive control WT 
histone H4 strain (Figure 4.23, second panel, compare lanes 2, 3, 4, 5 and 6 to lane 
1).This indicated that these five histone H4 mutant proteins complemented the 
genomic deletion of histone H4 as well as the positive control WT histone H4 protein. 
 
 
Figure 4.23 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 N-terminal lysine to arginine single-point mutant proteins. The WT histone 
H4 expressed from YCplac111 served as the positive control. The L- plate served as the loading control. 
Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C for three days.  
L-: media lacking leucine, H-: media lacking histidine, FOA: 5-FOA. 
 
4IV.2.1 Phenotype testing of the histone H4 N-terminal lysine residue mutant strains 
As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
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3-AT, the H4Y98A mutant strain exhibited the AT phenotype (Figure 4.24, second 
panel, compare lane 2 to lane 1). Similarly, the H4K16A and H4K20A mutant strains 
also exhibited the AT phenotype (Figure 4.24, second panel, compare lanes 6 and 7 to 
lane 1). However, the H4K5A, H4K8A and H4K12A mutant strains did not display 
the AT phenotype as they exhibited growth comparable to the positive control WT 
histone H4 strain (Figure 4.24, second panel, compare lanes 3, 4 and 5 to lane 1). 
 
 
Figure 4.24 Observable AT phenotype of the histone H4 N-terminal lysine to alanine single-point 
mutant strains. The histone H4 deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 
served as the positive control. The L- plate served as the loading control. Tenfold serial dilutions were 
titrated onto the indicated plates and incubated at 28°C for six days, unless otherwise indicated.  
L-: media lacking leucine, H-: media lacking histidine, AT: 3-amino-1,2,4-triazole. 
 
As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
3-AT, the H4Y98A mutant strain exhibited the AT phenotype (Figure 4.25, second 
panel, compare lane 2 to lane 1). Similarly, the H4K16R mutant strain also exhibited 
the AT phenotype (Figure 4.25, second panel, compare lane 6 to lane 1). However, 
the H4K5R, H4K8R, H4K12R and H4K20R mutant strains did not display the AT 
phenotype as they exhibited growth comparable to the positive control WT histone H4 





Figure 4.25 Observable AT phenotype of the histone H4 N-terminal lysine to arginine single-
point mutant strains. The histone H4 deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 
served as the positive control. The L- plate served as the loading control. Tenfold serial dilutions were 
titrated onto the indicated plates and incubated at 28°C for six days, unless otherwise indicated.  
L-: media lacking leucine, H-: media lacking histidine, AT: 3-amino-1,2,4-triazole. 
 
The above results indicate that the histone H4 N-terminal K5, K8 and K12 residues 
are likely not to be required for the Gcn4-mediated transcriptional activation of the 
HIS3 gene, or at the very least, are less important for the Gcn4-mediated 
transcriptional activation of the HIS3 gene. This is because site-directed alanine and 
arginine mutagenesis of these lysine residues did not phenocopy the conditional 
histone H4Y98A mutant strain (Table 4.8). 
 
On the other hand, the histone H4 N-terminal K16 and K20 residues are likely to be 
required for the Gcn4-mediated transcriptional activation of the HIS3 gene, where 
K16 may have a more important role for the Gcn4-mediated transcriptional activation 
of the HIS3 gene. This is because site-directed alanine and arginine mutagenesis of 
K16 phenocopied the conditional histone H4Y98A mutant strain (Table 4.8), while 
only site-directed alanine mutagenesis of K20 phenocopied the conditional histone 






Table 4.8 Tabulation of observable AT phenotype of site-directed alanine and 
arginine mutagenesis of the histone H4 N-terminal lysine residues 
Histone H4 N-terminal 
lysine residue 
AT phenotype 
Alanine mutagenesis Arginine mutagenesis 
K5 × × 
K8 × × 
K12 × × 
K16 √ √ 
K20 √ × 
 
4IV.3 Alanine- and arginine-scanning mutagenesis of the histone H4 N-terminal 
lysine residues in combination with H4Y98A 
As site-directed alanine and arginine mutagenesis of certain histone H4 N-terminal 
lysine residues conferred an observable AT phenotype (refer to section 4IV.2.1), it 
was of interest to determine whether site-directed alanine and arginine mutagenesis of 
the histone H4 N-terminal lysine residues in combination with H4Y98A would confer 
a similar observable AT phenotype. 
 
On media containing 5-FOA, the H4K5A Y98A, H4K8A Y98A, H4K12A Y98A, 
H4K16A Y98A and H4K20A Y98A double mutant strains exhibited reduced growth 
as compared to the positive control WT histone H4 strain (Figure 4.26, second panel, 
compare lanes 4, 5, 6, 7 and 8 to lane 1). This indicated that these five histone H4 
double mutant proteins complemented the genomic deletion of histone H4, although 
to different degrees. 
 
In fact, the H4K5A Y98A, H4K8A Y98A and H4K12A Y98A double mutant strains 
exhibited less growth as compared to the H4Y98A mutant strain (Figure 4.26, second 
panel, compare lanes 4, 5 and 6 to lane 3), where this additive phenotypic effect 
indicated that these N-terminal and C-terminal mutations are independent of each 
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other. On the other hand, the H4K16A Y98A and H4K20A Y98A double mutant 
strains exhibited growth comparable to the H4Y98A mutant strain (Figure 4.26, 
second panel, compare lanes 7 and 8 to lane 3), where the lack of an additive 
phenotypic effect indicated that these N-terminal and C-terminal mutations are not 
independent of each other. 
 
 
Figure 4.26 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 N-terminal lysine to alanine single-point mutant proteins in combination 
with H4Y98A. The WT histone H4 expressed from YCplac111 served as the positive control, while 
the YCplac111 empty vector served as the negative control. The L- plate served as the loading control. 
Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C for three days.  
L-: media lacking leucine, H-: media lacking histidine, FOA: 5-FOA. 
 
On media containing 5-FOA, the H4K5R Y98A, H4K8R Y98A, H4K12R Y98A, 
H4K16R Y98A and H4K20R Y98A double mutant strains exhibited reduced growth 
as compared to the positive control WT histone H4 strain (Figure 4.27, second panel, 
compare lanes 2, 3, 4, 5 and 6 to lane 1). This indicated that these five histone H4 
double mutant proteins complemented the genomic deletion of histone H4, although 
to different degrees. 
 
In fact, the H4K5R Y98A and H4K8R Y98A double mutant strains exhibited less 
growth as compared to the H4Y98A mutant strain (Figure 4.27, second panel, 
compare lanes 2 and 3 to lane 3 in Figure 4.26), where this additive phenotypic effect 
indicated that these N-terminal and C-terminal mutations are independent of each 
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other. On the other hand, the H4K12R Y98A, H4K16R Y98A and H4K20R Y98A 
double mutant strains exhibited growth comparable to the H4Y98A mutant strain 
(Figure 4.27, second panel, compare lanes 4, 5 and 6 to lane 3 in Figure 4.26), where 
the lack of an additive phenotypic effect indicated that these N-terminal and  
C-terminal mutations are not independent of each other. 
 
 
Figure 4.27 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 N-terminal lysine to arginine single-point mutant proteins in combination 
with H4Y98A. The WT histone H4 expressed from YCplac111 served as the positive control. The L- 
plate served as the loading control. Tenfold serial dilutions were titrated onto the indicated plates and 
incubated at 28°C for three days. L-: media lacking leucine, H-: media lacking histidine, FOA: 5-FOA. 
 
4IV.3.1 Phenotype testing of the histone H4 N-terminal lysine residue mutant strains 
in combination with H4Y98A 
As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
3-AT, the H4Y98A mutant strain exhibited the AT phenotype (Figure 4.28, second 
panel, compare lane 2 to lane 1). Similarly, the H4K5A Y98A, H4K8A Y98A, 
H4K12A Y98A, H4K16A Y98A and H4K20A Y98A double mutant strains also 
exhibited the AT phenotype (Figure 4.28, second panel, compare lanes 3, 4, 5, 6 and 7 
to lane 1). Interestingly, the H4K8A Y98A double mutant strain exhibited the AT 
phenotype that was less severe than the one of the H4Y98A mutant strain (Figure 4.28, 





Figure 4.28 Observable AT phenotype of the histone H4 N-terminal lysine to alanine single-point 
mutant strains in combination with H4Y98A. The histone H4 deletion strain BY4742∆W∆HHF1/2 
expressing WT histone H4 served as the positive control. The L- plate served as the loading control. 
Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C for six days, 
unless otherwise indicated. L-: media lacking leucine, H-: media lacking histidine, AT: 3-amino-1,2,4-
triazole. 
 
As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
3-AT, the H4Y98A mutant strain exhibited the AT phenotype (Figure 4.29, second 
panel, compare lane 2 to lane 1). Similarly, the H4K5R Y98A, H4K8R Y98A, 
H4K12R Y98A, H4K16R Y98A and H4K20R Y98A double mutant strains also 
exhibited the AT phenotype (Figure 4.29, second panel, compare lanes 3, 4, 5, 6 and 7 
to lane 1). Interestingly, the H4K5R Y98A, H4K8R Y98A, H4K16R Y98A and 
H4K20R Y98A double mutant strains exhibited the AT phenotype that was less 
severe than the one of the H4Y98A mutant strain (Figure 4.29, second panel, compare 








Figure 4.29 Observable AT phenotype of the histone H4 N-terminal lysine to arginine single-
point mutant strains in combination with H4Y98A. The histone H4 deletion strain 
BY4742∆W∆HHF1/2 expressing WT histone H4 served as the positive control. The L- plate served as 
the loading control. Tenfold serial dilutions were titrated onto the indicated plates and incubated at 
28°C for six days, unless otherwise indicated. L-: media lacking leucine, H-: media lacking histidine, 
AT: 3-amino-1,2,4-triazole. 
 
4IV.3.2 Suppression studies via over-expression of HATs for AT phenotype of the 
histone H4 N-terminal lysine residue mutant strains in combination with H4Y98A 
As discussed earlier (refer to section 4IV.3.1), on histidine-depleted media containing 
3-AT, the histone H4 N-terminal lysine to alanine and lysine to arginine single-point 
mutant strains in combination with H4Y98A exhibited the AT phenotype. Thus, it 
was of interest to determine whether the HATs Gcn5, Hpa1 and Hpa2 (which are 
multi-copy phenotypic suppressors for the AT phenotype of the H4Y98A mutant 
strain) could also suppress the AT phenotype of these mutant strains, in order to 
elucidate the histone H4 N-terminal lysine targets of the HATs. However, results were 
generally inconclusive and further experimentation via mass spectrometry would be 
necessary to determine the histone H4 N-terminal lysine targets of the HATs Gcn5, 





Figure 4.30 Suppression by Gcn5, Hpa1 and Hpa2 of observable AT phenotype of the histone H4 
N-terminal lysine to alanine single-point mutant strains in combination with H4Y98A. The 
histone H4 deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 and PactT424-HA empty 
vector served as the positive control. The W- plate served as the loading control. Tenfold serial 
dilutions were titrated onto the indicated plates and incubated at 28°C for six days, unless otherwise 






Figure 4.31 Suppression by Gcn5, Hpa1 and Hpa2 of observable AT phenotype of the histone H4 
N-terminal lysine to arginine single-point mutant strains in combination with H4Y98A. The 
histone H4 deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 and PactT424-HA empty 
vector served as the positive control. The W- plate served as the loading control. Tenfold serial 
dilutions were titrated onto the indicated plates and incubated at 28°C for six days, unless otherwise 






4IV.4 Arginine-scanning mutagenesis of histone H4 N-terminal K8 and K16 residues 
As discussed earlier (refer to section 4IV.2.1), histone H4 N-terminal K16 and K20 
residues are likely to be required for the Gcn4-mediated transcriptional activation of 
the HIS3 gene, where K16 may have a more important role for the Gcn4-mediated 
transcriptional activation of the HIS3 gene. Previous reports have shown that Gcn5 
targets H4K8 and H4K16 for acetylation (Table 4.7). Thus, it was of interest to 
determine whether the histone H4 N-terminal K8,16R double mutant strain without 
and in combination with H4Y98A could phenocopy the conditional histone H4Y98A 
mutant strain. 
 
On media containing 5-FOA, the H4K8,16R double mutant strain exhibited growth 
comparable to the positive control WT histone H4 strain (Figure 4.32, second panel, 
compare lane 2 to lane 1). This indicated that the H4K8,16R double mutant protein 
complemented the genomic deletion of histone H4 as well as the positive control WT 
histone H4 protein. On the other hand, the growth of the H4K8,16R Y98A triple 
mutant strain was completely inhibited as compared to the WT histone H4 strain 
(Figure 4.32, second panel, compare lane 3 to lane 1). This indicated that the 
H4K8,16R Y98A triple mutant protein was unable to complement the genomic 
deletion of histone H4. 
 
 
Figure 4.32 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 N-terminal K8 and K16 residues lysine to arginine double mutant proteins 
without and in combination with H4Y98A. The WT histone H4 expressed from YCplac111 served as 
the positive control. The L- plate served as the loading control. Tenfold serial dilutions were titrated 
onto the indicated plates and incubated at 28°C for three days. L-: media lacking leucine, H-: media 




4IV.4.1 Phenotype testing of the histone H4K8,16R double mutant strain 
As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
3-AT, the H4Y98A mutant strain exhibited the AT phenotype (Figure 4.33, second 
panel, compare lane 2 to lane 1). Similarly, the H4K8,16R double mutant strain also 
exhibited the AT phenotype (Figure 4.33, second panel, compare lane 3 to lane 1). 
 
 
Figure 4.33 Observable AT phenotype of the histone H4K8,16R double mutant strain. The histone 
H4 deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 served as the positive control. The 
L- plate served as the loading control. Tenfold serial dilutions were titrated onto the indicated plates 
and incubated at 28°C for six days, unless otherwise indicated. L-: media lacking leucine, H-: media 
lacking histidine, AT: 3-amino-1,2,4-triazole. 
 
4IV.4.2 Suppression of the AT phenotype of the histone H4K8,16R double mutant 
strain by the over-expression of HATs 
As discussed earlier (refer to section 4IV.4.1), on histidine-depleted media containing 
3-AT, the histone H4K8,16R double mutant strain exhibited the AT phenotype. Thus, 
it was of interest to determine whether the HATs Gcn5, Hpa1 and Hpa2 (which are 
multi-copy phenotypic suppressors for the AT phenotype of the H4Y98A mutant 
strain) could also suppress the AT phenotype of the histone H4K8,16R double mutant 
strain in order to elucidate the histone H4 N-terminal lysine targets of the HATs. 
 
On histidine-depleted media containing 3-AT, the H4K8,16R double mutant strain 
over-expressing HA-tagged Gcn5, Hpa1 and Hpa2 exhibited growth comparable to 
the negative control PactT424-HA empty vector (Figure 4.34, second panel, compare 
lanes 4, 5 and 6 to lane 3). This indicated that over-expression of the HATs Gcn5, 
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Hpa1 and Hpa2 was unable to suppress the AT phenotype of the H4K8,16R double 
mutant strain. Thus, it is likely that the HATs Gcn5, Hpa1 and Hpa2 either target 
H4K8 and/or H4K16 directly for acetylation or that the histone H4K8R and H4K16R 
mutations mask their recognition motif required for acetylation to take place. 
 
 
Figure 4.34 The over-expression of the HATs Gcn5, Hpa1 and Hpa2 did not suppress the AT 
phenotype of the H4K8,16R double mutant strain. The histone H4 deletion strain 
BY4742∆W∆HHF1/2 expressing WT histone H4 and PactT424-HA empty vector served as the 
positive control. The W- plate served as the loading control. Tenfold serial dilutions were titrated onto 
the indicated plates and incubated at 28°C for six days, unless otherwise indicated. W-: media lacking 
tryptophan, HW-: media lacking histidine and tryptophan, AT: 3-amino-1,2,4-triazole. 
 
4IV.5 Alanine- and arginine-scanning mutagenesis of multiple histone H4 N-terminal 
lysine residues without and in combination with H4Y98A 
As alanine- and arginine-scanning mutagenesis of certain histone H4 N-terminal 
lysine residues without and in combination with H4Y98A conferred an observable AT 
phenotype (refer to sections 4IV.2, 4IV.3 and 4IV.4), it was of interest to determine 
whether alanine- and arginine-scanning mutagenesis of multiple histone H4  
N-terminal lysine residues without and in combination with H4Y98A would confer a 
similar observable AT phenotype. 
 
On media containing 5-FOA, the H4K5,8,12,16A and H4K5,8,12,16A Y98A mutant 
strains exhibited reduced growth as compared to the positive control WT histone H4 
strain (Figure 4.35, second panel, compare lanes 4 and 7 to lane 1). In fact, the 
H4K5,8,12,16A Y98A mutant strain exhibited less growth as compared to the 
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H4K5,8,12,16A mutant strain (Figure 4.35, second panel, compare lane 7 to lane 4). 
The H4K5,8,12A and H4K5,8,12,20A mutant strains exhibited growth comparable to 
the positive control WT histone H4 strain (Figure 4.35, second panel, compare lanes 3 
and 5 to lane 1). This indicated that these four histone H4 mutant proteins 
complemented the genomic deletion of histone H4, although to different degrees. On 
the other hand, the growth of the H4K5,8,12A Y98A and the H4K5,8,12,20A Y98A 
mutant strains was completely inhibited as compared to the WT histone H4 strain 
(Figure 4.35, second panel, compare lanes 6 and 8 to lane 1). This indicated that the 
H4K5,8,12A Y98A and the H4K5,8,12,20A Y98A mutant proteins were unable to 
complement the genomic deletion of histone H4. 
 
 
Figure 4.35 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 N-terminal lysine to alanine multiple point mutant proteins without and in 
combination with H4Y98A. The WT histone H4 expressed from YCplac22 served as the positive 
control, while the YCplac22 empty vector served as the negative control. The W- plate served as the 
loading control. Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C 
for three days. W-: media lacking tryptophan, H-: media lacking histidine, FOA: 5-FOA. 
 
On media containing 5-FOA, all histone H4 N-terminal lysine to arginine multiple 
point mutants exhibited reduced growth as compared to the positive control WT 
histone H4 strain (Figure 4.36, second panel, compare lanes 2–7 to lane 1). In fact, the 
H4K5,8,12,16R mutant strain and the H4K5,8,12,16,20R mutant strain exhibited less 
growth as compared to the H4K8,12,16,20R mutant strain, the H4K5,12,16,20R 
mutant strain, the H4K5,8,16,20R mutant strain and the H4K5,8,12,20R mutant strain 
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(Figure 4.36, second panel, compare lanes 2 and 6 to lanes 3, 4, 5 and 7). This 
indicated that these six histone H4 mutant proteins complemented the genomic 
deletion of histone H4, although to different degrees. 
 
 
Figure 4.36 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 N-terminal lysine to arginine multiple point mutant proteins. The WT 
histone H4 expressed from YCplac111 served as the positive control. The L- plate served as the 
loading control. Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C 
for three days. L-: media lacking leucine, H-: media lacking histidine, FOA: 5-FOA. 
 
On the other hand, on media containing 5-FOA, the growth of all histone H4  
N-terminal lysine to arginine multiple point mutants in combination with H4Y98A 
was completely inhibited as compared to the WT histone H4 strain (Figure 4.37, 
second panel, compare lanes 3–8 to lane 1). This indicated that these six histone H4 
mutant proteins were unable to complement the genomic deletion of histone H4. 
 
 
Figure 4.37 Plasmid shuffling and complementation of histone H4 genomic deletion of cells 
expressing histone H4 N-terminal lysine to arginine multiple point mutant proteins in 
combination with H4Y98A. The WT histone H4 expressed from YCplac111 served as the positive 
control. The L- plate served as the loading control. Tenfold serial dilutions were titrated onto the 
indicated plates and incubated at 28°C for three days. L-: media lacking leucine, H-: media lacking 




4IV.5.1 Phenotype testing of the histone H4 N-terminal multiple lysine residues 
mutant strains without and in combination with H4Y98A 
As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
3-AT, the H4Y98A mutant strain exhibited the AT phenotype (Figure 4.38, second 
panel, compare lane 6 to lane 1). Similarly, the H4K5,8,12A mutant strain, the 
H4K5,8,12,16A mutant strain, the H4K5,8,12,20A mutant strain and the 
H4K5,8,12,16A Y98A mutant strain also exhibited the AT phenotype (Figure 4.38, 
second panel, compare lanes 2, 3, 4 and 5 to lane 1). 
 
 
Figure 4.38 Observable AT phenotype of the histone H4 N-terminal lysine to alanine multiple 
point mutant strains without and in combination with H4Y98A. The histone H4 deletion strain 
BY4742∆W∆HHF1/2 expressing WT histone H4 served as the positive control. The W- plate served as 
the loading control. Tenfold serial dilutions were titrated onto the indicated plates and incubated at 
28°C for six days, unless otherwise indicated. W-: media lacking tryptophan, H-: media lacking 
histidine, AT: 3-amino-1,2,4-triazole. 
 
As discussed earlier (refer to section 4I.1), on histidine-depleted media containing  
3-AT, the H4Y98A mutant strain exhibited the AT phenotype (Figure 4.39, second 
panel, compare lane 2 to lane 1). Similarly, all histone H4 N-terminal lysine to 
arginine multiple point mutants also exhibited the AT phenotype (Figure 4.39, second 
panel, compare lanes 3–8 to lane 1). In fact, the H4K5,8,12,16R mutant strain and the 
H4K5,8,12,16,20R mutant strain exhibited a more severe AT phenotype as compared 
to the H4K8,12,16,20R mutant strain, the H4K5,12,16,20R mutant strain, the 
H4K5,8,16,20R mutant strain and the H4K5,8,12,20R mutant strain (Figure 4.39, 




Figure 4.39 Observable AT phenotype of the histone H4 N-terminal lysine to arginine multiple 
point mutant strains. The histone H4 deletion strain BY4742∆W∆HHF1/2 expressing WT histone H4 
served as the positive control. The L- plate served as the loading control. Tenfold serial dilutions were 
titrated onto the indicated plates and incubated at 28°C for six days, unless otherwise indicated.  
L-: media lacking leucine, H-: media lacking histidine, AT: 3-amino-1,2,4-triazole. 
 
4IV.6 Acetylation status of histone H4 N-terminal K8 and K16 residues 
As discussed earlier (refer to section 4IV.4.2), the HATs Gcn5, Hpa1 and Hpa2 may 
target histone H4 N-terminal K8 and K16 residues for acetylation. Thus, it was of 
interest to determine whether there are differences in the acetylation status of H4K8 
and H4K16 in the WT histone H4 strain as compared to the H4Y98A mutant strain. In 
addition, it would be interesting to determine whether the over-expression of the 
HATs Gcn5, Hpa1 and Hpa2 in the H4Y98A mutant strain affects the acetylation 
status of H4K8 and H4K16. 
 
Upon induction in histidine-depleted media containing 3-AT, there were no 
significant differences in the acetylation status of H4K8 in the WT histone H4 strain 
(Figures 4.40 and 4.41, compare lane 2 to lane 1). Similarly, upon induction in 
histidine-depleted media containing 3-AT, there were no significant differences in the 
acetylation status of H4K8 in the H4Y98A mutant strain (Figures 4.40 and 4.41, 
compare lane 4 to lane 3). In addition, the over-expression of the HATs Gcn5, Hpa1 
and Hpa2 in the H4Y98A mutant strain did not affect the acetylation status of H4K8 
significantly (Figures 4.40 and 4.41, compare lanes 5–10 to lanes 3 and 4). This 
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indicated that the HATs Gcn5, Hpa1 and Hpa2 are not likely to target histone H4K8 
for acetylation upon histidine starvation. 
 
Figure 4.40 Acetylation status of H4K8. The WT histone H4 strain and the H4Y98A mutant strain 
were grown in glucose complete liquid media to an OD600 value of 1 and induced in histidine-depleted 
media containing 3-AT for 2 h. The H4Y98A mutant strain over-expressing the HATs Gcn5, Hpa1 or 
Hpa2 was grown in tryptophan-depleted liquid media to an OD600 value of 1 and induced in histidine-
depleted media containing 3-AT for 2 h. The expression of total histone H4 detected by α-H4 antibody 
served as the control. WT: BY4742∆W∆HHF1/2 + YCplac111-HHF1 WT,  
Y98A: BY4742∆W∆HHF1/2 + YCplac111-HHF1 Y98A. 
 
 
Figure 4.41 ImageJ quantification of the acetylation status of H4K8. The WT histone H4 strain and 
the H4Y98A mutant strain were grown in glucose complete liquid media to an OD600 value of 1 and 
induced in histidine-depleted media containing 3-AT for 2 h. The H4Y98A mutant strain over-
expressing the HATs Gcn5, Hpa1 or Hpa2 was grown in tryptophan-depleted liquid media to an OD600 
value of 1 and induced in histidine-depleted media containing 3-AT for 2 h. The expression of total 
histone H4 detected by α-H4 antibody served as the control. The ImageJ quantification values obtained 
for acetylated histone H4K8 were normalised to the ImageJ quantification values obtained for total 
histone H4, which was carried out only once. The values obtained were then calculated relative to the 
uninduced WT histone H4 strain that was set as 1 (Appendix 8.27, Table 8.34).  
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Upon induction in histidine-depleted media containing 3-AT, there were no 
significant differences in the acetylation status of H4K16 in the WT histone H4 strain 
(Figures 4.42 and 4.43, compare lane 2 to lane 1). However, upon induction in 
histidine-depleted media containing 3-AT, the acetylation status of H4K16 in the 
H4Y98A mutant strain decreased significantly (Figures 4.42 and 4.43, compare lane 4 
to lane 3). In addition, the over-expression of the HATs Gcn5, Hpa1 and Hpa2 in the 
H4Y98A mutant strain increased the acetylation status of H4K16 significantly 
(Figures 4.42 and 4.43, compare lanes 5–10 to lanes 3 and 4). This indicated that the 




Figure 4.42 Acetylation status of H4K16. The WT histone H4 strain and the H4Y98A mutant strain 
were grown in glucose complete liquid media to an OD600 value of 1 and induced in histidine-depleted 
media containing 3-AT for 2 h. The H4Y98A mutant strain over-expressing the HATs Gcn5, Hpa1 or 
Hpa2 was grown in tryptophan-depleted liquid media to an OD600 value of 1 and induced in histidine-
depleted media containing 3-AT for 2 h. The expression of total histone H4 detected by α-H4 antibody 
served as the control. WT: BY4742∆W∆HHF1/2 + YCplac111-HHF1 WT,  





Figure 4.43 ImageJ quantification of the acetylation status of H4K16. The WT histone H4 strain 
and the H4Y98A mutant strain were grown in glucose complete liquid media to an OD600 value of 1 
and induced in histidine-depleted media containing 3-AT for 2 h. The H4Y98A mutant strain over-
expressing the HATs Gcn5, Hpa1 or Hpa2 was grown in tryptophan-depleted liquid media to an OD600 
value of 1 and induced in histidine-depleted media containing 3-AT for 2 h. The expression of total 
histone H4 detected by α-H4 antibody served as the control. The ImageJ quantification values obtained 
for acetylated histone H4K16 were normalised to the ImageJ quantification values obtained for total 
histone H4, which was carried out only once. The values obtained were then calculated relative to the 
uninduced WT histone H4 strain that was set as 1 (Appendix 8.28, Table 8.35).  
WT: BY4742∆W∆HHF1/2 + YCplac111-HHF1 WT, Y98A: BY4742∆W∆HHF1/2 + YCplac111-
HHF1 Y98A. 
 
The results obtained above for the acetylation status of histone H4 N-terminal K8 and 
K16 residues reflect the global histone levels in the cells. However, as this study was 
focused on 3-AT sensitivity that arose due to defects in transcriptional activation of 
the HIS3 gene by Gcn4, it would be of more interest to analyse the local histone levels 
in the cells specifically at the HIS3 locus through chromatin immunoprecipitation. 
This is because the global histone levels in the cells may not be representative of the 
local histone levels in the cells at the HIS3 locus, which was the locus of interest. 
 
4IV.7 Chromatin immunoprecipitation (ChIP) 
As discussed earlier (refer to section 1.2.5), ChIP is an immunoprecipitation 
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DNA in a cell. After cell lysis, cell lysates for the uninduced and induced WT histone 
H4 strain was sonicated over a time course to identify the optimum sonication 
conditions to be used for the remaining samples (refer to section 3.3.6). It was 
determined that the cell lysate should be sonicated at a continuous power output of 50 % 
for 15 s six times as this sonication condition yielded the highest amount of chromatin 
DNA with the desired fragment sizes of 100–500 bp (Figure 4.44, compare lanes 3 
and 6 to lanes 1, 2, 4 and 5). 
 
 
Figure 4.44 Sonication over a time course to identify the optimum sonication conditions. The cell 
lysate for uninduced and induced WT histone H4 strain was sonicated at a continuous power output of 
50 % for 15 s two, four and six times. The amount of chromatin DNA with the desired fragment sizes 
of 100–500 bp was separated on a 1.5 % agarose gel. 
 
In order to check both input DNA resuspension and immunoprecipitated DNA 
resuspension for presence of DNA before quantitative real-time PCR, a PCR reaction 
was carried out using primers against the target HIS3 gene promoter and ORF. The 
HIS3 promoter primers amplify a 131 bp DNA fragment from position 721813 to 
721943 on chromosome XV. The HIS3 ORF primers amplify a 114 bp DNA fragment 
from position 722197 to 722310 on chromosome XV. 
 152 
 
It was determined that DNA was present in both uninduced and induced WT histone 
H4 strain and H4Y98A mutant strain (Figures 4.45 and 4.46, lanes 3 and 4). It was 
also determined that the no antibody control used in ChIP for both uninduced and 
induced WT histone H4 strain and H4Y98A mutant strain had a very low background 
(Figures 4.45 and 4.46, lanes 5 and 7). 
 
 
Figure 4.45 PCR to check for presence of DNA in samples obtained for WT histone H4 strain. 
The antibody used was rabbit α-H4, where the PCR results obtained are representative for the other 
antibodies used in immunoprecipitation. +ve: positive control, -ve: negative control. 
 
 
Figure 4.46 PCR to check for presence of DNA in samples obtained for the H4Y98A mutant 
strain. The antibody used was rabbit α-H4, where the PCR results obtained are representative for the 





4IV.7.1 Histone H4 occupancy at the HIS3 promoter and ORF 
Occupancy of histone H4 at the HIS3 promoter and ORF decreased in the WT histone 
H4 strain upon histidine starvation (Figures 4.47 and 4.48, compare lane 2 to lane 1), 
and the decrease was more significant at the HIS3 promoter. However, occupancy of 
histone H4 at the HIS3 promoter was even lower in the H4Y98A mutant strain than in 
the WT histone H4 strain under both inducing and non-inducing conditions (Figure 
4.47, compare lanes 3 and 4 to lanes 1 and 2), indicating that occupancy of histone H4 
at the HIS3 promoter might not be relevant for the AT sensitivity of the H4Y98A 
mutant strain. Interestingly, occupancy of histone H4 at the HIS3 ORF was higher in 
the H4Y98A mutant strain than in the WT histone H4 strain under both inducing and 
non-inducing conditions (Figure 4.48, compare lanes 3 and 4 to lanes 1 and 2), 
indicating that excess histone H4Y98A at the HIS3 ORF under inducing conditions 
could be the cause for the AT sensitivity of the H4Y98A mutant strain. 
 
Consistently, over-expression of Gcn5 reduced occupancy of histone H4 at the HIS3 
ORF in the H4Y98A mutant strain down to levels even lower than in the WT histone 
H4 strain (Figure 4.48, compare lanes 5 and 6 to lanes 1 and 2). Therefore, the over-
expression of Gcn5 restored both the histidine starvation-induced histone eviction 
from the HIS3 ORF and the transcriptional activation of the HIS3 gene in the 
H4Y98A mutant strain, confirming the hypothesis that the inability to remove 






Figure 4.47 Histone H4 occupancy at the HIS3 promoter. Samples were grown in liquid media 
containing histidine to an OD600 value of 1 and induced in histidine-depleted liquid media containing  
3-AT for the indicated number of hours before carrying out the crosslinking reaction. The chromatin 
solution for each sample was prepared and immunoprecipitation using α-H4 antibody was carried out. 
Immunoprecipitation without using an antibody served as the negative control. The results are means ± 
S.D. for three replicate experiments, where the values were normalised to the input DNA sample with 
no-antibody control for each strain after factoring a dilution factor of 50 into the calculations. The 
values obtained were then calculated relative to the uninduced WT histone H4 strain that was set as 1 
(Appendix 8.29, Table 8.36). WT: WT histone H4 strain, Y98A: H4Y98A mutant strain,  



























Figure 4.48 Histone H4 occupancy at the HIS3 ORF. Samples were grown in liquid media 
containing histidine to an OD600 value of 1 and induced in histidine-depleted liquid media containing  
3-AT for the indicated number of hours before carrying out the crosslinking reaction. The chromatin 
solution for each sample was prepared and immunoprecipitation using α-H4 antibody was carried out. 
Immunoprecipitation without using an antibody served as the negative control. The results are means ± 
S.D. for three replicate experiments, where the values were normalised to the input DNA sample with 
no-antibody control for each strain after factoring a dilution factor of 50 into the calculations. The 
values obtained were then calculated relative to the uninduced WT histone H4 strain that was set as 1 
(Appendix 8.29, Table 8.36). WT: WT histone H4 strain, Y98A: H4Y98A mutant strain,  
GCN5: H4Y98A mutant strain over-expressing the HAT Gcn5. 
 
4IV.7.2 Histone H4K16ac occupancy at the HIS3 promoter and ORF 
Occupancy of histone H4K16ac at the HIS3 promoter and ORF decreased in the WT 
histone H4 strain upon histidine starvation (Figures 4.49 and 4.50, compare lane 2 to 
lane 1) and the decrease was more significant at the HIS3 promoter. Occupancy of 
histone H4K16ac at the HIS3 ORF was higher in the H4Y98A mutant strain than in 
the WT histone H4 strain under both inducing and non-inducing conditions (Figure 
4.50, compare lanes 3 and 4 to lanes 1 and 2), reflecting the higher nucleosome 
occupancy in the H4Y98A mutant strain (Figure 4.48, lanes 3 and 4). 
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HIS3 ORF in the H4Y98A mutant strain down to levels even lower than in the WT 
histone H4 strain under inducing conditions (Figure 4.50, compare lane 6 to lanes 1 
and 2), reflecting the lower nucleosome occupancy in the H4Y98A mutant strain 
over-expressing Gcn5 (Figure 4.48, lanes 5 and 6). 
 
 
Figure 4.49 Histone H4K16ac occupancy at the HIS3 promoter. Samples were grown in liquid 
media containing histidine to an OD600 value of 1 and induced in histidine-depleted liquid media 
containing 3-AT for the indicated number of hours before carrying out the crosslinking reaction. The 
chromatin solution for each sample was prepared and immunoprecipitation using α-H4K16ac antibody 
was carried out. Immunoprecipitation without using an antibody served as the negative control. The 
results are means ± S.D. for three replicate experiments, where the values were normalised to the input 
DNA sample with no-antibody control for each strain after factoring a dilution factor of 50 into the 
calculations. The values obtained were then calculated relative to the uninduced WT histone H4 strain 
that was set as 1 (Appendix 8.29, Table 8.36). WT: WT histone H4 strain, Y98A: H4Y98A mutant 































Figure 4.50 Histone H4K16ac occupancy at the HIS3 ORF. Samples were grown in liquid media 
containing histidine to an OD600 value of 1 and induced in histidine-depleted liquid media containing  
3-AT for the indicated number of hours before carrying out the crosslinking reaction. The chromatin 
solution for each sample was prepared and immunoprecipitation using α-H4K16ac antibody was 
carried out. Immunoprecipitation without using an antibody served as the negative control. The results 
are means ± S.D. for three replicate experiments, where the values were normalised to the input DNA 
sample with no-antibody control for each strain after factoring a dilution factor of 50 into the 
calculations. The values obtained were then calculated relative to the uninduced WT histone H4 strain 
that was set as 1 (Appendix 8.29, Table 8.36). WT: WT histone H4 strain, Y98A: H4Y98A mutant 
strain, GCN5: H4Y98A mutant strain over-expressing the HAT Gcn5. 
 
4IV.7.3 Gcn5 occupancy at the HIS3 promoter and ORF 
As the over-expression of the HAT Gcn5 had restored the histidine starvation-induced 
histone eviction from the HIS3 ORF and the transcriptional activation of the HIS3 
gene in the H4Y98A mutant strain, it was of interest to determine Gcn5 occupancy at 
the HIS3 promoter and ORF. 
 
Occupancy of Gcn5 at the HIS3 promoter and ORF increased in the WT histone H4 
strain upon histidine starvation (Figures 4.51 and 4.52, compare lane 2 to lane 1). 
Interestingly, occupancy of Gcn5 at the HIS3 ORF was lower in the H4Y98A mutant 
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compare lane 4 to lane 2), indicating that the recruitment of Gcn5 to the HIS3 ORF is 
influenced by the histone H4 tyrosine residue Y98. 
 
Consistently, over-expression of Gcn5 increased occupancy of Gcn5 at the HIS3 ORF 
in the H4Y98A mutant strain up to levels even higher than in the WT histone H4 
strain (Figure 4.52, compare lanes 5 and 6 to lanes 1 and 2), indicating that the 
recruitment of Gcn5 to the HIS3 ORF had suppressed the AT sensitivity of the 
H4Y98A mutant strain. 
 
 
Figure 4.51 Gcn5 occupancy at the HIS3 promoter. Samples were grown in liquid media containing 
histidine to an OD600 value of 1 and induced in histidine-depleted liquid media containing 3-AT for the 
indicated number of hours before carrying out the crosslinking reaction. The chromatin solution for 
each sample was prepared and immunoprecipitation using α-Gcn5 antibody was carried out. 
Immunoprecipitation without using an antibody served as the negative control. The results are means ± 
S.D. for three replicate experiments, where the values were normalised to the input DNA sample with 
no-antibody control for each strain after factoring a dilution factor of 50 into the calculations. The 
values obtained were then calculated relative to the uninduced WT histone H4 strain that was set as 1 
(Appendix 8.29, Table 8.36). WT: WT histone H4 strain, Y98A: H4Y98A mutant strain,  





























Figure 4.52 Gcn5 occupancy at the HIS3 ORF. Samples were grown in liquid media containing 
histidine to an OD600 value of 1 and induced in histidine-depleted liquid media containing 3-AT for the 
indicated number of hours before carrying out the crosslinking reaction. The chromatin solution for 
each sample was prepared and immunoprecipitation using α-Gcn5 antibody was carried out. 
Immunoprecipitation without using an antibody served as the negative control. The results are means ± 
S.D. for three replicate experiments, where the values were normalised to the input DNA sample with 
no-antibody control for each strain after factoring a dilution factor of 50 into the calculations. The 
values obtained were then calculated relative to the uninduced WT histone H4 strain that was set as 1 
(Appendix 8.29, Table 8.36). WT: WT histone H4 strain, Y98A: H4Y98A mutant strain,  


































4V.1 Plasmid shuffling of histone H3 and H4 
As discussed earlier (refer to section 2.2.3.2), there are several examples of 
interdependency and crosstalk between different residues on the same histone or on 
different histones. Thus, it was of interest to elucidate further nuances in histone H3 
and H4 crosstalk. 
 
On media containing 5-FOA, combinations of different histone H3 mutants with WT 
histone H4 exhibited growth comparable to the positive control WT histone H3/H4 
strain (Figure 4.53, second panel, compare lanes 4, 6 and 8 to lane 2), except the 
combination of histone H3T118A with WT histone H4 that exhibited reduced growth 
as compared to the positive control WT histone H3/H4 strain (Figure 4.53, second 
panel, compare lane 10 to lane 2). This indicated that histone H3T118 may be 
essential for cell viability. 
 
On media containing 5-FOA, combinations of different histone H3 mutants with 
histone H4Y98A exhibited growth comparable to the combination of WT histone H3 
with histone H4Y98A (Figure 4.53, second panel, compare lanes 5, 7 and 9 to lane 3), 
except the combination of histone H3T118A with histone H4Y98A that exhibited 
reduced growth as compared to the combination of WT histone H3 with histone 
H4Y98A (Figure 4.53, second panel, compare lane 11 to lane 3). This also indicated 





Figure 4.53 Plasmid shuffling and complementation of histone H3 and H4 genomic deletion of 
cells expressing combinations of different histone H3 and histone H4 derivatives. The WT histone 
H4 expressed from YCplac22 in combination with WT histone H3 expressed from YCplac111 served 
as the positive control, while the YCplac22 empty vector in combination with YCplac111 empty vector 
served as the negative control. The WL- plate served as the loading control. Tenfold serial dilutions 
were titrated onto the indicated plates and incubated at 28°C for three days. WL-: media lacking 
tryptophan and leucine, HWL-: media lacking histidine, tryptophan and leucine, FOA: 5-FOA. 
 
4V.1.1 Phenotype testing of cells expressing combinations of different histone H3 
derivatives and WT histone H4 
On histidine-depleted media containing 3-AT, the combinations of histone H3K4A 
with WT histone H4 and histone H3T118A with WT histone H4 did not exhibit the 
AT phenotype as they showed more growth than the positive control WT histone 
H3/H4 strain (Figure 4.54, second panel, compare lanes 2 and 5 to lane 1). On the 
other hand, the combinations of histone H3K14A with WT histone H4 and histone 
H3T32A with WT histone H4 exhibited the AT phenotype as they showed less 
growth than the positive control WT histone H3/H4 strain (Figure 4.54, second panel, 
compare lanes 3 and 4 to lane 1). This indicated that histone H4K14 and histone 
H4T32 were likely to be involved in the Gcn4-mediated transcriptional activation of 





Figure 4.54 Observable AT phenotype of cells expressing combinations of different histone H3 
derivatives and WT histone H4. The WT histone H4 expressed from YCplac22 in combination with 
WT histone H3 expressed from YCplac111 served as the positive control. The WL- plate served as the 
loading control. Tenfold serial dilutions were titrated onto the indicated plates and incubated at 28°C 
for six days. WL-: media lacking tryptophan and leucine, H-: media lacking histidine, AT: 3-amino-
1,2,4-triazole. 
 
4V.1.2 Phenotype testing of cells expressing combinations of different histone H3 
derivatives and histone H4Y98A 
On histidine-depleted media containing 3-AT, the combination of histone H3T118A 
with histone H4Y98A did not exhibit the AT phenotype as it showed growth 
comparable to the positive control WT histone H3/H4 strain (Figure 4.55, second 
panel, compare lane 5 to lane 1 in Figure 4.54). On the other hand, the combinations 
of histone H3K4A with histone H4Y98A, histone H3K14A with histone H4Y98A and 
histone H3T32A with histone H4Y98A exhibited the AT phenotype as they showed 
less growth than the positive control WT histone H3/H4 strain (Figure 4.55, second 
panel, compare lanes 2, 3 and 4 to lane 1 in Figure 4.54). 
 
In fact, the combinations of histone H3K4A with histone H4Y98A and histone 
H3T32A with histone H4Y98A exhibited growth comparable to the combination of 
WT histone H3 with histone H4Y98A (Figure 4.55, second panel, compare lanes 2 
and 4 to lane 1), while the combination of histone H3K14A with histone H4Y98A 
exhibited a more severe AT phenotype as it showed less growth than the combination 
of WT histone H3 with histone H4Y98A (Figure 4.55, second panel, compare lane 3 





Figure 4.55 Observable AT phenotype of cells expressing combinations of different histone H3 
derivatives and histone H4Y98A. The WL- plate served as the loading control. Tenfold serial 
dilutions were titrated onto the indicated plates and incubated at 28°C for six days. WL-: media lacking 









Epigenetics, by definition, is the study of all mitotically and meiotically heritable 
changes in phenotype that do not result from changes in the genomic 
deoxyribonucleic acid (DNA) nucleotide sequence (Petronis, 2010; Zhu and Reinberg, 
2011). The epigenome refers to a complete description of potentially heritable 
changes across the entire genome (Bernstein et al., 2007). Several epigenome studies 
and recent advances in technology to allow for comprehensive epigenetic mapping 
have emerged, where they are only beginning to describe the global distributions and 
dynamics of the diverse and immensely complex epigenetic regulatory network that 
controls genomic function in normal physiology, development and cellular 
differentiation (Bernstein et al., 2007; Goldberg et al., 2007; Turner, 2007; Martens et 
al., 2011). As the perturbation of proper epigenetic regulation may predispose one 
towards diseases, including cancers, neurological disorders, autoimmune diseases and 
respiratory diseases (Waggoner, 2007; Urdinguio et al., 2009; Chi et al., 2010; Portela 
and Esteller, 2010; Sawan and Herceg, 2010; Ghizzoni et al., 2011; Meda et al., 2011; 
Villeneuve et al., 2011; Godley and Le Beau, 2012; Sun et al., 2012), the emerging 
technology of epigenetic analysis is likely to encompass the diagnosis, prognostic 
assessment and therapeutic treatment of such malignant diseases (Stebbing et al., 
2006; Chuang et al., 2009; Lane and Chabner, 2009; Di Marcotullio et al., 2011; 
Sarfstein et al., 2011; Xu et al., 2011; Fujita et al., 2012). 
 
One basis for epigenetics is histone modifications (refer to section 1.1.3), where 
experimental evidence has shown histones to be dynamic and integral in regulating 
chromatin condensation and DNA accessibility (Egger et al., 2004). Post-translational 
modification (PTMs) of histones are important in the regulation of all aspects of DNA 
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biology, including transcriptional activation or repression, homologous recombination, 
DNA repair or replication, cell cycle regulation and chromatin compaction in 
apoptosis. This study was focused on histone H4, which is the most highly conserved 
in evolution, with a difference of only eight amino acids out of 102 between  
S. cerevisiae and humans (Table 5.1; Wolffe, 1995), i.e. the amino acid sequence 
identity between S. cerevisiae and humans is 92 % for histone H4 (Huang et al., 2009). 
 
Table 5.1 Histone H4 amino acid sequence identity between S. cerevisiae (S) and 
humans (H) 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
H S G R G K G G K G L G K G G A 
S S G R G K G G K G L G K G G A 
                
 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 
H K R H R K V L R D N I Q G I T 
S K R H R K I L R D N I Q G I T 
                
 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
H K P A I R R L A R R G G V K R 
S K P A I R R L A R R G G V K R 
                
 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 
H I S G L I Y E E T R G V L K V 
S I S G L I Y E E V R A V L K S 
                
 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 
H F L E N V I R D A V T Y T E H 
S F L E S V I R D S V T Y T E H 
                
 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 
H A K R K T V T A M D V V Y A L 
S A K R K T V T S L D V V Y A L 
                
 91 92 93 94 95 96 97 98 99 100 101 102    
H K R Q G R T L Y G F G G    





5.2 Histone H4 amino acid residues Y51, E53 and Y98 
In this study, single alanine exchange mutations to generate three histone H4 mutants 
Y51A, E53A and Y98A had been carried out in order to study the role of histone H4 
in the transcriptional regulation of gene expression, upon the loss of potential sites of 
PTMs. It was found that the H4Y51A mutant strain exhibited AT and TS phenotypes, 
the H4E53A mutant strain exhibited TS phenotype, and the H4Y98A mutant strain 
exhibited AT, TS and AA phenotypes (Figure 4.1 and Table 4.1). In addition, the 
H4Y51A mutant strain was reported to exhibit suppressor of Ty (Spt) and sensitivity 
to methyl-methanesulfonate (MMS) phenotypes (Matsubara et al., 2007), the H4E53A 
mutant strain was reported to exhibit sensitivity to 6-azauracil and nicotinamide 
(6AU-NAM) phenotype (Sato et al., 2010) and the H4Y98A mutant strain was 
reported to exhibit MMS and sensitivity to hydroxyurea (HU) phenotypes (Matsubara 
et al., 2007). 
 
The histone H4 amino acid residues Y51 and E53 are situated near the nucleosome 
entry site (Figure 5.1; Matsubara et al., 2007; Sato et al., 2010), where H4Y51 had 
been found to interact with H4I34, H4I46 and H4I50, while H4E53 had been found to 
interact with H3I124 (Sakamoto et al., 2009). Thus, it is likely that the phenotypes 
conferred by the H4Y51A and H4E53A mutations involved a perturbation of the 
interactions necessary for proper nucleosome entry (Figure 4.1 and Table 4.1). 
Interestingly, H4Y51 was reported to be unreactive in the (H3-H4)2 heterotetramer 
but could be modified when individual histones were isolated (Figure 5.1B; Zweidler, 
1992). In addition, H4E53 was reported to be closely associated with amino acid 
residue M217 of Cse4 (Glowczewski et al., 2000), which agreed with the results 
obtained in this study, where over-expression of Cse4 was found to suppress the TS 
 169 
 
phenotype of the H4E53A mutant strain (Table 4.4). 
 
The histone H4 amino acid residue Y98 was reported to form one of two independent 
binding surfaces between each histone H4 in the (H3-H4)2 heterotetramer and the 
flanking H2A-H2B heterodimers (Figure 5.1A; Arents et al., 1991; Luger et al., 1997; 
Santisteban et al., 1997). In addition, H4Y98 had been found to interact with histone 
H2A residues L98, V101 and I103, histone H2B residues I64, S67, F68 and D71, as 
well as histone H4 residues T96 and L97 (Sakamoto et al., 2009). Thus, it is likely 
that the phenotypes conferred by the H4Y98A mutation involved a perturbation of the 
interactions necessary for proper histone octamer formation (Figure 4.1 and Table 
4.1). In addition, the H4Y98A mutant strain exhibited a more severe AT phenotype as 
compared to the H4Y51A mutant strain (Figure 4.1), which indicates that H4Y98 may 
be a more crucial residue for the Gcn4-mediated transcriptional activation of the HIS3 





Figure 5.1 Locations of tyrosine residues in histone binding sites within the nucleosome core 
particle. (A) The view of the nucleosome core particle, with histone H4 tyrosine residues Y51, Y72, 
Y88 and Y98 in yellow. (B) The view of the isolated histones of the nucleosome core particle, with 
histone H4 tyrosine residues Y51, Y72, Y88 and Y98 in yellow. Figure adapted from Zweidler, 1992. 
Reproduced with permission from American Chemical Society. 
 
5.3 Histone H4 tyrosine residues Y51, Y72, Y88 and Y98 
In this study, single alanine exchange mutations to generate the four histone H4 
mutants Y51A, Y72A, Y88A and Y98A had been carried out in order to study the 
roles of the tyrosine residues in the biological functions of histone H4 and their 
impact on transcriptional regulation of gene expression. The H4Y72A mutant protein 
was found to be unable to complement the genomic deletion of histone H4, while the 













as well as WT histone H4 protein (Figure 4.3). The H4Y51A and H4Y98A mutant 
proteins were found to complement the genomic deletion of histone H4 to varying 
degrees, where the H4Y98A mutant protein complemented to a lesser degree as 
compared to the H4Y51A mutant protein (Figure 4.3). 
 
In a nucleosome, each H2A-H2B heterodimer interacts with the (H3-H4)2 
heterotetramer via a four helix bundle arrangement to form the compact octamer core 
(Luger et al., 1997; Wood et al., 2005; Peng et al., 2012). The interfaces between the 
(H3-H4)2 heterotetramer and the flanking H2A-H2B heterodimers are formed from 
fold and non-fold elements, which include four tyrosine residues in two distinct 
groups (Figure 5.1; Zweidler, 1992; Santisteban et al., 1997; Santisteban et al., 2000; 
Xu et al., 2005). In the first group, H4Y72 and H4Y88 interact directly with H2BY83 
to form a large hydrophobic cluster (Figure 5.2C), which creates a molecular 
interaction that contributes to the integrity of the nucleosome core particle (Recht and 
Osley, 1999). In the second group, H4Y98 inserts its large tyrosyl ring into a 





Figure 5.2 Tyrosine residues in the interfaces between the (H3-H4)2 heterotetramer and the 
flanking H2A-H2B heterodimers. (A) The view of the nucleosome core particle with one H2A-H2B 
heterodimer removed, showing the histone H4 tyrosine residues Y72 (yellow), Y88 (red) and Y98 
(black). (B) The view of the nucleosome core particle with both H2A-H2B heterodimers removed, 
showing the histone H4 tyrosine residues Y72 (yellow), Y88 (red) and Y98 (black). (C) A ribbon 
representation of the interfaces between the (H3-H4)2 heterotetramer and the flanking H2A-H2B 
heterodimers, showing the histone H4 tyrosine residues Y72, Y88 and Y98 and the histone H2B 
tyrosine residue Y83. Figure adapted from Santisteban et al., 1997. Reproduced with permission from 
Nature Publishing Group. 
 
The H4Y72G mutant strain was reported to exhibit TS phenotype and arrest at G1 
phase due to the failure to transcribe G1 cyclin genes, possibly resulting from an 
altered interaction with the flanking H2A-H2B heterodimer (Santisteban et al., 1997; 
Glowczewski et al., 2000; Santisteban et al., 2000). In addition, H4Y72 had been 





residues D68, D85, Y88, A89 and R92 (Sakamoto et al., 2009). Thus, the H4Y72A 
mutant protein was found to be unable to complement the genomic deletion of histone 
H4 (Figure 4.3), possibly due to destabilising interactions between the (H3-H4)2 
heterotetramer and the flanking H2A-H2B heterodimer during nucleosome assembly 
and disassembly (Sakamoto et al., 2009). 
 
The H4Y88G mutant strain was reported to exhibit TS (Santisteban et al., 1997; 
Santisteban et al., 2000) and MMS (Yu et al., 2009) phenotypes, which indicates that 
hydrophobic interactions between the (H3-H4)2 heterotetramer and the flanking H2A-
H2B heterodimer are important for cellular functions. Thus, it is likely that the 
H4Y88A mutant protein was able to complement the genomic deletion of histone H4 
as well as WT histone H4 protein due to the maintenance of the necessary 
hydrophobic interactions (Figure 4.3). In addition, the H4Y88F mutant strain was 
reported to support cell viability but not the H4Y88E mutant strain (Dai et al., 2008). 
This suggests that H4Y88 may serve as a molecular spring to maintain tensile strength 
in the nucleosome core particle, where H4Y88 stacks on top of H2BY86 to form the 
molecular spring-like structure (Dai et al., 2008). However, unlike the H4Y51A and 
H4Y98A mutant strains, the H4Y88A mutant strain did not exhibit the AT phenotype 
(Figure 4.4), which indicates that H4Y88 may not be involved in the Gcn4-mediated 
transcriptional activation of the HIS3 gene. 
 
5.3.1 Histone H4 tyrosine residue Y98 
The H4Y98A mutant strain was reported to exhibit a growth defect on media 
containing 5-FOA (Yu et al., 2011a), which agreed with the results obtained in this 
study, where the H4Y98A mutant protein was found to complement the genomic 
 174 
 
deletion of histone H4 to a low degree (Figure 4.3). In addition, the H4Y98A mutant 
strain was reported to have poor cell viability unless it obtained compensatory 
mutations (Yu et al., 2011a) and was in fact, reported to be lethal in one strain 
background but slow growing in another strain background (Dai et al., 2008). This is 
likely due to the improper assembly of kinetochores, which caused the H4Y98A 
mutant strain to grow slowly, become polyploid or aneuploid rapidly and lose 
chromosomes rapidly (Yu et al., 2011a). 
 
Site-directed mutagenesis of H4Y98 yielded a plethora of observable phenotypes, 
which indicates that the functions of histone H4 are highly sensitive to different 
amino acid substitutions at H4Y98. In this study, the H4Y98A mutant strain was 
found to exhibit AT, TS and AA phenotypes (Figure 4.1 and Table 4.1). The H4Y98A 
mutant strain was also reported to exhibit MMS and HU phenotypes (Matsubara et al., 
2007). The H4Y98H mutant strain was reported to function only partially and 
exhibited MMS (Yu et al., 2009) and TS phenotypes, with poor growth at 25°C 
(Santisteban et al., 1997; Santisteban et al., 2000). The TS phenotype of the H4Y98H 
mutant strain was reported to be suppressed by over-expression of histone variant 
H2A.Z (Santisteban et al., 2000), which suggests that the buried residue H4Y98 is 
important for incorporation of histone variant H2A.Z via interaction between H4Y98 
and H2BD71 (Kawashima et al., 2011). The H4Y98G mutant strain was reported to 
be inviable (Santisteban et al., 1997), possibly due to the disruption of histones H2A-
H4 β sheet docking interactions and histones H2A-H3-H4 molecular cluster 
interactions (Santisteban et al., 1997; Wood et al., 2005). In this study, the H4Y98D 
mutant protein was found to be unable to complement the genomic deletion of histone 
H4 (Figures 4.5 and 4.6). 
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On the other hand, the H4Y98F and H4Y98W mutant strains were reported to 
function and grow as well as the WT histone H4 strain (Santisteban et al., 1997; Yu et 
al., 2009; Yu et al., 2011a), which agreed with the results obtained in this study, 
where the H4Y98F mutant protein was able to fully complement the genomic deletion 
of histone H4 (Figures 4.5 and 4.6). In addition, the H4Y98F and H4Y98W mutant 
strains were reported not to exhibit any observable phenotypes (Santisteban et al., 
1997; Yu et al., 2009; Yu et al., 2011a), which also agreed with the results obtained in 
this study for the H4Y98F mutant strain (Figure 4.7). 
 
The comparison of the lethality conferred by the smaller glycine (G) residue and the 
partial or complete functional restoration conferred by the larger alanine (A), histidine 
(H), tryptophan (W) or phenylalanine (F) residues indicates that the larger the side 
chain structure of the substituted amino acid residue, the more likely the restoration of 
the functions of histone H4. In addition, the comparison of the lethality conferred by 
the negatively charged aspartic acid (D) residue and the lack of observable 
phenotypes conferred by the hydrophobic tryptophan (W) or phenylalanine (F) 
residues indicate that the hydrophobicity of the side chain structure of the substituted 
amino acid residue allows the restoration of the functions of histone H4. These 
support the notion that H4Y98 inserts its large tyrosyl ring into a hydrophobic cleft on 
the surface of the H2A-H2B heterodimer (Zweidler, 1992; Santisteban et al., 1997; 
Santisteban et al., 2000; Xu et al., 2005), where experimental calculations also 
revealed that position 98 of histone H4 is suitable only for aromatic residues 
(Ramachandran et al., 2011). 
 
Tryptophan (W) resembles tyrosine (Y) structurally, where it conserves the side chain 
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aromatic ring and can be phosphorylated (Santisteban et al., 1997; Yu et al., 2009). 
Phenylalanine (F) resembles tyrosine (Y) structurally, except that the hydroxyl group 
on the aromatic ring is absent, which prevents phosphorylation from taking place. As 
the H4Y98F and H4Y98W mutant strains were reported to function and grow as well 
as the WT histone H4 strain (Santisteban et al., 1997; Yu et al., 2009; Yu et al., 
2011a), it is unlikely that phosphorylation of H4Y98 is important for the functions of 
histone H4 (Yu et al., 2011a). In fact, it is most likely that hydrophobic interactions 
between the (H3-H4)2 heterotetramer and the flanking H2A-H2B heterodimer 
mediated by H4Y98 are important for cellular functions (Yu et al., 2009), including 
the Gcn4-mediated transcriptional activation of the HIS3 gene. 
 
In addition, it was reported that H4Y98 is sometimes modified by nitration, where this 
tyrosine modification serves as a biomarker to detect nitric oxide dependent oxidative 
stress (Haqqani et al., 2002). In other words, the genomic instability associated with 
cancer cells may arise due to nitration of H4Y98 (Yu et al., 2011a), thus forming an 
interesting link between H4Y98 and the advent of cancer. 
 
5.3.2 Histone H4 tyrosine residue Y98 in relation to the HATs Gcn5, Hpa1 and Hpa2 
In this study, it was found that the H4Y98A mutant strain exhibited the AT phenotype 
(Figure 4.1 and Table 4.1), which was suppressed by over-expression of the HATs 
Gcn5, Hpa1 and Hpa2 (Figures 4.9 and 4.10). It was also found that the multi-copy 
phenotypic suppressors Gcn5, Hpa1 and Hpa2 were specific for both the AT 
phenotype (Figure 4.13) and for the H4Y98A allele (Figure 4.14). 
 
The above observations were further corroborated by quantitative real-time PCR 
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analysis of the activation level of the HIS3 gene by Gcn4. As upregulation of HIS3 
transcription in S. cerevisiae involves a delay upon sensing histidine starvation or 
disruptions in the cross pathway regulatory system named general amino acid control, 
differences in mRNA expression levels serve as a useful indicator of transcriptional 
activity in order to understand the kinetics behind the response to 3-AT competitive 
inhibition (Joo et al., 2011). It was found that transcriptional activation of the HIS3 
mRNA by histidine starvation was abolished in the H4Y98A mutant strain (Figure 
4.20). When the HATs Gcn5, Hpa1 and Hpa2 were over-expressed, the HIS3 mRNA 
expression levels in the H4Y98A mutant strain increased upon histidine starvation 
(Figure 4.20). This indicates that H4Y98 may be involved in the Gcn4-mediated 
transcriptional activation of the HIS3 gene, which is also likely to be mediated by the 
HATs Gcn5, Hpa1 and Hpa2. 
 
As discussed earlier (refer to section 2.3.1.1), the HAT activity of Gcn5 is important 
for both basal level and activated level of HIS3 expression and acetylation (Mai et al., 
2006). Under histidine starvation conditions, histone hyperacetylation and HIS3 
transcription are induced, where Gcn4 has been shown to recruit Gcn5 to the HIS3 
promoter to lead to activated levels of HIS3 expression (Kuo and Allis, 1998; Kuo et 
al., 1998; Mai et al., 2000). Thus, it is likely that the HAT activity of Gcn5, Hpa1 and 
Hpa2 is responsible for the suppression of the AT phenotype of the H4Y98A mutant 
strain (Figures 4.9 and 4.10). In this study, it was found that the GCN5 deletion strain 
exhibited the AT phenotype (Figure 4.15), which became more severe when the 
GCN5 deletion was combined with the HPA1 or the HPA2 deletion (Figure 4.18),  
i.e. an additive effect on the AT phenotype. In addition, the AT phenotype of the 
GCN5 deletion strain was complemented by the over-expression of Gcn5, while the 
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over-expression of Hpa1 and Hpa2 had no effect (Figure 4.16). This indicates that the 
HATs Gcn5, Hpa1 and Hpa2 are likely to function independently of each other. 
 
Although different HATs have their own specific targets, those of Gcn5, Hpa1 and 
Hpa2 sometimes overlap, especially at the N-terminal histone tails of core histones. 
The HATs Gcn5, Hpa1 and Hpa2 are known to target H3K14 for acetylation, while 
Gcn5 and Hpa1 are known to target H4K8 for acetylation (Tables 2.2 and 4.7). In 
addition, acetylation by Gcn5 and Hpa1 is known to activate transcription, while 
acetylation by Hpa2 has unknown functions yet to be elucidated (Table 2.2). More 
importantly, a strain expressing a histone H4 deletion derivative lacking the first 19 
amino acid residues was found to exhibit the AT phenotype, which phenocopied the 
conditional histone H4Y98A mutant strain (Figure 4.21). This indicates that the  
N-terminal 19 amino acid residues of histone H4 and H4Y98 may be involved in the 
Gcn4-mediated transcriptional activation of the HIS3 gene. It is also possible that the 
deletion of the N-terminal 19 amino acid residues of histone H4 may affect either the 
recognition of H4K20 for PTM or the recognition of modified H4K20 for subsequent 
functionalities (Sarg et al., 2004). In fact, it was reported that acetylation of H4K16 
suppresses methylation of H4K20 and vice versa (Nishioka et al., 2002). 
 
5.3.3 Histone H4 tyrosine residue Y98 and N-terminal lysine residues 
In this study, the lysine to alanine and lysine to arginine single-point mutations of 
histone H4 N-terminal lysine residues K5, K8, K12, K16 and K20 were analysed to 
determine whether they could phenocopy the conditional histone H4Y98A allele. It 
was found that the H4K5A, H4K8A, H4K12A, H4K16A and H4K20A mutant 
proteins fully complemented the genomic deletion of histone H4 (Figure 4.22). 
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Similarly, the H4K5R, H4K8R, H4K12R, H4K16R and H4K20R mutant proteins 
fully complemented the genomic deletion of histone H4 (Figure 4.23). 
 
The H4K16A, H4K20A and H4K16R mutant strains but not the other mutant strains 
were found to display the AT phenotype, which phenocopied the conditional histone 
H4Y98A mutant strain (Figures 4.24 and 4.25). This indicates that the histone H4  
N-terminal lysine residues K5, K8 and K12 are not as important for the Gcn4-
mediated transcriptional activation of the HIS3 gene as compared to H4K16 and 
H4K20. In addition, H4K16 may be a more crucial residue for the Gcn4-mediated 
transcriptional activation of the HIS3 gene as compared to H4K20, where a positive 
charge and the lack of a charge at position 16 of histone H4 are detrimental for the 
Gcn4-mediated transcriptional activation of the HIS3 gene. In fact, it was reported 
that H4K16 is the predominant site of acetylation in mono-acetylated histone H4, 
followed by H4K12 and H4K8, then finally H4K5 (Smith et al., 2003). Interestingly, 
it was reported that H4K16A and H4K16R reduced the negative supercoiling of HML 
DNA, with H4K16R having a significantly smaller effect on the disruption of 
heterochromatin structure as compared to H4K16A (Yu et al., 2011b). 
 
As discussed earlier (refer to section 2.2.3.1.1), in the charge neutralisation model, 
histone acetylation may reduce the affinity between nucleosomes and DNA as 
acetylation neutralises the positive charge of the lysine side chain in the core histone 
tails (Hong et al., 1993). This change in the local chromatin structure may become 
more permissive for the access of the transcription machinery to gene promoters 
(Grunstein, 1997). Although it is not wrong to think that acetylation at different 
positions in the histone H4 N-terminal tail are functionally interchangeable, it is clear 
 180 
 
from this study that histone H4K16 acetylation has distinct functional roles. In 
addition, histone H4K16 acetylation has been reported to have profound effects on 
chromatin structure, where it inhibits the formation of the 30 nm fibre and the 
generation of higher order structures via cross-fibre interactions to form compact 
chromatin fibre in vitro (Shogren-Knaak et al., 2006). It was also reported that histone 
H4K16 acetylation reduces the propensity for histone H4 N-terminal tail to form an  
α-helix that can dock into an acidic patch groove of the nucleosome, which leads to 
the partial unfolding of chromatin (Yang and Arya, 2011). Interestingly, the class III 
HDAC Sir2 in S. cerevisiae and SirT2 in humans were found to induce chromatin 
condensation in vivo by having some HDAC activity on acetylated histone H4K16 
(Kouzarides, 2007; Vaquero et al., 2007). 
 
In this study, H4Y98A mutant proteins carrying additionally the lysine to alanine and 
lysine to arginine single-point mutations of histone H4 N-terminal lysine residues K5, 
K8, K12, K16 and K20 were also analysed to determine the effects on the histone 
H4Y98A mutant allele. It was found that these mutant proteins complemented the 
genomic deletion of histone H4 to varying degrees, where histone H4 N-terminal 
lysine residues K5, K8 and K12 lysine to alanine and lysine to arginine single-point 
mutant proteins in combination with H4Y98A complemented to a lesser degree as 
compared to histone H4 N-terminal lysine residues K16 and K20 lysine to alanine and 
lysine to arginine single-point mutant proteins in combination with H4Y98A (Figures 
4.26 and 4.27). The additive effect on growth of strains expressing H4Y98A mutant 
proteins carrying additionally the lysine to alanine and lysine to arginine single-point 
mutations of histone H4 N-terminal lysine residues K5, K8 and K12 indicates that 
these three histone H4 N-terminal lysine residues and H4Y98 are likely to function 
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independently of each other. Similarly, the lack of an additive effect on growth of 
strains expressing H4Y98A mutant proteins carrying additionally the lysine to alanine 
and lysine to arginine single-point mutations of histone H4 N-terminal lysine residues 
K16 and K20 indicates that these two histone H4 N-terminal lysine residues and 
H4Y98 are likely not to function independently of each other. 
 
Interestingly, it was found that the H4K12R Y98A double mutant protein was able to 
complement the genomic deletion of histone H4 as well as the H4K16R Y98A and 
H4K20R Y98A double mutant proteins (Figure 4.27). This indicates that H4K12 may 
have some contribution to the recognition of H4K16 or vice versa, where it was 
reported that the acetylation status of both residues may play critical roles in 
transcriptional elongation (Sato et al., 2010). It was also reported that acetylation of 
H4K16 recruits class I HDACs to facilitate the deacetylation of H4K12 (Zhou and 
Grummt, 2005), which indicates a direct association between H4K12ac and H4K16ac 
in S. cerevisiae. 
 
5.3.4 Histone H4 tyrosine residue Y98 and N-terminal lysine residues K8 and K16 in 
relation to the HATs Gcn5, Hpa1 and Hpa2 
Recombinant S. cerevisiae Gcn5 was reported to acetylate H3K14 preferentially and 
H4K8 and K4K16 to a lesser degree in vitro (Kuo et al., 1996). Thus, H4K8 and 
H4K16 lysine to arginine double-point mutant proteins without and with the H4Y98A 
mutation were analysed in this study to determine whether the mutant strains could 
exhibit any observable phenotypes. The H4K8,16R Y98A triple mutant protein was 
unable to complement the genomic deletion of histone H4, while the H4K8,16R 
double mutant protein was able to fully complement the genomic deletion of histone 
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H4 (Figure 4.32). This indicates that H4Y98 is a crucial residue to support cell 
viability, especially when H4K8 and K4K16 undergo mutation such that they cannot 
be acetylated. This also indicates that under normal conditions, H4K8 and K4K16 are 
not acetylated globally in order to maintain cell viability (refer to section 5.3.3). 
 
In this study, it was found that the H4K8,16R double mutant strain exhibited a less 
severe AT phenotype as compared to the H4Y98A mutant strain (Figure 4.33), which 
could not be suppressed by over-expression of the HATs Gcn5, Hpa1 and Hpa2 
(Figure 4.34). This indicates that the HAT activity of Gcn5, Hpa1 and Hpa2 either 
acetylates H4K8 and/or K4K16 or that the H4K8,16R double mutation masked the 
recognition motif required for acetylation to occur at another lysine residue. 
 
In order to determine whether H4K8 and K4K16 are involved in the Gcn4-mediated 
transcriptional activation of the HIS3 gene, the acetylation status of H4K8 and H4K16 
in the WT histone H4 strain and in the H4Y98A mutant strain were analysed in this 
study. It was found that there were no significant differences in the acetylation status 
of H4K8 in the WT histone H4 strain, in the H4Y98A mutant strain and in the 
H4Y98A mutant strain over-expressing the HATs Gcn5, Hpa1 and Hpa2 upon 
histidine starvation (Figures 4.40 and 4.41). It was also found that there were no 
significant differences in the acetylation status of H4K16 in the WT histone H4 strain 
upon histidine starvation (Figures 4.42 and 4.43). Interestingly, the acetylation status 
of H4K16 in the H4Y98A mutant strain decreased significantly upon histidine 
starvation, which was restored by the over-expression of the HATs Gcn5, Hpa1 and 
Hpa2 (Figures 4.42 and 4.43). This indicates that the HATs Gcn5, Hpa1 and Hpa2 
target H4K16 for acetylation and not H4K8 in the H4Y98A mutant strain. In fact, it 
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was reported that H4K8ac and H4K16ac have distinct roles and mark separate regions 
of chromatin as shown in the selective staining of H4K16ac in transcriptionally 
hyperactive X chromosome in male D. melanogaster polytene chromosomes (Turner 
et al., 1992). 
 
5.3.4.1 Recruitment of Gcn5 to the HIS3 locus is dependent on H4Y98 
It was reported that ChIP carried out to compare the occupancy of histone H4 at three 
S. cerevisiae loci — CENIII, GAL10 and PMA1 — showed that there was less 
H4Y98A as compared to WT histone H4 (Yu et al., 2011a). This observation partially 
agreed with the results obtained in this study, where ChIP carried out to compare the 
occupancy of histone H4 at the HIS3 promoter showed that there was less H4Y98A as 
compared to WT histone H4 (Figure 4.47). However, this was not observed at the 
HIS3 ORF, where ChIP demonstrated that there was instead more H4Y98A as 
compared to WT histone H4 (Figure 4.48). 
 
While the observations made at the HIS3 promoter are insufficient to explain the in 
vivo effects of the H4Y98A mutant strain (Figure 4.1) and how these effects are 
rescued upon the over-expression of the HATs Gcn5, Hpa1 and Hpa2 (Figures 4.9 
and 4.10), the observations made at the HIS3 ORF indicate an exciting possibility. In 
the WT histone H4 strain at the HIS3 ORF, the occupancy of Gcn5 increased upon 
histidine starvation (Figure 4.52), while the occupancy of acetylated histone H4K16 
decreased upon histidine starvation (Figure 4.50). As Gcn5 was shown to target 
histone H4K16 for acetylation (Kuo et al., 1996; Figures 4.42 and 4.43), the 
observations made from the ChIP experiment indicated the possibility of histone 
eviction after the acetylation of histone H4K16, where this correlated with the 
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decrease in the occupancy of histone H4 upon histidine starvation (Figure 4.48). Thus, 
it is likely that the higher amount of Gcn5 present at the HIS3 ORF mediated 
increased acetylation of histone H4K16, leading to histone eviction and an overall 
decrease in the amount of histone H4 that reflects an overall decrease in nucleosome 
occupancy. This decrease in nucleosome occupancy upon histidine starvation allows 
for an increase in the expression of the HIS3 gene in the WT histone H4 strain. 
 
It is important to note that histone acetylation leads to eviction, making it difficult to 
correlate the levels of histone H4K16ac occupancy with transcription. In addition, 
phosphorylation of Gcn5 by Snf1 could regulate its enzymatic activity (Liu et al., 
2005), also making it difficult to correlate Gcn5 occupancy with H4 acetylation levels. 
 
Under inducing conditions, there was less Gcn5 at the HIS3 ORF in the H4Y98A 
mutant strain as compared to the WT histone H4 strain (Figure 4.52), which was 
correlated with higher nucleosome occupancy at the HIS3 ORF in the H4Y98A 
mutant strain (Figure 4.48). Thus, it is likely that the lower amount of Gcn5 present at 
the HIS3 ORF resulted in decreased acetylation of histone H4K16, leading to reduced 
histone eviction and an overall increase in the amount of histone H4 that reflects an 
overall increase in nucleosome occupancy. According to this model, the inability of 
the H4Y98A mutant strain to evict histones from the HIS3 ORF upon histidine 
starvation had caused the transcriptional defect of the H4Y98A mutant strain. 
 
The over-expression of Gcn5 led to an increase in the occupancy of Gcn5 at the HIS3 
ORF under inducing conditions (Figure 4.52). This correlated with the decrease in the 
occupancy of histone H4 upon histidine starvation to levels comparable to that of the 
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WT histone H4 strain (Figure 4.48). Thus, it is likely that the higher amount of Gcn5 
present at the HIS3 ORF mediated increased acetylation of histone H4K16, leading to 
histone eviction and an overall decrease in the amount of histone H4 that reflects an 
overall decrease in nucleosome occupancy. Due to this decrease in nucleosome 
occupancy upon histidine starvation, there is an increase in the transcriptional 
activation of the HIS3 gene in the H4Y98A mutant strain over-expressing the HAT 
Gcn5 as compared to the H4Y98A mutant strain. This also indicates that the 
recruitment of Gcn5 to the HIS3 locus is dependent on H4Y98, where H4Y98A 
affects the recruitment of Gcn5 negatively and this effect is restored to WT levels 
upon the over-expression of the HAT Gcn5. 
 
In fact, it was reported that Gcn5, functioning in the SAGA complex, carries out 
histone PTMs and stimulates optimal histone eviction from highly transcribed ORF 
coding sequences, which promotes Pol II elongation (Govind et al., 2007). It was also 
reported that Gcn5 stimulates the eviction of histones that are positioned downstream 
of promoters to allow for efficient Pol II progression (Sansó et al., 2011), where this 
corresponds to the observations made in this study that the effect of Gcn5 over-
expression was more significant at the HIS3 ORF as compared to the HIS3 promoter. 
In addition, it was reported that histone eviction kinetics were delayed in the absence 
of Gcn5 (Wippo et al., 2009), where Gcn5 may function together with the SWI/SNF 
complex to mediate either the sliding of the acetylated nucleosomes or the eviction of 
the histones (Kim et al., 2010). 
 
5.4 Histone H3 and H4 crosstalk 
In this study, combinations of different histone H3 mutants with WT histone H4 or 
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H4Y98A were analysed to elucidate further nuances in histone H3 and H4 crosstalk. 
It was found that all combinations of different histone H3 mutant proteins with WT 
histone H4 protein were able to fully complement the genomic deletion of histone H3 
and H4, except histone H3T118A + histone H4 WT proteins (Figure 4.53). It was also 
found that all combinations of different histone H3 mutant proteins with H4Y98A 
complemented the genomic deletion of histone H3 and H4 to varying degrees, with 
histone H3T118A + histone H4Y98A proteins being the least able to complement 
(Figure 4.53). This indicated that H3T118 is a crucial residue to support cell viability 
and agreed with the previous report that H3T118 may be important for histone H3 and 
H4 crosstalk (Teo, 2008). In fact, H3T118 is a site of phosphorylation and is involved 
in transcriptional regulation and DNA repair (North et al., 2011). H3T118ph was 
found to reduce DNA-histone binding, increase nucleosome mobility and increase 
DNA accessibility near the nucleosome dyad region (North et al., 2011). 
 
Strains expressing combinations of histone H3K4A, H3K14A and H3T32A mutant 
proteins with H4Y98A were found to display the AT phenotype, where the histone 
H3K14A + histone H4Y98A strain exhibited the most severe AT phenotype (Figure 
4.55). This indicates that H3K4, H3K14 and H3T32 may be crucial residues for 
histone H3 and H4 crosstalk to lead to the Gcn4-mediated transcriptional activation of 
the HIS3 gene. An example of histone H3 and H4 crosstalk was previously reported, 
where it was found that the acetylation levels of H3K14 was lower in the H4Y98A 
mutant strain (Teo, 2008). Thus, it is likely that histone H3 and H4 crosstalk may play 
a role in the Gcn4-mediated transcriptional activation of the HIS3 gene, although this 








6.1 Conclusion and future studies 
The HATs Gcn5, Hpa1 and Hpa2 were found to be multi-copy phenotypic 
suppressors of the AT phenotype of the H4Y98A mutant strain. It was found that at 
the HIS3 ORF, there was reduced histidine starvation-induced histone eviction in the 
H4Y98A mutant strain as compared to that of the WT histone H4 strain, which was 
restored to the WT levels upon the over-expression of Gcn5 in the H4Y98A mutant 
strain. 
 
In order to further validate the targeting specificity of the HATs Gcn5, Hpa1 and 
Hpa2 identified in this study, Western blot using antibodies specific to acetylated 
histone H4 N-terminal lysine residues K5, K12 and K20 could be carried out. These 
Western blot results could also be further evaluated through MALDI-TOF mass 
spectrometry analysis or synthetic genetic array analysis. In addition, in vitro 
expression of full length Gcn5 and truncated Gcn5 containing the three functional 
domains — catalytic HAT domain, Ada2 interaction domain and C-terminal 
bromodomain — in separate truncations may elucidate the domain of Gcn5 that is 
affected by the H4Y98A mutation through co-immunoprecipitation studies or crystal 
structure studies. It would also be interesting to determine the induction kinetics at the 
HIS3 locus in the WT histone H4 strain, the H4Y98A mutant strain and the H4Y98A 
mutant strain over-expressing Gcn5. 
 
It was reported that two small molecules 2-methyl-3-carbethoxyquinoline 9 and its  
2-desmethyl analogue 18 have been discovered as inhibitors of Gcn5 (Mai et al., 
2006). This is very exciting news as it shows that there is potential for drug 







Alani E, Cao L, Kleckner N. A method for gene disruption that allows repeated use of 
URA3 selection in the construction of multiply disrupted yeast strains. Genetics. 
1987;116(4):541-5. 
Albaugh BN, Arnold KM, Denu JM. KAT(ching) metabolism by the tail: insight into 
the links between lysine acetyltransferases and metabolism. Chembiochem. 
2011;12(2):290-8. 
Angus-Hill ML, Dutnall RN, Tafrov ST, Sternglanz R, Ramakrishnan V. Crystal 
structure of the histone acetyltransferase Hpa2: A tetrameric member of the Gcn5-
related N-acetyltransferase superfamily. J Mol Biol. 1999;294(5):1311-25. 
Arents G, Burlingame RW, Wang BC, Love WE, Moudrianakis EN. The nucleosomal 
core histone octamer at 3.1 A resolution: a tripartite protein assembly and a left-
handed superhelix. Proc Natl Acad Sci U S A. 1991;88(22):10148-52. 
Atanassov BS, Koutelou E, Dent SY. The role of deubiquitinating enzymes in 
chromatin regulation. FEBS Lett. 2011;585(13):2016-23. 
Ausió J. Histone variants--the structure behind the function. Brief Funct Genomic 
Proteomic. 2006;5(3):228-43. 
Ausubel F, Brent R, Kingston RE, Moore DD, Seifman JG, Smith JA, Struhl K. 2006. 
Current Protocols in Molecular Biology. John Wiley & Sons Inc., New York, NY. 
Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell 
Res. 2011;21(3):381-95. 
Barth TK, Imhof A. Fast signals and slow marks: the dynamics of histone 
modifications. Trends Biochem Sci. 2010;35(11):618-26. 
Bauer UM, Daujat S, Nielsen SJ, Nightingale K, Kouzarides T. Methylation at 
arginine 17 of histone H3 is linked to gene activation. EMBO Rep. 2002;3(1):39-44. 
Baxevanis AD, Landsman D. Homology model building of Hho1p supports its role as 
a yeast histone H1 protein. In Silico Biol. 1998;1(1):5-11. 
Becker PB, Hörz W. ATP-dependent nucleosome remodeling. Annu Rev Biochem. 
2002;71:247-73. 
Belch Y, Yang J, Liu Y, Malkaram SA, Liu R, Riethoven JJ, Ladunga I. Weakly 
positioned nucleosomes enhance the transcriptional competency of chromatin. PLoS 
One. 2010;5(9):e12984. 
Berger SL. Histone modifications in transcriptional regulation. Curr Opin Genet Dev. 
2002;12(2):142-8. 
Berger SL. The complex language of chromatin regulation during transcription. 
Nature. 2007;447(7143):407-12. 
Bernstein BE, Liu CL, Humphrey EL, Perlstein EO, Schreiber SL. Global nucleosome 
occupancy in yeast. Genome Biol. 2004;5(9):R62. 
 191 
 
Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell. 
2007;128(4):669-81. 
Bernstein E, Hake SB. The nucleosome: a little variation goes a long way. Biochem 
Cell Biol. 2006;84(4):505-17. 
Besant PG, Attwood PV. Histone H4 histidine phosphorylation: kinases, phosphatases, 
liver regeneration and cancer. Biochem Soc Trans. 2012;40(1):290-3. 
Bhat RA, Riehl M, Santandrea G, Velasco R, Slocombe S, Donn G, Steinbiss HH, 
Thompson RD, Becker HA. Alteration of GCN5 levels in maize reveals dynamic 
responses to manipulating histone acetylation. Plant J. 2003;33(3):455-69. 
Bhaumik SR, Green MR. SAGA is an essential in vivo target of the yeast acidic 
activator Gal4p. Genes Dev. 2001;15(15):1935-45. 
Bhaumik SR. Distinct regulatory mechanisms of eukaryotic transcriptional activation 
by SAGA and TFIID. Biochim Biophys Acta. 2011;1809(2):97-108. 
Biswas M, Voltz K, Smith JC, Langowski J. Role of histone tails in structural stability 
of the nucleosome. PLoS Comput Biol. 2011;7(12):e1002279. 
Bithell A, Johnson R, Buckley NJ. Transcriptional dysregulation of coding and non-
coding genes in cellular models of Huntington's disease. Biochem Soc Trans. 
2009;37(Pt 6):1270-5. 
Boeger H, Griesenbeck J, Strattan JS, Kornberg RD. Removal of promoter 
nucleosomes by disassembly rather than sliding in vivo. Mol Cell. 2004;14(5):667-73. 
Botstein D, Chervitz SA, Cherry JM. Yeast as a model organism. Science. 
1997;277(5330):1259-60. 
Botstein D, Fink GR. Yeast: an experimental organism for 21st Century biology. 
Genetics. 2011;189(3):695-704. 
Braunstein M, Sobel RE, Allis CD, Turner BM, Broach JR. Efficient transcriptional 
silencing in Saccharomyces cerevisiae requires a heterochromatin histone acetylation 
pattern. Mol Cell Biol. 1996;16(8):4349-56. 
Brown CE, Lechner T, Howe L, Workman JL. The many HATs of transcription 
coactivators. Trends Biochem Sci. 2000;25(1):15-9. 
Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY, Allis CD. 
Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone 
acetylation to gene activation. Cell. 1996;84(6):843-51. 
Burgess RJ, Zhang Z. Roles for Gcn5 in promoting nucleosome assembly and 
maintaining genome integrity. Cell Cycle. 2010;9(15):2979-85. 
Burgess SM, Ajimura M, Kleckner N. GCN5-dependent histone H3 acetylation and 
RPD3-dependent histone H4 deacetylation have distinct, opposing effects on IME2 
 192 
 
transcription, during meiosis and during vegetative growth, in budding yeast. Proc 
Natl Acad Sci U S A. 1999;96(12):6835-40. 
Camporeale G, Shubert EE, Sarath G, Cerny R, Zempleni J. K8 and K12 are 
biotinylated in human histone H4. Eur J Biochem. 2004;271(11):2257-63. 
Candau R, Moore PA, Wang L, Barlev N, Ying CY, Rosen CA, Berger SL. 
Identification of human proteins functionally conserved with the yeast putative 
adaptors ADA2 and GCN5. Mol Cell Biol. 1996;16(2):593-602. 
Candau R, Zhou JX, Allis CD, Berger SL. Histone acetyltransferase activity and 
interaction with ADA2 are critical for GCN5 function in vivo. EMBO J. 
1997;16(3):555-65. 
Chen D, Ma H, Hong H, Koh SS, Huang SM, Schurter BT, Aswad DW, Stallcup MR. 
Regulation of transcription by a protein methyltransferase. Science. 
1999;284(5423):2174-7. 
Chen Y, Sprung R, Tang Y, Ball H, Sangras B, Kim SC, Falck JR, Peng J, Gu W, 
Zhao Y. Lysine propionylation and butyrylation are novel post-translational 
modifications in histones. Mol Cell Proteomics. 2007;6(5):812-9. 
Chen YC, Gatchel JR, Lewis RW, Mao CA, Grant PA, Zoghbi HY, Dent SY. Gcn5 
loss-of-function accelerates cerebellar and retinal degeneration in a SCA7 mouse 
model. Hum Mol Genet. 2012;21(2):394-405. 
Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD. 
Synergistic coupling of histone H3 phosphorylation and acetylation in response to 
epidermal growth factor stimulation. Mol Cell. 2000;5(6):905-15. 
Chi P, Allis CD, Wang GG. Covalent histone modifications--miswritten, 
misinterpreted and mis-erased in human cancers. Nat Rev Cancer. 2010;10(7):457-69. 
Chuang DM, Leng Y, Marinova Z, Kim HJ, Chiu CT. Multiple roles of HDAC 
inhibition in neurodegenerative conditions. Trends Neurosci. 2009;32(11):591-601. 
Cohen I, Poręba E, Kamieniarz K, Schneider R. Histone modifiers in cancer: friends 
or foes? Genes Cancer. 2011;2(6):631-47. 
Cunningham BC, Wells JA. High-resolution epitope mapping of hGH-receptor 
interactions by alanine-scanning mutagenesis. Science. 1989;244(4908):1081-5. 
Dai J, Hyland EM, Yuan DS, Huang H, Bader JS, Boeke JD. Probing nucleosome 
function: a highly versatile library of synthetic histone H3 and H4 mutants. Cell. 
2008;134(6):1066-78. 
Daujat S, Bauer UM, Shah V, Turner B, Berger S, Kouzarides T. Crosstalk between 
CARM1 methylation and CBP acetylation on histone H3. Curr Biol. 
2002;12(24):2090-7. 
Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM. Structure and 
ligand of a histone acetyltransferase bromodomain. Nature. 1999;399(6735):491-6. 
 193 
 
Di Marcotullio L, Canettieri G, Infante P, Greco A, Gulino A. Protected from the 
inside: endogenous histone deacetylase inhibitors and the road to cancer. Biochim 
Biophys Acta. 2011;1815(2):241-52. 
Eberharter A, Sterner DE, Schieltz D, Hassan A, Yates JR 3rd, Berger SL, Workman 
JL. The ADA complex is a distinct histone acetyltransferase complex in 
Saccharomyces cerevisiae. Mol Cell Biol. 1999;19(10):6621-31. 
Edwards CR, Dang W, Berger SL. Histone H4 lysine 20 of Saccharomyces cerevisiae 
is monomethylated and functions in subtelomeric silencing. Biochemistry. 
2011;50(48):10473-83. 
Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects 
for epigenetic therapy. Nature. 2004;429(6990):457-63. 
Felsenfeld G, McGhee JD. Structure of the 30 nm chromatin fiber. Cell. 
1986;44(3):375-7. 
Feng Y, Wang J, Asher S, Hoang L, Guardiani C, Ivanov I, Zheng YG. Histone H4 
acetylation differentially modulates arginine methylation by an in Cis mechanism. J 
Biol Chem. 2011;286(23):20323-34. 
Ferreira R, Eberharter A, Bonaldi T, Chioda M, Imhof A, Becker PB. Site-specific 
acetylation of ISWI by GCN5. BMC Mol Biol. 2007;8:73. 
Fischle W, Wang Y, Allis CD. Histone and chromatin cross-talk. Curr Opin Cell Biol. 
2003;15(2):172-83. 
Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, 
Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Pérez-Rosado A, Calvo E, Lopez 
JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, 
Jenuwein T, Esteller M. Loss of acetylation at Lys16 and trimethylation at Lys20 of 
histone H4 is a common hallmark of human cancer. Nat Genet. 2005;37(4):391-400. 
Freidkin I, Katcoff DJ. Specific distribution of the Saccharomyces cerevisiae linker 
histone homolog HHO1p in the chromatin. Nucleic Acids Res. 2001;29(19):4043-51. 
Frisch SM, Mymryk JS. Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell 
Biol. 2002;3(6):441-52. 
Fujita Y, Morinobu S, Takei S, Fuchikami M, Matsumoto T, Yamamoto S, 
Yamawaki S. Vorinostat, a histone deacetylase inhibitor, facilitates fear extinction 
and enhances expression of the hippocampal NR2B-containing NMDA receptor gene. 
J Psychiatr Res. 2012;46(5):635-43. 
Füllgrabe J, Kavanagh E, Joseph B. Histone onco-modifications. Oncogene. 
2011;30(31):3391-403. 
Garcia BA, Hake SB, Diaz RL, Kauer M, Morris SA, Recht J, Shabanowitz J, Mishra 
N, Strahl BD, Allis CD, Hunt DF. Organismal differences in post-translational 
modifications in histones H3 and H4. J Biol Chem. 2007;282(10):7641-55. 
 194 
 
Gardner KE, Zhou L, Parra MA, Chen X, Strahl BD. Identification of lysine 37 of 
histone H2B as a novel site of methylation. PLoS One. 2011;6(1):e16244. 
Georgakopoulos T, Thireos G. Two distinct yeast transcriptional activators require the 
function of the GCN5 protein to promote normal levels of transcription. EMBO J. 
1992;11(11):4145-52. 
Ghizzoni M, Haisma HJ, Maarsingh H, Dekker FJ. Histone acetyltransferases are 
crucial regulators in NF-κB mediated inflammation. Drug Discov Today. 2011;16(11-
12):504-11. 
Glowczewski L, Yang P, Kalashnikova T, Santisteban MS, Smith MM. Histone-
histone interactions and centromere function. Mol Cell Biol. 2000;20(15):5700-11. 
Godley LA, Le Beau MM. The histone code and treatments for acute myeloid 
leukemia. N Engl J Med. 2012;366(10):960-1. 
Goffrini P, Ferrero I, Donnini C. Respiration-dependent utilisation of sugars in yeasts: 
a determinant role for sugar transporters. J Bacteriol. 2002;184(2):427-32. 
Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 
2007;128(4):635-8. 
Govind CK, Zhang F, Qiu H, Hofmeyer K, Hinnebusch AG. Gcn5 promotes 
acetylation, eviction, and methylation of nucleosomes in transcribed coding regions. 
Mol Cell. 2007;25(1):31-42. 
Grant PA, Berger SL. Histone acetyltransferase complexes. Semin Cell Dev Biol. 
1999;10(2):169-77. 
Grant PA, Duggan L, Côté J, Roberts SM, Brownell JE, Candau R, Ohba R, Owen-
Hughes T, Allis CD, Winston F, Berger SL, Workman JL. Yeast Gcn5 functions in 
two multisubunit complexes to acetylate nucleosomal histones: characterization of an 
Ada complex and the SAGA (Spt/Ada) complex. Genes Dev. 1997;11(13):1640-50. 
Grant PA, Eberharter A, John S, Cook RG, Turner BM, Workman JL. Expanded 
lysine acetylation specificity of Gcn5 in native complexes. J Biol Chem. 
1999;274(9):5895-900. 
Gregory PD, Schmid A, Zavari M, Lui L, Berger SL, Hörz W. Absence of Gcn5 HAT 
activity defines a novel state in the opening of chromatin at the PHO5 promoter in 
yeast. Mol Cell. 1998;1(4):495-505. 
Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 
1997;389(6649):349-52. 
Guillemette B, Drogaris P, Lin HH, Armstrong H, Hiragami-Hamada K, Imhof A, 
Bonneil E, Thibault P, Verreault A, Festenstein RJ. H3 lysine 4 is acetylated at active 




Hahn S, Young ET. Transcriptional regulation in Saccharomyces cerevisiae: 
transcription factor regulation and function, mechanisms of initiation, and roles of 
activators and coactivators. Genetics. 2011;189(3):705-36. 
Hall IM, Shankaranarayana GD, Noma K, Ayoub N, Cohen A, Grewal SI. 
Establishment and maintenance of a heterochromatin domain. Science. 
2002;297(5590):2232-7. 
Hampsey M, Na JG, Pinto I, Ware DE, Berroteran RW. Extragenic suppressors of a 
translation initiation defect in the cyc1 gene of Saccharomyces cerevisiae. Biochimie. 
1991;73(12):1445-55. 
Hampsey M. A review of phenotypes in Saccharomyces cerevisiae. Yeast. 
1997;13(12):1099-133. 
Hanover JA, Krause MW, Love DC. Bittersweet memories: linking metabolism to 
epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol. 2012;13(5):312-21. 
Haqqani AS, Kelly JF, Birnboim HC. Selective nitration of histone tyrosine residues 
in vivo in mutatect tumors. J Biol Chem. 2002;277(5):3614-21. 
Harashima S, Hinnebusch AG. Multiple GCD genes required for repression of GCN4, 
a transcriptional activator of amino acid biosynthetic genes in Saccharomyces 
cerevisiae. Mol Cell Biol. 1986;6(11):3990-8. 
Hargreaves DC, Crabtree GR. ATP-dependent chromatin remodeling: genetics, 
genomics and mechanisms. Cell Res. 2011;21(3):396-420. 
Haring M, Offermann S, Danker T, Horst I, Peterhansel C, Stam M. Chromatin 
immunoprecipitation: optimisation, quantitative analysis and data normalisation. 
Plant Methods. 2007;3:11. 
He H, Lehming N. Global effects of histone modifications. Brief Funct Genomic 
Proteomic. 2003;2(3):234-43. 
Hettmann C, Soldati D. Cloning and analysis of a Toxoplasma gondii histone 
acetyltransferase: a novel chromatin remodelling factor in Apicomplexan parasites. 
Nucleic Acids Res. 1999;27(22):4344-52. 
Hong L, Schroth GP, Matthews HR, Yau P, Bradbury EM. Studies of the DNA 
binding properties of histone H4 amino terminus. Thermal denaturation studies reveal 
that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J Biol 
Chem. 1993;268(1):305-14. 
Horn PJ, Peterson CL. Molecular biology. Chromatin higher order folding--wrapping 
up transcription. Science. 2002;297(5588):1824-7. 




Howe L, Auston D, Grant P, John S, Cook RG, Workman JL, Pillus L. Histone H3 
specific acetyltransferases are essential for cell cycle progression. Genes Dev. 
2001;15(23):3144-54. 
Huang H, Maertens AM, Hyland EM, Dai J, Norris A, Boeke JD, Bader JS. 
HistoneHits: a database for histone mutations and their phenotypes. Genome Res. 
2009;19(4):674-81. 
Huang S, Litt M, Felsenfeld G. Methylation of histone H4 by arginine 
methyltransferase PRMT1 is essential in vivo for many subsequent histone 
modifications. Genes Dev. 2005;19(16):1885-93. 
Huisinga KL, Pugh BF. A genome-wide housekeeping role for TFIID and a highly 
regulated stress-related role for SAGA in Saccharomyces cerevisiae. Mol Cell. 
2004;13(4):573-85. 
Hunter T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell. 
2007;28(5):730-8. 
Iyer V, Struhl K. Poly(dA:dT), a ubiquitous promoter element that stimulates 
transcription via its intrinsic DNA structure. EMBO J. 1995;14(11):2570-9. 
Jacobson RH, Ladurner AG, King DS, Tjian R. Structure and function of a human 
TAFII250 double bromodomain module. Science. 2000;288(5470):1422-5. 
Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074-
80. 
Jenuwein T. Re-SET-ting heterochromatin by histone methyltransferases. Trends Cell 
Biol. 2001;11(6):266-73. 
Jin B, Li Y, Robertson KD. DNA methylation: superior or subordinate in the 
epigenetic hierarchy? Genes Cancer. 2011;2(6):607-17. 
Joo YJ, Kim JH, Kang UB, Yu MH, Kim J. Gcn4p-mediated transcriptional 
repression of ribosomal protein genes under amino-acid starvation. EMBO J. 
2011;30(5):859-72. 
Kamakaka RT, Biggins S. Histone variants: deviants? Genes Dev. 2005;19(3):295-
310. 
Kamieniarz K, Izzo A, Dundr M, Tropberger P, Ozretic L, Kirfel J, Scheer E, Tropel 
P, Wisniewski JR, Tora L, Viville S, Buettner R, Schneider R. A dual role of linker 
histone H1.4 Lys 34 acetylation in transcriptional activation. Genes Dev. 
2012;26(8):797-802. 
Kawano A, Hayashi Y, Noguchi S, Handa H, Horikoshi M, Yamaguchi Y. Global 
analysis for functional residues of histone variant Htz1 using the comprehensive point 
mutant library. Genes Cells. 2011;16(5):590-607. 
 197 
 
Kawashima S, Nakabayashi Y, Matsubara K, Sano N, Enomoto T, Tanaka K, Seki M, 
Horikoshi M. Global analysis of core histones reveals nucleosomal surfaces required 
for chromosome bi-orientation. EMBO J. 2011;30(16):3353-67. 
Keppler BR, Archer TK. Chromatin-modifying enzymes as therapeutic targets--Part 1. 
Expert Opin Ther Targets. 2008a;12(10):1301-12. 
Keppler BR, Archer TK. Chromatin-modifying enzymes as therapeutic targets--Part 2. 
Expert Opin Ther Targets. 2008b;12(11):1457-67. 
Khavari DA, Sen GL, Rinn JL. DNA methylation and epigenetic control of cellular 
differentiation. Cell Cycle. 2010;9(19):3880-3. 
Khorasanizadeh S. The nucleosome: from genomic organization to genomic 
regulation. Cell. 2004;116(2):259-72. 
Kikuchi H, Takami Y, Nakayama T. GCN5: a supervisor in all-inclusive control of 
vertebrate cell cycle progression through transcription regulation of various cell cycle-
related genes. Gene. 2005;347(1):83-97. 
Kim JH, Saraf A, Florens L, Washburn M, Workman JL. Gcn5 regulates the 
dissociation of SWI/SNF from chromatin by acetylation of Swi2/Snf2. Genes Dev. 
2010;24(24):2766-71. 
Kornberg RD, Lorch Y. Twenty-five years of the nucleosome, fundamental particle of 
the eukaryote chromosome. Cell. 1999;98(3):285-94. 
Kouzarides T. Chromatin modifications and their function. Cell. 2007;128(4):693-705. 
Kozak ML, Chavez A, Dang W, Berger SL, Ashok A, Guo X, Johnson FB. 
Inactivation of the Sas2 histone acetyltransferase delays senescence driven by 
telomere dysfunction. EMBO J. 2010;29(1):158-70. 
Krebs AR, Karmodiya K, Lindahl-Allen M, Struhl K, Tora L. SAGA and ATAC 
histone acetyl transferase complexes regulate distinct sets of genes and ATAC defines 
a class of p300-independent enhancers. Mol Cell. 2011;44(3):410-23. 
Kulis M, Esteller M. DNA methylation and cancer. Adv Genet. 2010;70:27-56. 
Kuo MH, Allis CD. Roles of histone acetyltransferases and deacetylases in gene 
regulation. Bioessays. 1998;20(8):615-26. 
Kuo MH, Brownell JE, Sobel RE, Ranalli TA, Cook RG, Edmondson DG, Roth SY, 
Allis CD. Transcription-linked acetylation by Gcn5p of histones H3 and H4 at 
specific lysines. Nature. 1996;383(6597):269-72. 
Kuo MH, vom Baur E, Struhl K, Allis CD. Gcn4 activator targets Gcn5 histone 




Kuo MH, Zhou J, Jambeck P, Churchill ME, Allis CD. Histone acetyltransferase 
activity of yeast Gcn5p is required for the activation of target genes in vivo. Genes 
Dev. 1998;12(5):627-39. 
Kurdistani SK, Grunstein M. Histone acetylation and deacetylation in yeast. Nat Rev 
Mol Cell Biol. 2003;4(4):276-84. 
Kusch T, Florens L, Macdonald WH, Swanson SK, Glaser RL, Yates JR 3rd, Abmayr 
SM, Washburn MP, Workman JL. Acetylation by Tip60 is required for selective 
histone variant exchange at DNA lesions. Science. 2004;306(5704):2084-7. 
Lane AA, Chabner BA. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol. 
2009;27(32):5459-68. 
Lee SYL. (2007). Suppressors of conditional histone H4 mutants. Unpublished 
Honours thesis, Department of Biological Sciences, The National University of 
Singapore. 
Lee TI, Causton HC, Holstege FC, Shen WC, Hannett N, Jennings EG, Winston F, 
Green MR, Young RA. Redundant roles for the TFIID and SAGA complexes in 
global transcription. Nature. 2000;405(6787):701-4. 
Lee TI, Young RA. Transcription of eukaryotic protein-coding genes. Annu Rev 
Genet. 2000;34:77-137. 
Lefèvre F, Rémy MH, Masson JM. Alanine-stretch scanning mutagenesis: a simple 
and efficient method to probe protein structure and function. Nucleic Acids Res. 
1997;25(2):447-8. 
Li A, Yu Y, Lee SC, Ishibashi T, Lees-Miller SP, Ausió J. Phosphorylation of histone 
H2A.X by DNA-dependent protein kinase is not affected by core histone acetylation, 
but it alters nucleosome stability and histone H1 binding. J Biol Chem. 
2010;285(23):17778-88. 
Li F, Lu J, Han Q, Zhang G, Huang B. The Elp3 subunit of human Elongator complex 
is functionally similar to its counterpart in yeast. Mol Genet Genomics. 
2005;273(3):264-72. 
Li G, Reinberg D. Chromatin higher-order structures and gene regulation. Curr Opin 
Genet Dev. 2011;21(2):175-86. 
Li X, Wong J, Tsai SY, Tsai MJ, O'Malley BW. Progesterone and glucocorticoid 
receptors recruit distinct coactivator complexes and promote distinct patterns of local 
chromatin modification. Mol Cell Biol. 2003;23(11):3763-73. 
Liu Y, Xu X, Singh-Rodriguez S, Zhao Y, Kuo MH. Histone H3 Ser10 
phosphorylation-independent function of Snf1 and Reg1 proteins rescues a gcn5- 
mutant in HIS3 expression. Mol Cell Biol. 2005;25(23):10566-79. 
Ljungdahl PO, Daignan-Fornier B. Regulation of amino acid, nucleotide, and 
phosphate metabolism in Saccharomyces cerevisiae. Genetics. 2012;190(3):885-929. 
 199 
 
Lo WS, Trievel RC, Rojas JR, Duggan L, Hsu JY, Allis CD, Marmorstein R, Berger 
SL. Phosphorylation of serine 10 in histone H3 is functionally linked in vitro and in 
vivo to Gcn5-mediated acetylation at lysine 14. Mol Cell. 2000;5(6):917-26. 
Losa R, Omari S, Thoma F. Poly(dA).poly(dT) rich sequences are not sufficient to 
exclude nucleosome formation in a constitutive yeast promoter. Nucleic Acids Res. 
1990;18(12):3495-502. 
Lu X, Simon MD, Chodaparambil JV, Hansen JC, Shokat KM, Luger K. The effect of 
H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin 
structure. Nat Struct Mol Biol. 2008;15(10):1122-4. 
Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of 
the nucleosome core particle at 2.8 A resolution. Nature. 1997;389(6648):251-60. 
Lusser A, Kadonaga JT. Chromatin remodeling by ATP-dependent molecular 
machines. Bioessays. 2003;25(12):1192-200. 
Mai A, Rotili D, Tarantino D, Ornaghi P, Tosi F, Vicidomini C, Sbardella G, 
Nebbioso A, Miceli M, Altucci L, Filetici P. Small-molecule inhibitors of histone 
acetyltransferase activity: identification and biological properties. J Med Chem. 
2006;49(23):6897-907. 
Mai X, Chou S, Struhl K. Preferential accessibility of the yeast his3 promoter is 
determined by a general property of the DNA sequence, not by specific elements. Mol 
Cell Biol. 2000;20(18):6668-76. 
Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone 
code? Curr Opin Genet Dev. 2005;15(2):163-76. 
Mariño-Ramírez L, Kann MG, Shoemaker BA, Landsman D. Histone structure and 
nucleosome stability. Expert Rev Proteomics. 2005;2(5):719-29. 
Marmorstein R, Roth SY. Histone acetyltransferases: function, structure, and catalysis. 
Curr Opin Genet Dev. 2001;11(2):155-61. 
Martens JA, Winston F. Recent advances in understanding chromatin remodeling by 
Swi/Snf complexes. Curr Opin Genet Dev. 2003;13(2):136-42. 
Martens JH, Stunnenberg HG, Logie C. The decade of the epigenomes? Genes 
Cancer. 2011;2(6):680-7. 
Martinato F, Cesaroni M, Amati B, Guccione E. Analysis of Myc-induced histone 
modifications on target chromatin. PLoS One. 2008;3(11):e3650. 
Matsubara K, Sano N, Umehara T, Horikoshi M. Global analysis of functional 
surfaces of core histones with comprehensive point mutants. Genes Cells. 
2007;12(1):13-33. 
McCusker JH, Haber JE. crl mutants of Saccharomyces cerevisiae resemble both 
mutants affecting general control of amino acid biosynthesis and omnipotent 
translational suppressor mutants. Genetics. 1988;119(2):317-27. 
 200 
 
Meda F, Folci M, Baccarelli A, Selmi C. The epigenetics of autoimmunity. Cell Mol 
Immunol. 2011;8(3):226-36. 
Messner S, Altmeyer M, Zhao H, Pozivil A, Roschitzki B, Gehrig P, Rutishauser D, 
Huang D, Caflisch A, Hottiger MO. PARP1 ADP-ribosylates lysine residues of the 
core histone tails. Nucleic Acids Res. 2010;38(19):6350-62. 
Millar CB, Grunstein M. Genome-wide patterns of histone modifications in yeast. Nat 
Rev Mol Cell Biol. 2006;7(9):657-66. 
Morris KV. siRNA-mediated transcriptional gene silencing: the potential mechanism 
and a possible role in the histone code. Cell Mol Life Sci. 2005;62(24):3057-66. 
Muller S, Filippakopoulos P, Knapp S. Bromodomains as therapeutic targets. Expert 
Rev Mol Med. 2011;13:e29. 
Murr R. Interplay between different epigenetic modifications and mechanisms. Adv 
Genet. 2010;70:101-41. 
Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate 
chromatin structure and transcription. Cell. 2002;108(4):475-87. 
Nasmyth KA, Reed SI. Isolation of genes by complementation in yeast: molecular 
cloning of a cell-cycle gene. Proc Natl Acad Sci U S A. 1980;77(4):2119-23. 
Nelson CJ, Santos-Rosa H, Kouzarides T. Proline isomerization of histone H3 
regulates lysine methylation and gene expression. Cell. 2006;126(5):905-16. 
Neuwald AF, Landsman D. GCN5-related histone N-acetyltransferases belong to a 
diverse superfamily that includes the yeast SPT10 protein. Trends Biochem Sci. 
1997;22(5):154-5. 
Nishioka K, Rice JC, Sarma K, Erdjument-Bromage H, Werner J, Wang Y, Chuikov 
S, Valenzuela P, Tempst P, Steward R, Lis JT, Allis CD, Reinberg D. PR-Set7 is a 
nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is 
associated with silent chromatin. Mol Cell. 2002;9(6):1201-13. 
North JA, Javaid S, Ferdinand MB, Chatterjee N, Picking JW, Shoffner M, Nakkula 
RJ, Bartholomew B, Ottesen JJ, Fishel R, Poirier MG. Phosphorylation of histone 
H3(T118) alters nucleosome dynamics and remodeling. Nucleic Acids Res. 
2011;39(15):6465-74. 
Nowak SJ, Corces VG. Phosphorylation of histone H3: a balancing act between 
chromosome condensation and transcriptional activation. Trends Genet. 
2004;20(4):214-20. 
Oettinger MA, Struhl K. Suppressors of Saccharomyces cerevisiae his3 promoter 
mutations lacking the upstream element. Mol Cell Biol. 1985;5(8):1901-9. 




Otero G, Fellows J, Li Y, de Bizemont T, Dirac AM, Gustafsson CM, Erdjument-
Bromage H, Tempst P, Svejstrup JQ. Elongator, a multisubunit component of a novel 
RNA polymerase II holoenzyme for transcriptional elongation. Mol Cell. 
1999;3(1):109-18. 
Panzeter PL, Zweifel B, Malanga M, Waser SH, Richard M, Althaus FR. Targeting of 
histone tails by poly(ADP-ribose). J Biol Chem. 1993;268(24):17662-4. 
Paolinelli R, Mendoza-Maldonado R, Cereseto A, Giacca M. Acetylation by GCN5 
regulates CDC6 phosphorylation in the S phase of the cell cycle. Nat Struct Mol Biol. 
2009;16(4):412-20. 
Park S, Hanekamp T, Thorsness MK, Thorsness PE. Yme2p is a mediator of nucleoid 
structure and number in mitochondria of the yeast Saccharomyces cerevisiae. Curr 
Genet. 2006;50(3):173-82. 
Parthun MR. Hat1: the emerging cellular roles of a type B histone acetyltransferase. 
Oncogene. 2007;26(37):5319-28. 
Peng Z, Mizianty MJ, Xue B, Kurgan L, Uversky VN. More than just tails: intrinsic 
disorder in histone proteins. Mol Biosyst. 2012;8(7):1886-901. 
Pérez-Martín J, Johnson AD. Mutations in chromatin components suppress a defect of 
Gcn5 protein in Saccharomyces cerevisiae. Mol Cell Biol. 1998;18(2):1049-54. 
Peterson CL, Laniel MA. Histones and histone modifications. Curr Biol. 
2004;14(14):R546-51. 
Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and 
diseases. Nature. 2010;465(7299):721-7. 
Phillips DM. The presence of acetyl groups of histones. Biochem J. 1963;87:258-63. 
Phizicky EM, Fields S. Protein-protein interactions: methods for detection and 
analysis. Microbiol Rev. 1995;59(1):94-123. 
Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, Lee TI, Bell GW, 
Walker K, Rolfe PA, Herbolsheimer E, Zeitlinger J, Lewitter F, Gifford DK, Young 
RA. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell. 
2005;122(4):517-27. 
Pollard KJ, Peterson CL. Role for ADA/GCN5 products in antagonizing chromatin-
mediated transcriptional repression. Mol Cell Biol. 1997;17(11):6212-22. 
Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 
2010;28(10):1057-68. 
Pray-Grant MG, Daniel JA, Schieltz D, Yates JR 3rd, Grant PA. Chd1 chromodomain 




Pray-Grant MG, Schieltz D, McMahon SJ, Wood JM, Kennedy EL, Cook RG, 
Workman JL, Yates JR 3rd, Grant PA. The novel SLIK histone acetyltransferase 
complex functions in the yeast retrograde response pathway. Mol Cell Biol. 
2002;22(24):8774-86. 
Prelich G. Gene overexpression: uses, mechanisms, and interpretation. Genetics. 
2012;190(3):841-54. 
Qian C, Zhou MM. SET domain protein lysine methyltransferases: Structure, 
specificity and catalysis. Cell Mol Life Sci. 2006;63(23):2755-63. 
Qiu H, Hu C, Zhang F, Hwang GJ, Swanson MJ, Boonchird C, Hinnebusch AG. 
Interdependent recruitment of SAGA and Srb mediator by transcriptional activator 
Gcn4p. Mol Cell Biol. 2005;25(9):3461-74. 
Ramachandran S, Vogel L, Strahl BD, Dokholyan NV. Thermodynamic stability of 
histone H3 is a necessary but not sufficient driving force for its evolutionary 
conservation. PLoS Comput Biol. 2011;7(1):e1001042. 
Rando OJ, Winston F. Chromatin and transcription in yeast. Genetics. 
2012;190(2):351-87. 
Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun ZW, Schmid M, Opravil S, 
Mechtler K, Ponting CP, Allis CD, Jenuwein T. Regulation of chromatin structure by 
site-specific histone H3 methyltransferases. Nature. 2000;406(6796):593-9. 
Recht J, Osley MA. Mutations in both the structured domain and N-terminus of 
histone H2B bypass the requirement for Swi-Snf in yeast. EMBO J. 1999;18(1):229-
40. 
Reinke H, Hörz W. Histones are first hyperacetylated and then lose contact with the 
activated PHO5 promoter. Mol Cell. 2003;11(6):1599-607. 
Rice JC, Allis CD. Histone methylation versus histone acetylation: new insights into 
epigenetic regulation. Curr Opin Cell Biol. 2001;13(3):263-73. 
Robert F, Pokholok DK, Hannett NM, Rinaldi NJ, Chandy M, Rolfe A, Workman JL, 
Gifford DK, Young RA. Global position and recruitment of HATs and HDACs in the 
yeast genome. Mol Cell. 2004;16(2):199-209. 
Rosaleny LE, Ruiz-García AB, García-Martínez J, Pérez-Ortín JE, Tordera V. The 
Sas3p and Gcn5p histone acetyltransferases are recruited to similar genes. Genome 
Biol. 2007;8(6):R119. 
Ross CA, Shoulson I. Huntington disease: pathogenesis, biomarkers, and approaches 
to experimental therapeutics. Parkinsonism Relat Disord. 2009;15 Suppl 3:S135-8. 
Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu Rev Biochem. 
2001;70:81-120. 
Ruiz-García AB, Sendra R, Pamblanco M, Tordera V. Gcn5p is involved in the 
acetylation of histone H3 in nucleosomes. FEBS Lett. 1997;403(2):186-90. 
 203 
 
Sakamoto M, Noguchi S, Kawashima S, Okada Y, Enomoto T, Seki M, Horikoshi M. 
Global analysis of mutual interaction surfaces of nucleosomes with comprehensive 
point mutants. Genes Cells. 2009;14(11):1271-330. 
Sampley ML, Ozcan S. Regulation of insulin gene transcription by multiple histone 
acetyltransferases. DNA Cell Biol. 2012;31(1):8-14. 
Sansó M, Vargas-Pérez I, Quintales L, Antequera F, Ayté J, Hidalgo E. Gcn5 
facilitates Pol II progression, rather than recruitment to nucleosome-depleted stress 
promoters, in Schizosaccharomyces pombe. Nucleic Acids Res. 2011;39(15):6369-79. 
Santisteban MS, Arents G, Moudrianakis EN, Smith MM. Histone octamer function 
in vivo: mutations in the dimer-tetramer interfaces disrupt both gene activation and 
repression. EMBO J. 1997;16(9):2493-506. 
Santisteban MS, Kalashnikova T, Smith MM. Histone H2A.Z regulates transcription 
and is partially redundant with nucleosome remodeling complexes. Cell. 
2000;103(3):411-22. 
Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, 
Schreiber SL, Mellor J, Kouzarides T. Active genes are tri-methylated at K4 of 
histone H3. Nature. 2002;419(6905):407-11. 
Sarfstein R, Bruchim I, Fishman A, Werner H. The mechanism of action of the 
histone deacetylase inhibitor vorinostat involves interaction with the insulin-like 
growth factor signaling pathway. PLoS One. 2011;6(9):e24468. 
Sarg B, Helliger W, Talasz H, Koutzamani E, Lindner HH. Histone H4 
hyperacetylation precludes histone H4 lysine 20 trimethylation. J Biol Chem. 
2004;279(51):53458-64. 
Sato L, Noguchi S, Hayashi Y, Sakamoto M, Horikoshi M. Global analysis of 
functional relationships between histone point mutations and the effects of histone 
deacetylase inhibitors. Genes Cells. 2010;15(6):553-94. 
Sawan C, Herceg Z. Histone modifications and cancer. Adv Genet. 2010;70:57-85. 
Schiltz RL, Mizzen CA, Vassilev A, Cook RG, Allis CD, Nakatani Y. Overlapping 
but distinct patterns of histone acetylation by the human coactivators p300 and PCAF 
within nucleosomal substrates. J Biol Chem. 1999;274(3):1189-92. 
Selvi BR, Cassel JC, Kundu TK, Boutillier AL. Tuning acetylation levels with HAT 
activators: therapeutic strategy in neurodegenerative diseases. Biochim Biophys Acta. 
2010;1799(10-12):840-53. 
Shahbazian MD, Zhang K, Grunstein M. Histone H2B ubiquitylation controls 
processive methylation but not monomethylation by Dot1 and Set1. Mol Cell. 
2005;19(2):271-7. 
Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL. Histone H4-




Shogren-Knaak M, Peterson CL. Switching on chromatin: mechanistic role of histone 
H4-K16 acetylation. Cell Cycle. 2006;5(13):1361-5. 
Singh RK, Gunjan A. Histone tyrosine phosphorylation comes of age. Epigenetics. 
2011;6(2):153-60. 
Sinha SC, Chaudhuri BN, Burgner JW, Yakovleva G, Davisson VJ, Smith JL. Crystal 
structure of imidazole glycerol-phosphate dehydratase: duplication of an unusual fold. 
J Biol Chem. 2004;279(15):15491-8. 
Smith CM, Gafken PR, Zhang Z, Gottschling DE, Smith JB, Smith DL. Mass 
spectrometric quantification of acetylation at specific lysines within the amino-
terminal tail of histone H4. Anal Biochem. 2003;316(1):23-33. 
Smith ER, Belote JM, Schiltz RL, Yang XJ, Moore PA, Berger SL, Nakatani Y, Allis 
CD. Cloning of Drosophila GCN5: conserved features among metazoan GCN5 family 
members. Nucleic Acids Res. 1998;26(12):2948-54. 
Smith ER, Pannuti A, Gu W, Steurnagel A, Cook RG, Allis CD, Lucchesi JC. The 
drosophila MSL complex acetylates histone H4 at lysine 16, a chromatin modification 
linked to dosage compensation. Mol Cell Biol. 2000;20(1):312-8. 
Smith MM, Santisteban MS. Genetic dissection of histone function. Methods. 
1998;15(4):269-81. 
Spedale G, Timmers HT, Pijnappel WW. ATAC-king the complexity of SAGA 
during evolution. Genes Dev. 2012;26(6):527-41. 
Stebbing J, Bower M, Syed N, Smith P, Yu V, Crook T. Epigenetics: an emerging 
technology in the diagnosis and treatment of cancer. Pharmacogenomics. 
2006;7(5):747-57. 
Sterner DE, Belotserkovskaya R, Berger SL. SALSA, a variant of yeast SAGA, 
contains truncated Spt7, which correlates with activated transcription. Proc Natl Acad 
Sci U S A. 2002a;99(18):11622-7. 
Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. 
Microbiol Mol Biol Rev. 2000;64(2):435-59. 
Sterner DE, Grant PA, Roberts SM, Duggan LJ, Belotserkovskaya R, Pacella LA, 
Winston F, Workman JL, Berger SL. Functional organization of the yeast SAGA 
complex: distinct components involved in structural integrity, nucleosome acetylation, 
and TATA-binding protein interaction. Mol Cell Biol. 1999;19(1):86-98. 
Sterner DE, Nathan D, Reindle A, Johnson ES, Berger SL. Sumoylation of the yeast 
Gcn5 protein. Biochemistry. 2006;45(3):1035-42. 
Sterner DE, Wang X, Bloom MH, Simon GM, Berger SL. The SANT domain of 
Ada2 is required for normal acetylation of histones by the yeast SAGA complex. J 
Biol Chem. 2002b;277(10):8178-86. 
 205 
 
Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 
2000;403(6765):41-5. 
Struhl K. Constitutive and inducible Saccharomyces cerevisiae promoters: evidence 
for two distinct molecular mechanisms. Mol Cell Biol. 1986;6(11):3847-53. 
Struhl K. Nucleotide sequence and transcriptional mapping of the yeast pet56-his3-
ded1 gene region. Nucleic Acids Res. 1985;13(23):8587-601. 
Sujatha S, Ishihama A, Chatterji D. Functional complementation between mutations 
at two distant positions in Escherichia coli RNA polymerase as revealed by second-
site suppression. Mol Gen Genet. 2001;264(5):531-8. 
Suka N, Luo K, Grunstein M. Sir2p and Sas2p opposingly regulate acetylation of 
yeast histone H4 lysine16 and spreading of heterochromatin. Nat Genet. 
2002;32(3):378-83. 
Suka N, Suka Y, Carmen AA, Wu J, Grunstein M. Highly specific antibodies 
determine histone acetylation site usage in yeast heterochromatin and euchromatin. 
Mol Cell. 2001;8(2):473-9. 
Sun WJ, Zhou X, Zheng JH, Lu MD, Nie JY, Yang XJ, Zheng ZQ. Histone 
acetyltransferases and deacetylases: molecular and clinical implications to 
gastrointestinal carcinogenesis. Acta Biochim Biophys Sin (Shanghai). 2012;44(1):80-
91. 
Sun ZW, Allis CD. Ubiquitination of histone H2B regulates H3 methylation and gene 
silencing in yeast. Nature. 2002;418(6893):104-8. 
Syntichaki P, Thireos G. The Gcn5.Ada complex potentiates the histone 
acetyltransferase activity of Gcn5. J Biol Chem. 1998;273(38):24414-9. 
Teo SHR. (2008). Genetic analysis of histone mutants (Mechanisms of suppression of 
conditional histone alleles). Unpublished UROPS thesis, Department of Microbiology, 
The National University of Singapore. 
Timmermann S, Lehrmann H, Polesskaya A, Harel-Bellan A. Histone acetylation and 
disease. Cell Mol Life Sci. 2001;58(5-6):728-36. 
Tsaprouni LG, Ito K, Powell JJ, Adcock IM, Punchard N. Differential patterns of 
histone acetylation in inflammatory bowel diseases. J Inflamm (Lond). 2011;8(1):1. 
Tse C, Georgieva EI, Ruiz-García AB, Sendra R, Hansen JC. Gcn5p, a transcription-
related histone acetyltransferase, acetylates nucleosomes and folded nucleosomal 
arrays in the absence of other protein subunits. J Biol Chem. 1998;273(49):32388-92. 
Turner BM, Birley AJ, Lavender J. Histone H4 isoforms acetylated at specific lysine 
residues define individual chromosomes and chromatin domains in Drosophila 
polytene nuclei. Cell. 1992;69(2):375-84. 
Turner BM. Defining an epigenetic code. Nat Cell Biol. 2007;9(1):2-6. 
 206 
 
Turner BM. Histone acetylation and an epigenetic code. Bioessays. 2000;22(9):836-
45. 
Turner EL, Malo ME, Pisclevich MG, Dash MD, Davies GF, Arnason TG, Harkness 
TA. The Saccharomyces cerevisiae anaphase-promoting complex interacts with 
multiple histone-modifying enzymes to regulate cell cycle progression. Eukaryot Cell. 
2010;9(10):1418-31. 
Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological 
diseases: genes, syndromes, and therapies. Lancet Neurol. 2009;8(11):1056-72. 
Ushinsky SC, Bussey H, Ahmed AA, Wang Y, Friesen J, Williams BA, Storms RK. 
Histone H1 in Saccharomyces cerevisiae. Yeast. 1997;13(2):151-61. 
Vakoc CR, Mandat SA, Olenchock BA, Blobel GA. Histone H3 lysine 9 methylation 
and HP1gamma are associated with transcription elongation through mammalian 
chromatin. Mol Cell. 2005;19(3):381-91. 
van den Brink J, Akeroyd M, van der Hoeven R, Pronk JT, de Winde JH, Daran-
Lapujade P. Energetic limits to metabolic flexibility: responses of Saccharomyces 
cerevisiae to glucose-galactose transitions. Microbiology. 2009;155(Pt 4):1340-50. 
Van Den Broeck A, Brambilla E, Moro-Sibilot D, Lantuejoul S, Brambilla C, Eymin 
B, Khochbin S, Gazzeri S. Loss of histone H4K20 trimethylation occurs in 
preneoplasia and influences prognosis of non-small cell lung cancer. Clin Cancer Res. 
2008;14(22):7237-45. 
VanDemark AP, Kasten MM, Ferris E, Heroux A, Hill CP, Cairns BR. 
Autoregulation of the rsc4 tandem bromodomain by gcn5 acetylation. Mol Cell. 
2007;27(5):817-28. 
Vaquero A, Sternglanz R, Reinberg D. NAD+-dependent deacetylation of H4 lysine 
16 by class III HDACs. Oncogene. 2007;26(37):5505-20. 
Vernarecci S, Tosi F, Filetici P. Tuning acetylated chromatin with HAT inhibitors: a 
novel tool for therapy. Epigenetics. 2010;5(2):105-11. 
Villeneuve LM, Reddy MA, Natarajan R. Epigenetics: deciphering its role in diabetes 
and its chronic complications. Clin Exp Pharmacol Physiol. 2011;38(7):451-9. 
Waggoner D. Mechanisms of disease: epigenesis. Semin Pediatr Neurol. 
2007;14(1):7-14. 
Waldmann T, Izzo A, Kamieniarz K, Richter F, Vogler C, Sarg B, Lindner H, Young 
NL, Mittler G, Garcia BA, Schneider R. Methylation of H2AR29 is a novel repressive 
PRMT6 target. Epigenetics Chromatin. 2011;4:11. 
Wang H, Cao R, Xia L, Erdjument-Bromage H, Borchers C, Tempst P, Zhang Y. 
Purification and functional characterization of a histone H3-lysine 4-specific 
methyltransferase. Mol Cell. 2001;8(6):1207-17. 
 207 
 
Winkler GS, Kristjuhan A, Erdjument-Bromage H, Tempst P, Svejstrup JQ. Elongator 
is a histone H3 and H4 acetyltransferase important for normal histone acetylation 
levels in vivo. Proc Natl Acad Sci U S A. 2002;99(6):3517-22. 
Winkler GS, Petrakis TG, Ethelberg S, Tokunaga M, Erdjument-Bromage H, Tempst 
P, Svejstrup JQ. RNA polymerase II elongator holoenzyme is composed of two 
discrete subcomplexes. J Biol Chem. 2001;276(35):32743-9. 
Wippo CJ, Krstulovic BS, Ertel F, Musladin S, Blaschke D, Stürzl S, Yuan GC, Hörz 
W, Korber P, Barbaric S. Differential cofactor requirements for histone eviction from 
two nucleosomes at the yeast PHO84 promoter are determined by intrinsic 
nucleosome stability. Mol Cell Biol. 2009;29(11):2960-81. 
Wittschieben BO, Fellows J, Du W, Stillman DJ, Svejstrup JQ. Overlapping roles for 
the histone acetyltransferase activities of SAGA and elongator in vivo. EMBO J. 
2000;19(12):3060-8. 
Wittschieben BO, Otero G, de Bizemont T, Fellows J, Erdjument-Bromage H, Ohba 
R, Li Y, Allis CD, Tempst P, Svejstrup JQ. A novel histone acetyltransferase is an 
integral subunit of elongating RNA polymerase II holoenzyme. Mol Cell. 
1999;4(1):123-8. 
Wolffe AP. Centromeric chromatin. Histone deviants. Curr Biol. 1995;5(5):452-4. 
Wood CM, Nicholson JM, Lambert SJ, Chantalat L, Reynolds CD, Baldwin JP. High-
resolution structure of the native histone octamer. Acta Crystallogr Sect F Struct Biol 
Cryst Commun. 2005;61(Pt 6):541-5. 
Xu EY, Bi X, Holland MJ, Gottschling DE, Broach JR. Mutations in the nucleosome 
core enhance transcriptional silencing. Mol Cell Biol. 2005;25(5):1846-59. 
Xu K, Dai XL, Huang HC, Jiang ZF. Targeting HDACs: a promising therapy for 
Alzheimer's disease. Oxid Med Cell Longev. 2011;2011:143269. 
Xu W, Edmondson DG, Roth SY. Mammalian GCN5 and P/CAF acetyltransferases 
have homologous amino-terminal domains important for recognition of nucleosomal 
substrates. Mol Cell Biol. 1998;18(10):5659-69. 
Yang D, Arya G. Structure and binding of the H4 histone tail and the effects of lysine 
16 acetylation. Phys Chem Chem Phys. 2011;13(7):2911-21. 
Yang X, Yu W, Shi L, Sun L, Liang J, Yi X, Li Q, Zhang Y, Yang F, Han X, Zhang 
D, Yang J, Yao Z, Shang Y. HAT4, a Golgi apparatus-anchored B-type histone 
acetyltransferase, acetylates free histone H4 and facilitates chromatin assembly. Mol 
Cell. 2011;44(1):39-50. 
Ye J, Ai X, Eugeni EE, Zhang L, Carpenter LR, Jelinek MA, Freitas MA, Parthun 
MR. Histone H4 lysine 91 acetylation a core domain modification associated with 
chromatin assembly. Mol Cell. 2005;18(1):123-30. 
Yu Q, Kuzmiak H, Zou Y, Olsen L, Defossez PA, Bi X. Saccharomyces cerevisiae 
linker histone Hho1p functionally interacts with core histone H4 and negatively 
 208 
 
regulates the establishment of transcriptionally silent chromatin. J Biol Chem. 
2009;284(2):740-50. 
Yu Q, Olsen L, Zhang X, Boeke JD, Bi X. Differential contributions of histone H3 
and H4 residues to heterochromatin structure. Genetics. 2011b;188(2):291-308. 
Yu Y, Srinivasan M, Nakanishi S, Leatherwood J, Shilatifard A, Sternglanz R. A 
conserved patch near the C terminus of histone H4 is required for genome stability in 
budding yeast. Mol Cell Biol. 2011a;31(11):2311-25. 
Zegerman P, Canas B, Pappin D, Kouzarides T. Histone H3 lysine 4 methylation 
disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor 
complex. J Biol Chem. 2002;277(14):11621-4. 
Zhang H, Han J, Kang B, Burgess R, Zhang Z. Human histone acetyltransferase 1 
protein preferentially acetylates H4 histone molecules in H3.1-H4 over H3.3-H4. J 
Biol Chem. 2012;287(9):6573-81. 
Zhang K, Sridhar VV, Zhu J, Kapoor A, Zhu JK. Distinctive core histone post-
translational modification patterns in Arabidopsis thaliana. PLoS One. 
2007;2(11):e1210. 
Zhang K, Williams KE, Huang L, Yau P, Siino JS, Bradbury EM, Jones PR, Minch 
MJ, Burlingame AL. Histone acetylation and deacetylation: identification of 
acetylation and methylation sites of HeLa histone H4 by mass spectrometry. Mol Cell 
Proteomics. 2002;1(7):500-8. 
Zhang W, Bone JR, Edmondson DG, Turner BM, Roth SY. Essential and redundant 
functions of histone acetylation revealed by mutation of target lysines and loss of the 
Gcn5p acetyltransferase. EMBO J. 1998;17(11):3155-67. 
Zhou Y, Grummt I. The PHD finger/bromodomain of NoRC interacts with acetylated 
histone H4K16 and is sufficient for rDNA silencing. Curr Biol. 2005;15(15):1434-8. 
Zhu B, Reinberg D. Epigenetic inheritance: uncontested? Cell Res. 2011;21(3):435-41. 
Zippo A, Serafini R, Rocchigiani M, Pennacchini S, Krepelova A, Oliviero S. Histone 
crosstalk between H3S10ph and H4K16ac generates a histone code that mediates 
transcription elongation. Cell. 2009;138(6):1122-36. 
Zweidler A. Role of individual histone tyrosines in the formation of the nucleosome 








8.1 Gene derivatives of Bank 13 (YEp13) tested in the phenotypic assay 
Table 8.1 Gene derivatives of Bank 13 (YEp13) 
Vector Gene derivatives 
YEp13 CCT6ΔC + YDR187C + YDR186CΔN 





 YNL305C + MRPS18 
 
8.2 Genes inserted into PactT424 and PactT424-HA tested in the phenotypic assay 
Table 8.2 Genes inserted into PactT424 and PactT424-HA 
Vector Insert Vector Insert 
PactT424 ESA1 PactT424-HA ESA1 
 GCN5  GCN5 
 HAT1  HAT1 
 HAT2  HAT2 
 HPA1  HPA1 
 HPA2  HPA2 
 HPA3  HPA3 
 RTT109  RTT109 
 SAS2  SAS2 
   HHF1 WT 
   HHF1 Y98A 
   HHF1 Y98D 
   HHF1 Y98F 
 
8.3 HHF1 WT and mutant genes inserted into YCplac22 tested in the phenotypic 
assay 
Table 8.3 HHF1 WT and mutant genes inserted into YCplac22 
Vector HHF1 Insert 
YCplac22 HHF1 WT 
 HHF1 Y51A 
 HHF1 E53A 
 HHF1 Y98A 
 HHF1 K5A 
 HHF1 K5A Y98A 
 HHF1 K8A 
 HHF1 K8A Y98A 
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Vector HHF1 Insert 
 HHF1 K12A 
 HHF1 K12A Y98A 
 HHF1 K16A 
 HHF1 K16A Y98A 
 HHF1 K20A 
 HHF1 K20A Y98A 
 HHF1 K5,8,12A 
 HHF1 K5,8,12A Y98A 
 HHF1 K5,8,12,16A 
 HHF1 K5,8,12,16A Y98A 
 HHF1 K5,8,12,20A 
 HHF1 K5,8,12,20A Y98A 
 
8.4 HHT1 WT and mutant genes inserted into YCplac111 tested in the phenotypic 
assay 
Table 8.4 HHT1 WT and mutant genes inserted into YCplac111 
Vector HHT1 Insert 
YCplac111 HHT1 WT 
 HHT1 K4A 
 HHT1 K14A 
 HHT1 T32A 
 HHT1 T118A 
 
8.5 HHF1 WT and mutant genes inserted into YCplac111 tested in the phenotypic 
assay 
Table 8.5 HHF1 WT and mutant genes inserted into YCplac111 
Vector HHF1 Insert 
YCplac111 HHF1 WT 
 HHF1 Y51A 
 HHF1 Y72A 
 HHF1 Y88A 
 HHF1 Y98A 
 HHF1 Y98D 
 HHF1 Y98F 
 HHF1 K5A 
 HHF1 K5A Y98A 
 HHF1 K5R 
 HHF1 K5R Y98A 
 HHF1 K8A 
 HHF1 K8A Y98A 
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Vector HHF1 Insert 
 HHF1 K8R 
 HHF1 K8R Y98A 
 HHF1 K12A 
 HHF1 K12A Y98A 
 HHF1 K12R 
 HHF1 K12R Y98A 
 HHF1 K16A 
 HHF1 K16A Y98A 
 HHF1 K16R 
 HHF1 K16R Y98A 
 HHF1 K20A 
 HHF1 K20A Y98A 
 HHF1 K20R 
 HHF1 K20R Y98A 
 HHF1 K8,16R 
 HHF1 K8,16R Y98A 
 HHF1 K5,8,12A 
 HHF1 K5,8,12A Y98A 
 HHF1 K5,8,12,16A 
 HHF1 K5,8,12,16A Y98A 
 HHF1 K5,8,12,20A 
 HHF1 K5,8,12,20A Y98A 
 HHF1 K5 K8,12,16,20R 
 HHF1 K5 K8,12,16,20R Y98A 
 HHF1 K8 K5,12,16,20R 
 HHF1 K8 K5,12,16,20R Y98A 
 HHF1 K12 K5,8,16,20R 
 HHF1 K12 K5,8,16,20R Y98A 
 HHF1 K16 K5,8,12,20R 
 HHF1 K16 K5,8,12,20R Y98A 
 HHF1 K20 K5,8,12,16R 
 HHF1 K20 K5,8,12,16R Y98A 
 HHF1 K5,8,12,16,20R 
 HHF1 K5,8,12,16,20R Y98A 
 
8.6 Genes inserted into YEplac181 tested in the phenotypic assay 



















8.7 Primers used for amplification of candidate suppressor genes in one-step PCR 
Table 8.7 Primers used for amplification of candidate suppressor genes in one-
step PCR 
Gene Primer name Sequence 
ATC1 5’ATC1pro-EcoRI GCCGAATTCTGTCTGGTGTTCCGAC 
 3’ATC1ter-SalI GCCGTCGACACATTCGAAATAAGAAAG 
HPA2 5’HPA2pro-HindIII GCCAAGCTTCCAACTACAAGTAATG 
 3’HPA2ter-BamHI TGGCACGCTGTTAGGATCCA 
HPA3 5’HPA3pro-EcoRI GCCGAATTCAGGTTAGCATGCCGT 
 3’HPA3ter-SalI GCCGTCGACAACCTCTTCAAATTC 
MCK1 5’MCK1pro-HindIII GCCAAGCTTCCCTCTTTCCCAATTCA 
 3’MCK1ter-BamHI CTTCGAGGATCCCGAATCTG 
YAP1 5’YAP1pro-HindIII GCCAAGTTTATCGGAAACGGCAG 
 3’YAP1ter-BamHI GGATCCCAAGGTAGTTACGATACTC 
YHR151C 5’YHR151Cpro-HindIII GCCAAGGGCTGACCTCCTAAAAAC 
 3’YHR151Cter-BamHI GGATCCCTTCTCGTGTCGTTAAG 
 
8.8 Preparation of DH5α E. coli 
1. Inoculate one colony of DH5α E. coli in 15 ml LB+300 μl 1 M magnesium 
sulphate (MgSO4) and incubate at 37°C for more than 12 h at 200 rpm. 
2. Inoculate 5 ml of culture in two sterile 2 L flasks containing 500 ml LB+10 ml 
1 M MgSO4 each and incubate at 37°C until OD600 = 0.5–0.7. 
3. Transfer cultures into ice chilled 200 ml bottles and leave on ice for 5 min to stop 
cells from growing. 
4. Centrifuge at 8000 rpm for 15 min at 4°C, remove supernatant and resuspend 
cells in cold TFBI solution (30 ml/bottle), then combine contents. 
5. Centrifuge at 8000 rpm for 10 min at 4°C, remove supernatant and resuspend 
cells in cold TFBII solution (20 ml/bottle), then prepare aliquots as required. 
6. Store DH5α E. coli at -80°C. 
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7. Incubate streaked cells on LB, LB+ampicillin and LB+chloramphenicol at 37°C 
for more than 12 h to check for contamination. 
 
Table 8.8 Preparation of TFBI and TFBII solutions 
TFBI solution (pH5.8) TFBII solution (pH6.5) 
Constituent Amount Constituent Amount 
Potassium acetate (KOAc) 2.944 g MOPS 1.047 g 
Rubidium chloride (RbCl) 1.209 g RbCl 0.605 g 
Calcium chloride (CaCl2) 1.47 g CaCl2 5.513 g 
Manganese chloride 
(MnCl2) 
9.895 g Deionised water Top up to 300 ml 
Deionised water Top up to 600 ml 100 % Glycerol 75 ml 
100 % Glycerol 150 ml Deionised water Top up to 450 ml 
Deionised water Top up to 850 ml 1 M Potassium 
hydroxide (KOH) 
Adjust to pH6.5 
1 M Acetic acid Adjust to pH5.8 Deionised water Top up to 500 ml 
Deionised water Top up to 
1000 ml 
Mix and autoclave 
Mix and autoclave 
 
8.9 Preparation of LB media 
Table 8.9 Preparation of LB media 
Constituent Amount 
Tryptone 10 g 
Yeast extract 5 g 
Sodium chloride (NaCl) 5 g 
5 N Sodium hydroxide (NaOH) Adjust to pH7.0 
 
1. For broth, add deionised water to final volume of 1 L, stir till homogeneous and 
autoclave. 
2. For plate, add deionised water to volume of 500 ml and stir till homogeneous. In 
a separate bottle, measure 15 g/L Bacto Agar and add deionised water to volume 
of 500 ml. Autoclave, cool at 55°C to prevent solidification of agar and mix the 
contents of both bottles. 
3. For LB+ampicillin, add 2 ml Amp 1000X stock (2.5 g Amp in 50 ml sterile water) 
to autoclaved 1 L LB media. 
4. For LB+chloramphenicol, add 4 ml Chl 500X stock (2.5 g Chl in 250 ml 100 % 
EtOH) to autoclaved 1 L LB media. 
 215 
 
8.10 Preparation of DH10β E. coli 
1. Inoculate one colony of DH10β E. coli in 10 ml LB and incubate at 37°C for 
more than 12 h at 200 rpm. 
2. Inoculate 5 ml of culture in two sterile 2 L flasks containing 500 ml LB each and 
incubate at 37°C until OD600 = 0.5–0.7. 
3. Transfer cultures into ice chilled 200 ml bottles and leave on ice for 15 min to 
stop cells from growing. 
4. Centrifuge at 8000 rpm for 5 min at 4°C, remove supernatant and resuspend cells 
in 5 ml ice cold sterile water, then top up with 150 ml ice cold sterile water. 
5. Centrifuge at 8000 rpm for 5 min at 4°C, remove supernatant and resuspend cells 
in 5 ml ice cold sterile water, then combine contents and top up with 150 ml ice 
cold sterile water. 
6. Centrifuge at 8000 rpm for 5 min at 4°C, remove supernatant and resuspend cells 
in 100 ml ice cold 10 % glycerol. 
7. Centrifuge at 8000 rpm for 5 min at 4°C, remove supernatant and resuspend cells 
in equal volume ice cold 10 % glycerol, then prepare aliquots as required. 
8. Store DH10β E. coli at -80°C. 
9. Incubate streaked cells on LB, LB+ampicillin and LB+chloramphenicol at 37°C 
for more than 12 h to check for contamination. 
 
8.11 Preparation of miniprep solutions 
Table 8.10 Preparation of miniprep solution I (cell suspension buffer) 
Constituent Amount 
1 M Tris-HCl (pH7.5) 25 ml 
0.5 M Ethylenediaminetetraacetic acid 
(EDTA) (pH8.0) 
10 ml 
Deionised water 465 ml 
Mix and autoclave 
10 μg/ml RNase A 25 mg to be added after autoclaving 
 
Table 8.11 Preparation of miniprep solution II (cell lysis buffer) 
Constituent Amount 
Sterile water 430 ml 
5 N NaOH 20 ml 
10 % SDS 50 ml 
Do not autoclave and add in the above order to prevent precipitation 
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Table 8.12 Preparation of miniprep solution III (cell neutralisation buffer) 
Constituent Amount 
KOAc 65 g 
Deionised water Top up to 200 ml 
100 % Acetic acid Adjust to pH4.8 
Deionised water Top up to 500 ml 
Mix and autoclave 
 
8.12 Preparation of 10X loading dye 
Table 8.13 Preparation of 10X loading dye 
Constituent Amount 
100 % Glycerol 550 μl 
0.5 M EDTA (pH8.0) 200 μl 
1 % Bromophenol blue (BPB) 250 μl 
 
8.13 Preparation of yeast extract peptone dextrose adenine (YPDA) 
Table 8.14 Preparation of YPDA 
Constituent Amount 
Yeast extract 10 g 
Peptone 20 g 
Glucose 20 g 
Adenine 0.04 g 
 
1. For broth, add deionised water to final volume of 1 L, stir till homogeneous and 
autoclave. 
2. For plate, add deionised water to volume of 500 ml and stir till homogeneous. In 
a separate bottle, measure 15 g/L Bacto Agar and add deionised water to volume 
of 500 ml. Autoclave, cool at 55°C to prevent solidification of agar and mix the 
contents of both bottles. 
 
8.14 Preparation of glucose/galactose complete or selective media 
Table 8.15 Preparation of glucose/galactose media 
Constituent Amount 
Glucose/galactose 20 g 
Yeast nitrogen base 7 g 
Amino acid premix (composition varies for different selective media) 0.7 g 
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1. For broth, add deionised water to final volume of 1 L, stir till homogeneous and 
autoclave. 
2. For plate, add deionised water to volume of 500 ml and stir till homogeneous. In 
a separate bottle, measure 15 g/L Bacto Agar and add deionised water to volume 
of 500 ml. Autoclave, cool at 55°C to prevent solidification of agar and mix the 
contents of both bottles. 
3. For media containing 5-fluoro-orotic acid (5-FOA), add 0.85 g 5-FOA per 1 L 
media and filter sterilise, instead of autoclaving. 
4. For media containing 3-amino-1,2,4-triazole (3-AT, Sigma-Aldrich), add 3-AT 
powder as follows per 500 ml media and filter sterilise, instead of autoclaving. 
a. 10 mM AT: 0.420 g 3-AT powder 
b. 50 mM AT: 2.102 g 3-AT powder 
c. 100 mM AT: 4.204 g 3-AT powder 
5. For media containing Antimycin A (AA, Merck), add 1 ml AA stock per 1 L 
media after autoclaving, where the AA stock is prepared by adding 1 mg AA to 
1 ml 100 % ethanol. 
6. For media containing copper sulphate (CuSO4), add 1 ml 100 mM CuSO4 stock 
per 1 L media after autoclaving. 
 
8.15 Preparation of 0.1 M LiAc 
Table 8.16 Preparation of 0.1 M LiAc 
Constituent Amount 
1 M LiAc 5 ml 
10X TE buffer 5 ml 
Sterile water 40 ml 
 
1. For 1 M LiAc stock, add 51 g LiAc to 500 ml deionised water and autoclave. 
2. For 10X TE buffer stock, add 50 ml 1 M Tris-HCl (pH7.5) and 10 ml 0.5 M 






8.16 Preparation of 40 % PEG 
Table 8.17 Preparation of 40 % PEG 
Constituent Amount 
50 % PEG 40 ml 
1 M LiAc 5 ml 
10X TE Buffer 5 ml 
 
1. For 50 % PEG stock, add 250 g PEG to 500 ml deionised water and autoclave. 
 
8.17 Preparation of yeast breaking buffer 
Table 8.18 Preparation of yeast breaking buffer 
Constituent Amount 
Triton X-100 10 ml 
10 % SDS 50 ml 
5 M NaCl 10 ml 
1 M Tris-HCl (pH8.0) 5 ml 
0.5 M EDTA (pH8.0) 1 ml 
Deionised water Top up to 500 ml 
Mix and autoclave 
 
8.18 Preparation of FA gel solutions 
Table 8.19 Preparation of 10X FA gel buffer 
Constituent Amount 
3-[N-morpholino]propanesulfonic acid (MOPS) 83.704 g 
EDTA 2.9224 g 
NaAc 8.203 g 
RNase-free water Top up to 1 L 
Mix and dissolve completely 
 
Table 8.20 Preparation of 1X FA gel running buffer 
Constituent Amount 
10X FA gel buffer 100 ml 
37 % formaldehyde 20 ml 





8.19 Preparation of SDS polyacrylamide denaturing gel 
Table 8.21 Preparation of 4 % stacking gel 
Constituent Amount for two gels 
Sterile water 4.5 ml 
30 % Acrylamide/Bis-acrylamide, 29:1 1.0 ml 
0.5 M Tris HCl (pH6.8) 1.875 ml 
10 % SDS 75 µl 




7.5 µl (added last to avoid premature 
solidification) 
 
Table 8.22 Preparation of resolving gels of varying percentages 
Constituent Amount for two gels 
10 % gel 12 % gel 18 % gel 
Sterile water 8.0 ml 6.6 ml 2.6 ml 
30 % Acrylamide/Bis-acrylamide, 29:1 6.6 ml 8.0 ml 12.0 ml 
1.5 M Tris HCl (pH8.8) 5.0 ml 5.0 ml 5.0 ml 
10 % SDS 200 µl 200 µl 200 µl 
10 % APS 200 µl 200 µl 200 µl 
TEMED 8 µl 8 µl 8 µl 
 
8.20 Preparation of 5X Western blot transfer buffer 
Table 8.23 Preparation of 5X Western blot transfer buffer 
Constituent Amount 
Tris 14.5 g 
Glycine 72.5 g 
10 % SDS 2.5 g 
Sterile water 500 ml 
 
8.21 Preparation of TBST 
Table 8.24 Preparation of TBST 
Constituent Amount 
1 M Tris-HCl (pH7.4) 100 ml 
5 M NaCl 30 ml 
10 % Tween-20 10 ml 
Sterile water 860 ml 




8.22 Preparation of Coomassie Blue staining solution and destaining solution 
Table 8.25 Preparation of Coomassie Blue staining solution 
Constituent Amount 
Sterile water 40 ml 
Methanol 50 ml 
Acetic acid 10 ml 
Coomassie brilliant blue R-250 0.05 g 
 
Table 8.26 Preparation of destaining solution 
Constituent Amount 
Sterile water 225 ml 
Methanol 225 ml 
Acetic acid 50 ml 
 
8.23 Preparation of yeast lysis buffer 
Table 8.27 Preparation of yeast lysis buffer 
Constituent Amount 
50 % NP40 1 ml 
1 M KCl 25 ml 
1 M Tris HCl (pH7.4) 50 ml 
0.5 M EDTA (pH8.0) 1 ml 
Deionised water Top up to 500 ml 
Mix and autoclave 
 
8.24 Preparation of pronase working buffer 
Table 8.28 Preparation of pronase working buffer 
Constituent Amount 
1 M Tris HCl (pH7.4) 5 ml 
10 % SDS 2.5 ml 
Sterile water 42.5 ml 
 
8.25 Preparation of immunoprecipitation buffers 
Table 8.29 Preparation of yeast lysis buffer with 0.5 M NaCl 
Constituent Amount 
Yeast lysis buffer 45 ml 
5 M NaCl 5 ml 
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Table 8.30 Preparation of ChIP wash buffer 
Constituent Amount 
1 M Tris-HCl (pH7.5) 5 ml 
1 M Lithium chloride (LiCl) 125 ml 
50 % NP40 5 ml 
50 % sodium deoxycholate 5 ml 
Sterile water 360 ml 
 
Table 8.31 Preparation of 1X TE buffer 
Constituent Amount 
10X TE buffer 5 ml 
Sterile water 45 ml 
 
Table 8.32 Preparation of ChIP elution buffer 
Constituent Amount 
1 M Tris-HCl (pH7.5) 25 ml 
0.5 M EDTA (pH8.0) 10 ml 
10 % SDS 50 ml 
Sterile water 415 ml 
 
8.26 Data for HIS3 mRNA expression levels 







∆Ct 2(-∆Ct) Sample:WT 0h Standard 
deviation 
WT 0h 20.90 24.32 3.42 0.09 1.00 0.00 
WT 2h 20.43 21.85 1.41 0.38 4.03 -0.76 
Y98A 0h 17.95 15.31 -2.64 6.22 0.97 -0.04 
Y98A 2h 19.66 17.04 -2.63 6.18 0.97 -0.03 
Y98A+Gcn5 0h 21.45 24.94 3.49 0.09 0.95 -0.43 
Y98A+Gcn5 2h 22.03 24.01 1.98 0.25 2.72 0.62 
Y98A+Hpa1 0h 21.10 24.04 2.94 0.13 1.40 0.23 
Y98A+Hpa1 2h 20.49 23.15 2.66 0.16 1.70 -0.37 
Y98A+Hpa2 0h 22.93 26.34 3.41 0.09 1.01 -1.28 
Y98A+Hpa2 2h 25.09 27.65 2.56 0.17 1.82 -2.18 
Y98A+Hpa3 0h 22.10 26.30 4.20 0.05 0.58 -0.27 





8.27 Data for ImageJ quantification of the acetylation status of H4K8 
Table 8.34 ImageJ quantification of the acetylation status of H4K8 
Strain H4K8 H4 H4K8:H4 Relative to WT 0h 
WT 0h 14704.44 25406.87 0.58 1.00 
WT 2h 20183.89 27883.77 0.72 1.25 
Y98A 0h 17439.05 22156.97 0.79 1.36 
Y98A 2h 20805.53 26513.14 0.78 1.36 
Y98A+Gcn5 0h 17168.85 19707.21 0.87 1.51 
Y98A+Gcn5 2h 21104.65 28462.42 0.74 1.28 
     
Y98A+Gcn5 0h 29059.97 16250.39 1.79 3.09 
Y98A+Gcn5 2h 33417.82 20567.92 1.62 2.81 
Y98A+Hpa1 0h 28778.50 16236.39 1.77 3.06 
Y98A+Hpa1 2h 27505.65 22223.05 1.24 2.14 
Y98A+Hpa2 0h 30149.17 17703.87 1.70 2.94 
Y98A+Hpa2 2h 27888.48 23496.84 1.19 2.05 
 
8.28 Data for ImageJ quantification of the acetylation status of H4K16 
Table 8.35 ImageJ quantification of the acetylation status of H4K16 
Strain H4K16 H4 H4K16:H4 Relative to WT 0h 
WT 0h 7684.59 11150.49 0.69 1.00 
WT 2h 9383.13 14595.85 0.64 0.93 
Y98A 0h 7962.42 12121.95 0.66 0.95 
Y98A 2h 1861.26 13820.56 0.13 0.20 
Y98A+Gcn5 0h 9160.30 14820.02 0.62 0.90 
Y98A+Gcn5 2h 7935.76 13870.68 0.57 0.83 
     
Y98A+Gcn5 0h 22152.12 16545.68 1.34 1.94 
Y98A+Gcn5 2h 22966.41 21957.41 1.05 1.52 
Y98A+Hpa1 0h 19270.95 17053.22 1.13 1.64 
Y98A+Hpa1 2h 21740.45 22986.05 0.95 1.37 
Y98A+Hpa2 0h 23074.26 18250.87 1.26 1.83 
Y98A+Hpa2 2h 22678.43 24592.97 0.92 1.34 
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